Unnamed: 0,title,date,stock,sentiment
1162372.0,Regeneron Highlights Collaborations on Dupixent During Sanofi R&D Investor Event,2020-06-11 05:55:00-04:00,SNY,neutral
1162373.0,"The Daily Biotech Pulse: Keytruda Setback For Merck, Denali Pulls The Plug On Neurological Asset",2020-06-10 07:30:00-04:00,SNY,positive
1162374.0,"Denali Therapeutics Intends To Accelerate DNL78 For Development, Plans To Initiate Clinical Testing By Early 2021; Safety Endpoints Were Met In Phase 1B",2020-06-09 16:31:00-04:00,SNY,positive
1162375.0,"The Daily Biotech Pulse: Soleno Flunks Late-Stage Study, Sanofi Strikes Breast Cancer Partnership, NanoViricides Shortlists Coronavirus Treatment Candidates",2020-06-09 07:46:00-04:00,SNY,negative
1162376.0,"Alphamab Oncology, Sanofi Enter Collaboration on KN026 in HER2+ Breast Cancer",2020-06-09 05:51:00-04:00,SNY,negative
1162377.0,4 Analysts On Why The Rumored AstraZeneca-Gilead Deal Is Unlikely To Materialize,2020-06-08 18:26:00-04:00,SNY,neutral
1162378.0,Revisiting The Coronavirus Vaccine Race: Updates On The 10 Candidates In Clinics,2020-06-03 17:53:00-04:00,SNY,neutral
1162379.0,"Sanofi's CEO On Cancer Research, Coronavirus Vaccine Progress",2020-06-02 16:51:00-04:00,SNY,negative
1162380.0,"U.S. Army Planning To Test Vaccines From Moderna, Astrazeneca, Johnson & Johnson And Sanofi; Army Will Test Its Own Vaccine Candidate In Human Trials Later This Summer",2020-06-02 12:03:00-04:00,SNY,neutral
1162381.0,"Sanofi Reports Sarclisa Combo Therapy Showed Superior Progression-Free Survival, Clinically Meaningful Depth Of Response In Patients With Relapsed Multiple Myeloma",2020-06-02 09:02:00-04:00,SNY,positive
1162382.0,Sanofi CEO Says Human Clinical Trials For COVID-19 Vaccine Will Be Towards The End Of The Year,2020-06-02 07:46:00-04:00,SNY,neutral
1162383.0,"The Daily Biotech Pulse: FDA Nod For Roche's Combo Therapy In Liver Cancer, Allena Rips Higher, Pfizer To Invest Up To $500M In Biotechs",2020-06-02 07:45:00-04:00,SNY,negative
1162384.0,UPDATE: Sanofi Says Has Put Hydroxychloroquine For Off-Label Use To Treat Coronavirus Patients Until Safety Concerns Cleared By WHO,2020-05-29 12:02:00-04:00,SNY,positive
1162385.0,Sanofi Suspends Recruitment Of New Patients In Hydroxychloroquine Coronavirus Trials,2020-05-29 12:02:00-04:00,SNY,neutral
1162386.0,Sanofi Reports Libtayo Longer-Term Results In Advanced Cutaneous Squamous Cell Carcinoma Presented At ASCO Show Durable Responses,2020-05-29 08:09:00-04:00,SNY,positive
1162387.0,"Shares of several healthcare companies are trading higher amid market strength. Strength potentially related to coronavirus efforts including testing, vaccine development and treatment measures from several names in the sector.",2020-05-28 12:33:00-04:00,SNY,positive
1162388.0,"The Daily Biotech Pulse: Cumberland's Positive Anti-Bacterial Readout, FDA Nods For Bristol-Myers, Astellas",2020-05-27 07:25:00-04:00,SNY,positive
1162389.0,11.8M Share Secondary Offering of Regeneron Common Stock Held by Sanofi Priced $515/Share,2020-05-27 05:50:00-04:00,SNY,positive
1162390.0,'List of external participants expected at Rose Garden event starting momentarily where @POTUS will announce @MedicareGov patients will be provided with new choices of Part D plans for insulin at no more than $35 for a month's supply.' -Steve Herman Tweet,2020-05-26 16:13:00-04:00,SNY,negative
1162391.0,Cannabis Company Aphria To Switch Listing From NYSE To Nasdaq,2020-05-26 12:41:00-04:00,SNY,neutral
1162392.0,"Benzinga Pro's Top 5 Stocks To Watch For Tues., May 26, 2020: NVAX, EWJ, SNY, SOXX, MRK",2020-05-26 08:13:00-04:00,SNY,positive
1162393.0,Sanofi Currently Holds ~20.6% of Regeneron's Capital,2020-05-25 12:54:00-04:00,SNY,neutral
1162394.0,Sanofi Says Business EPS Expected to Grow by ~5% in 2020 at Constant Exchange Rate,2020-05-25 12:52:00-04:00,SNY,neutral
1162395.0,Regeneron Announces Secondary Offering of its Common Stock Held by Sanofi and $5B Stock Repurchase,2020-05-25 12:45:00-04:00,SNY,neutral
1162396.0,The Week Ahead In Biotech: ASCO Presentations In The Spotlight,2020-05-24 14:40:00-04:00,SNY,neutral
1162397.0,"US Says Will Test Experimental Coronavirus Vaccines In 100,000+ People, Health Official Says Oxford Vaccine May Be Tested ""Side By Side"" With Moderna's Starting In July",2020-05-22 13:50:00-04:00,SNY,neutral
1162398.0,Checkpoint Therapeutics CEO On Tapping Into A $25 Billion Cancer Treatment Market,2020-05-20 08:33:00-04:00,SNY,negative
1162399.0,Telemedicine A COVID-19 Winner,2020-05-19 16:46:00-04:00,SNY,positive
1162400.0,"These 6 Coronavirus Vaccine Candidates Are The Likeliest To Succeed, Says Morgan Stanley",2020-05-18 12:07:00-04:00,SNY,positive
1162401.0,Sanofi Chair Says Its Coronavirus Vaccine Would Be Made Available To All Regions At The Same Time,2020-05-14 14:24:00-04:00,SNY,neutral
1162402.0,Sanofi CEO SAys Has Been Campaigning For Months To Be Ready For Vaccine Development,2020-05-14 10:18:00-04:00,SNY,positive
1162403.0,"The Daily Biotech Pulse: ASCO Abstracts Create Stock Ripples, Applied DNA's Coronavirus Test Receives EUA, Biopharmx Shareholders Vet Reverse Merger",2020-05-14 08:32:00-04:00,SNY,positive
1162404.0,Sanofi CEO Says US To Get Co.'s Coronavirus Vaccine First If It Succeeds,2020-05-13 09:12:00-04:00,SNY,positive
1162405.0,Novavax Analysts Say CEPI Funding 'Speaks Volumes' About Coronavirus Vaccine Development,2020-05-12 14:08:00-04:00,SNY,neutral
1162406.0,"The Daily Biotech Pulse: NASH Disappointment For Genfit, Novavax Lands $384M CEPI Funding For Coronavirus Vaccine, GW Pharma Earnings",2020-05-12 08:06:00-04:00,SNY,negative
1162407.0,"Benzinga Pro's Top 5 Stocks To Watch for Wed., May 6, 2020: SNY, GRUB, CLVS, NTDOY, FDS",2020-05-06 08:02:00-04:00,SNY,positive
1162408.0,UPDATE: Sanofi Says Has Started To Discuss Advance Purchases With Several Countries Including US,2020-05-05 17:46:00-04:00,SNY,neutral
1162409.0,UPDATE: Sanofi Says Trials Will Enroll Thousands Of Patients Globally,2020-05-05 17:45:00-04:00,SNY,neutral
1162410.0,Sanofi Says Has Trials Of Coronavirus Vaccine Candidate In Development With GlaxoSmithKline,2020-05-05 17:45:00-04:00,SNY,neutral
1162411.0,"The Daily Biotech Pulse: Bio-Rad's Coronavirus Test Gets EUA, Beat-And-Raise Quarter From GenMark, Adverum's Positive Gene Therapy Readout",2020-05-05 08:00:00-04:00,SNY,positive
1162412.0,Regeneron and Sanofi Announce Libtayo Shows Clinically-Meaningful and Durable Responses in Second-line Advanced Basal Cell Carcinoma,2020-05-05 05:30:00-04:00,SNY,positive
1162413.0,Sanofi shares are trading higher potentially after the company received a positive opinion from the CHMP for its insulin aspart biosimilar rival to competitor Novo Nordisk's NovoRapid.,2020-05-04 08:56:00-04:00,SNY,positive
1162414.0,Attention Biotech Investors: Mark Your Calendar For These May PDUFA Dates,2020-05-03 09:25:00-04:00,SNY,neutral
1162415.0,Why Regeneron's Stock Is Trading Lower Today,2020-04-27 10:51:00-04:00,SNY,negative
1162416.0,"Sanofi shares are trading higher after the company's Phase 2/3 trial of Kevzara with Regeneron met its primary endpoint. NOTE: The drug showed potential for treating the sickest coronavirus patients, but less benefit in patients with less-advanced disease.",2020-04-27 10:09:00-04:00,SNY,positive
1162417.0,Sanofi and Regeneron Say its Phase 2/3 Adaptive-Designed Trial of Kevzara in Hospitalized Coronavirus Patients Met its Primary Endpoint,2020-04-27 07:01:00-04:00,SNY,neutral
1162418.0,"The Week Ahead In Biotech (April 26-May 2): Cancer Conference, Earnings News Flow In The Spotlight",2020-04-26 16:37:00-04:00,SNY,negative
1162419.0,Sanofi shares are trading higher after the company reported better-than-expected Q1 EPS and sales results.,2020-04-24 10:39:00-04:00,SNY,positive
1162420.0,"Sanofi Earlier Reported Q1 EPS $1.800 Beats $1.280 Estimate, Sales $9.897B Beat $9.720B Estimate",2020-04-24 10:38:00-04:00,SNY,neutral
1162421.0,"The Daily Biotech Pulse: FDA Approves Sanofi's Meningococcal Vaccine, Pluristem Secures $54M In Funding For COVID-19 Treatment, Oric Pharma Prices IPO",2020-04-24 08:38:00-04:00,SNY,positive
1162422.0,"A Peek Into The Markets: US Stock Futures Up Ahead Of Verizon, American Express Earnings",2020-04-24 05:59:00-04:00,SNY,neutral
1162423.0,"Earnings Scheduled For April 24, 2020",2020-04-24 04:17:00-04:00,SNY,neutral
1162424.0,"The Daily Biotech Pulse: FDA Nod For Immunomedics, Lilly's Solid Q1 Beat, Predictive Oncology Restructures Debt",2020-04-23 07:53:00-04:00,SNY,negative
1162425.0,"The Week Ahead In Biotech (April 19-25): Eli Lilly, Biogen Earnings On Tap, Sanofi Awaits FDA Decision",2020-04-19 17:22:00-04:00,SNY,positive
1162426.0,Gilead's Encouraging Remdesivir Data: Rapid Reaction On The Stock,2020-04-16 19:10:00-04:00,SNY,positive
1162427.0,"Sanofi, Luminostics To Work On Smartphone-Based COVID-19 Self-Testing App",2020-04-16 09:17:00-04:00,SNY,neutral
1162428.0,Sanofi shares are treading higher after the company reported a partnership with Luminostics to develop a coronavirus smartphone-based self-testing solution.,2020-04-16 09:14:00-04:00,SNY,positive
1162429.0,Sanofi Reports Partnership With Luminostics To Develop Breakthrough Coronavirus Smartphone-Based Self-Testing Solution,2020-04-16 08:02:00-04:00,SNY,positive
1162430.0,Shares of several healthcare companies are trading higher as markets gain on positive coronavirus outlook. Other potential positive sector catalysts include demand for therapies and medical supplies amid the coronavirus pandemic.,2020-04-14 10:59:00-04:00,SNY,positive
1162431.0,"GlaxoSmithKline, Sanofi Collaborate On COVID-19 Vaccine Development: What You Should Know",2020-04-14 09:31:00-04:00,SNY,neutral
1162432.0,"The Daily Biotech Pulse: Amarin Reports Strong Q1 Vascepa Sales, BeiGene Aces Late-Stage Lung Cancer Study, Glaxo, Sanofi Strike COVID-19 Vaccine Partnership",2020-04-14 07:59:00-04:00,SNY,negative
1162433.0,Sanofi shares are trading higher after the company announced a coronavirus vaccine collaboration with GlaxoSmithKline.,2020-04-14 07:17:00-04:00,SNY,positive
1162434.0,"Sanofi And GlaxoSmithKline Announce Coronavirus Vaccine Collaboration, Expected To Start Trials In 2H 2020",2020-04-14 07:02:00-04:00,SNY,neutral
1162435.0,"Sanofi CEO Talks Coronavirus Vaccine Development, Potential Treatment",2020-04-08 15:07:00-04:00,SNY,neutral
1162436.0,"The Daily Biotech Pulse: Sanofi, Regeneron Finalize Praluent Restructuring, Natus Pre-Announces Q1 Shortfall, Alcon To Delay Dividend Initiation",2020-04-07 07:55:00-04:00,SNY,negative
1162437.0,Sanofi Finalizes Praluent Restructuring With Regeneron,2020-04-06 17:01:00-04:00,SNY,neutral
1162438.0,Sanofi Reports Successfully Priced Tap Offerings For €500M In Notes ON 2 Outstanding Tranches,2020-04-06 14:14:00-04:00,SNY,positive
1162439.0,Shares of several healthcare companies are trading higher as markets gain amid optimism that coronavirus cases in several US hotspots may be peaking. A sooner peak could mean a sooner return to economic activity.,2020-04-06 09:42:00-04:00,SNY,positive
1162440.0,"The Daily Biotech Pulse: Fate Therapeutics Inks Cell Therapy Deal With J&J, Zentalis IPO",2020-04-03 07:36:00-04:00,SNY,neutral
1162441.0,Sanofi Reports Dupixent Phase 3 Data Show Significant Improvement in Severe Atopic Dermatitis for Children Aged 6 to 11 Years,2020-04-03 05:24:00-04:00,SNY,positive
1162442.0,"Sanofi Says Decided In February To Produce Hydroxychloroquine At Maximum Capacity, Says Company Operating At More Than 93% Capacity, Keeps Building Inventory; Shared Hydroxychloroquine Data With Other Companies To Ensure Best Possible Patient Access",2020-04-02 16:14:00-04:00,SNY,positive
1162443.0,FDA Requests Removal Of All Ranitidine Products (Zantac) From The Market,2020-04-01 10:50:00-04:00,SNY,neutral
1162444.0,Shares of several healthcare companies are trading lower amid market weakness as growing coronavirus concerns in the US weigh on equities.,2020-04-01 09:20:00-04:00,SNY,negative
1162445.0,Attention Biotech Investors: Mark Your Calendar For These April PDUFA Dates,2020-03-31 17:15:00-04:00,SNY,neutral
1162446.0,Why Sanofi's Stock Is Trading Higher Today,2020-03-30 11:08:00-04:00,SNY,neutral
1162447.0,Regeneron and Sanofi shares are trading higher after the companies announced the dosing of the first patient in their trial of Kevzara for coronavirus.,2020-03-30 10:10:00-04:00,SNY,positive
1162448.0,Sanofi shares are trading higher after the company reported the first patient outside of the U.S. has been treated as part of a global clinical program evaluating Kevzara in patients hospitalized with severe COVID-19.,2020-03-30 09:52:00-04:00,SNY,negative
1162449.0,Sanofi Reports First Patient Outside U.S. Treated in Global Kevzara Clinical Trial Program for Patients with Severe COVID-19,2020-03-30 05:40:00-04:00,SNY,negative
1162450.0,"Shares of several healthcare companies are trading lower, selling off from this week's strength. While the US stimulus legislation has boosted economic optimism, demand concerns still exist amid the coronavirus outbreak.",2020-03-27 09:22:00-04:00,SNY,positive
1162451.0,"The Daily Biotech Pulse: Sanofi-Translate Bio Join Hands For Coronavirus Vaccine, TherapeuticsMD Suspends Guidance",2020-03-27 08:02:00-04:00,SNY,positive
1162452.0,Sanofi and Translate Bio Collaborate to Develop Novel mRNA Vaccine Candidate Against COVID-19,2020-03-27 05:22:00-04:00,SNY,positive
1162453.0,"Chloroquine, Hydroxychloroquine And Coronavirus: What You Should Know",2020-03-24 17:16:00-04:00,SNY,neutral
1162454.0,Novavax Shares Rally On Flu Vaccine Study Results: What You Need To Know,2020-03-24 09:30:00-04:00,SNY,negative
1162455.0,"The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test",2020-03-24 08:20:00-04:00,SNY,negative
1162456.0,"Shares of several healthcare companies are trading higher the Fed announced actions to support the U.S. economy. The Fed will do open-ended treasury, mortgage-backed securities and will buy $375 billion in treasury this week.",2020-03-23 11:07:00-04:00,SNY,positive
1162457.0,20 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-03-18 07:46:00-04:00,SNY,neutral
1162458.0,Regeneron Working To Rush 'Cocktail' COVID-19 Antibody To Clinics At Start Of Summer,2020-03-17 08:50:00-04:00,SNY,neutral
1162459.0,"The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Shipment, Regeneron Aims For 'Cocktail' COVID-19 Treatment",2020-03-17 08:48:00-04:00,SNY,neutral
1162460.0,"Shares of several healthcare companies are trading lower as the coronavirus outbreak continues to cause economic disruption around the globe, leading to a steep selloff in equities across sectors.",2020-03-16 10:50:00-04:00,SNY,negative
1162461.0,8 Biotechs With Coronavirus Vaccines In Development,2020-03-16 10:42:00-04:00,SNY,neutral
1162462.0,Sanofi And Regeneron Begin Global Kevzara Clinical Trial Program In Patients With 'Severe' Coronavirus,2020-03-16 08:03:00-04:00,SNY,neutral
1162463.0,Shares of several healthcare companies are trading higher as the market rebounds following Thursday's selloff. NOTE: Since the coronavirus outbreak the healthcare sector has been extremely volatile.,2020-03-13 09:29:00-04:00,SNY,positive
1162464.0,Shares of several healthcare companies are trading lower as equities sell off amid continued global coronavirus concerns. The virus has caused global economic disruption and negatively impacted stocks across sectors.,2020-03-12 09:26:00-04:00,SNY,negative
1162465.0,Shares of several healthcare companies are trading lower. Movement appears market related amid selloff in equities. The global coronavirus outbreak has caused volatility in global markets and impacted stocks across sectors.,2020-03-11 07:15:00-04:00,SNY,neutral
1162466.0,A Peek Into The Markets: US Stock Futures Drop After Tuesday's Market Rally,2020-03-11 06:20:00-04:00,SNY,negative
1162467.0,Goldman Sachs Upgrades Sanofi to Buy,2020-03-11 05:03:00-04:00,SNY,neutral
1162468.0,How Close Are Biotechs To Bringing A COVID-19 Treatment To Market?,2020-03-10 17:24:00-04:00,SNY,neutral
1162469.0,"Regeneron, Sanofi To Test Arthritis Drug As Potential Coronavirus Treatment",2020-03-10 16:48:00-04:00,SNY,neutral
1162470.0,Mylan Wins District Court Decision Against Sanofi's Lantus SoloSTAR Patent,2020-03-10 13:00:00-04:00,SNY,positive
1162471.0,Shares of several healthcare companies are trading higher as markets rebound following Monday's selloff. US President Trump on Monday indicated the US may implement payroll tax cuts and other measures to support the economy amid the coronavirus outbreak.,2020-03-10 07:54:00-04:00,SNY,positive
1162472.0,Shares of several healthcare  companies are trading lower. Movement appears market-related as markets continue to dip amid the global coronavirus outbreak and OPEC failing to reach production agreement.,2020-03-09 10:55:00-04:00,SNY,neutral
1162473.0,52 Healthcare Stocks Moving In Monday's Pre-Market Session,2020-03-09 08:04:00-04:00,SNY,neutral
1162474.0,Shares of several healthcare companies are trading lower. Movement appears market related as markets continue to dip amid the global coronavirus outbreak.,2020-03-06 09:11:00-05:00,SNY,neutral
1162475.0,36 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-03-04 08:00:00-05:00,SNY,neutral
1162476.0,Shares of several drugmakers and healthcare companies are trading higher following US Super Tuesday results in which Joe Biden won the highest number of delegates. Biden's more 'moderate' healthcare policies have been seen as more favorable for the sector.,2020-03-04 07:48:00-05:00,SNY,positive
1162477.0,How The COVID-19 Outbreak Is Benefiting Biotech Investors,2020-03-02 14:27:00-05:00,SNY,neutral
1162478.0,FDA Approves Sanofi's Sarclisa For Combo Treatment Of Multiple Myeloma,2020-03-02 12:42:00-05:00,SNY,positive
1162479.0,Sanofi Canada's Cablivi Approved By Health Canada For Adults Living With Acquired Thrombotic Thrombocytopenic Purpura,2020-03-02 11:28:00-05:00,SNY,positive
1162480.0,Shares of several healthcare companies are trading higher in sympathy with the overall market as it rebounds from a selloff caused by coronavirus fears.,2020-03-02 11:18:00-05:00,SNY,positive
1162481.0,Sanofi Reaches Settlement Agreement To Resolve Allegations Related To Patient Assistance For $11.85M,2020-02-28 16:22:00-05:00,SNY,positive
1162482.0,Shares of several healthcare companies are trading lower as the global coronavirus spread continues to cause equities across sectors to sell off amid worsened economic outlook.,2020-02-28 09:06:00-05:00,SNY,negative
1162483.0,"Sanofi Reports Will Create A Major Leading European Company Dedicated To Production, Marketing to Third Parties Of Active Pharma Ingredients",2020-02-24 10:06:00-05:00,SNY,positive
1162484.0,Shares of several healthcare and biotech companies are trading lower amid continued spread of coronavirus including notable upticks in Iran and Italy. NOTE: The virus has raised fear of a global economic slowdown.,2020-02-24 08:37:00-05:00,SNY,negative
1162485.0,"Watching Sanofi Shares As Hearing Co., Eli Lilly Will Face Claims Of Violation Of RICO Act Related To Pricing Of Insulin",2020-02-20 12:30:00-05:00,SNY,negative
1162486.0,"Argus Research Maintains Buy on Sanofi, Raises Price Target to $56",2020-02-19 07:53:00-05:00,SNY,neutral
1162487.0,Sanofi Joins Forces With U.S. Department Of Health And Human Services To Advance A Novel Coronavirus Vaccine,2020-02-18 10:06:00-05:00,SNY,positive
1162488.0,SVB Leerink Initiates Coverage On Sanofi with Market Perform Rating,2020-02-11 09:44:00-05:00,SNY,neutral
1162489.0,Sanofi shares are trading higher after the company issued business EPS growth of 5% in FY20.,2020-02-06 08:40:00-05:00,SNY,positive
1162490.0,Sanofi Sees FY20 Business EPS Growth 5%,2020-02-06 08:02:00-05:00,SNY,positive
1162491.0,"Sanofi Q4 EPS €1.34, Sales €9.608B",2020-02-06 08:01:00-05:00,SNY,neutral
1162492.0,"The Daily Biotech Pulse: Tonix Slumps On Failed Study, Applied Genetic Announces Offering, Beam Therapeutics, PPD Price IPOs",2020-02-06 07:47:00-05:00,SNY,negative
1162493.0,10 Healthcare Stocks Moving In Thursday's Pre-Market Session,2020-02-06 07:32:00-05:00,SNY,neutral
1162494.0,"Earnings Scheduled For February 6, 2020",2020-02-06 04:30:00-05:00,SNY,neutral
1162495.0,"The Daily Biotech Pulse: Sanofi Reports Positive Readout, Tonix Vaccine Candidate Aces Animal Study, Hologix's Weak Guidance",2020-01-30 09:26:00-05:00,SNY,positive
1162496.0,"The Daily Biotech Pulse: Acceleron's Positive Data Readout, Surface Oncology Gets Nod For Pushing 2 Antibodies Into Clinics",2020-01-28 07:12:00-05:00,SNY,positive
1162497.0,Stocks That Hit 52-Week Highs On Friday,2020-01-10 12:18:00-05:00,SNY,neutral
1162498.0,"The Daily Biotech Pulse: Positive Data Readouts To Spur Aclaris, Moderna And Ultragenyx",2020-01-10 07:13:00-05:00,SNY,positive
1162499.0,Stocks That Hit 52-Week Highs On Thursday,2020-01-09 15:15:00-05:00,SNY,neutral
1162500.0,"The Daily Biotech Pulse: Xeris Jumps On Positive Data, Mixed Results For Merck's Keytruda-Chemo Combo In Lung Cancer, Intra-Cellular Announces Offering",2020-01-07 07:57:00-05:00,SNY,negative
1162501.0,JP Morgan Upgrades Sanofi to Overweight,2020-01-06 06:13:00-05:00,SNY,neutral
1162502.0,Drugmakers Kick Off 2020 With Margin-Expanding Price Hikes,2020-01-02 10:41:00-05:00,SNY,neutral
1162503.0,"Drugmakers Including Pfizer, GlaxoSmithKline, Sanofi, To Hike US Prices On More Than 200 Drugs In January; Median US Drug Price Increase For Jan. 1 2020 Is Around 5%, According To Healthcare Research Firm",2019-12-31 15:56:00-05:00,SNY,positive
1162504.0,"Week Ahead In Biotech: PDUFA Date Ahead For Astra Zeneca, Merck's Lynparza, Pending Clinical Readouts In Focus",2019-12-29 18:38:00-05:00,SNY,neutral
1162505.0,Stocks That Hit 52-Week Highs On Friday,2019-12-27 11:27:00-05:00,SNY,neutral
1162506.0,10 Biotech M&A Targets Under The Scanner For 2020,2019-12-24 07:30:00-05:00,SNY,neutral
1162507.0,A Perspective On Biopharma's Record M&A Run In 2019,2019-12-23 14:57:00-05:00,SNY,neutral
1162508.0,550 Cases Confirmed of H1N1 Virus with 26 Deaths Reported in Past 3 Weeks in Sana'a Yemen,2019-12-22 11:54:00-05:00,SNY,neutral
1162509.0,"The Daily Biotech Pulse: Axovant Surges On Gene Therapy Study Results, FDA Approves Merck's Ebola Vaccine, Abeona Announces Offering",2019-12-20 08:12:00-05:00,SNY,positive
1162510.0,36 Healthcare Stocks Moving In Thursday's Pre-Market Session,2019-12-19 08:28:00-05:00,SNY,neutral
1162511.0,"The Daily Biotech Pulse: Roche Gets US Antitrust Clearance For Spark Purchase, An Orphan Drug Designation For Prevail, Dynavax Names CEO",2019-12-17 07:56:00-05:00,SNY,positive
1162512.0,5 Low Float Stocks to Watch This Week,2019-12-16 09:37:00-05:00,SNY,negative
1162513.0,"The Week Ahead In Biotech: Avadel, Epizyme In Focus In A Quiet Week",2019-12-15 15:49:00-05:00,SNY,neutral
1162514.0,Stocks That Hit 52-Week Highs On Friday,2019-12-13 11:19:00-05:00,SNY,neutral
1162515.0,"The Daily Biotech Pulse: Second Time's The Charm For Sarepta, Pfizer's Xeljanz Snags Third Approval, NewLink Genetics Rejects Competing Offer",2019-12-13 08:10:00-05:00,SNY,positive
1162516.0,Stocks That Hit 52-Week Highs On Thursday,2019-12-12 10:21:00-05:00,SNY,neutral
1162517.0,"The Daily Biotech Pulse: European Nod For Amgen, miRagen Overhauls Clinical Pipeline, Tonix Snags Patent Win",2019-12-12 07:38:00-05:00,SNY,positive
1162518.0,Stocks That Hit 52-Week Highs On Wednesday,2019-12-11 10:49:00-05:00,SNY,neutral
1162519.0,"The Daily Biotech Pulse: Correvio Faces FDA Panel Rejection, Iterum's Antibiotic Trial Narrowly Misses Primary Endpoint",2019-12-11 07:21:00-05:00,SNY,negative
1162520.0,66 Biggest Movers From Yesterday,2019-12-11 04:52:00-05:00,SNY,neutral
1162521.0,Stocks That Hit 52-Week Highs On Tuesday,2019-12-10 14:27:00-05:00,SNY,neutral
1162522.0,35 Stocks Moving In Tuesday's Mid-Day Session,2019-12-10 14:22:00-05:00,SNY,neutral
1162523.0,"Regeneron Shares Swing On Sanofi's Hint At Sale Of Ownership Stake, Amendments To Drug Collaborations",2019-12-10 12:28:00-05:00,SNY,positive
1162524.0,Regeneron And Sanofi Announce Intent To Restructure Antibody Collaboration For Kevzara And Praluent,2019-12-10 08:29:00-05:00,SNY,neutral
1162525.0,41 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-12-10 08:10:00-05:00,SNY,neutral
1162526.0,"The Daily Biotech Pulse: ASH Meeting Wraps, Fast Track Designation For Equillium, Pfizer To Buy $3M In ContraFect Shares",2019-12-10 07:56:00-05:00,SNY,positive
1162527.0,Sanofi Announces Results From Pivotal Phase 3 Trial Of Sutimlimab In People With Cold Agglutinin Disease; Results Met Primary And Secondary Endpoints,2019-12-10 07:33:00-05:00,SNY,neutral
1162528.0,Sanofi shares are trading higher. The company announced late Monday it will end its research in diabetes and cardiovascular and indicated it could sell its stake in Regeneron.,2019-12-10 07:22:00-05:00,SNY,positive
1162529.0,25 Stocks Moving in Tuesday's Pre-Market Session,2019-12-10 06:48:00-05:00,SNY,neutral
1162530.0,Hearing Sanofi May Sell Regeneron Stake After Lockup Expires,2019-12-09 16:32:00-05:00,SNY,neutral
1162531.0,"Sanofi Says Launches Reorganization Around Three Global Businesses And A Standalone Consumer Healthcare Unit, Will End Research In Diabetes And Cardiovascular; Targeting Savings Of €2B By 2022",2019-12-09 16:18:00-05:00,SNY,neutral
1162532.0,"PreMarket Prep Recap: Small Biotech Firms Looking Healthy, Street Fades Macy's Downgrade",2019-12-09 13:08:00-05:00,SNY,positive
1162533.0,Sanofi Awarded $226M By US Government To Expand Influenza Vaccine Production Capabilities,2019-12-09 08:35:00-05:00,SNY,positive
1162534.0,Synthorx To Be Acquired By Sanofi For $2.5B,2019-12-09 07:53:00-05:00,SNY,neutral
1162535.0,A Peek Into The Markets: US Stock Futures Down; Crude Oil Falls 1%,2019-12-09 07:27:00-05:00,SNY,negative
1162536.0,"7 Stocks To Watch For December 9, 2019",2019-12-09 05:22:00-05:00,SNY,neutral
1162537.0,Sanofi to Acquire Synthorx to for $68/Share in Cash,2019-12-09 05:11:00-05:00,SNY,neutral
1162538.0,"The Week Ahead In Biotech: ASH Presentations Pick Up Steam, Correvio Awaits Adcom Ruling",2019-12-07 08:35:00-05:00,SNY,positive
1162539.0,Barclays Downgrades Sanofi to Underweight,2019-12-06 07:14:00-05:00,SNY,neutral
1162540.0,"Najarian Brothers Highlight Unusual Option Activity In Sanofi, JetBlue And More",2019-12-04 16:43:00-05:00,SNY,positive
1162541.0,Sanofi Option Alert: Jan 17 $48 Calls Sweep (14) near the Ask: 1324 @ $1.1 vs 768 OI; Ref=$46.4,2019-12-04 11:09:00-05:00,SNY,positive
1162542.0,Why Lexicon Pharma Shares Are Moving Lower,2019-12-02 11:09:00-05:00,SNY,neutral
1162543.0,Sanofi to Sell its Seprafilm Device to Baxter for $350M,2019-12-02 07:33:00-05:00,SNY,neutral
1162544.0,Hearing Unconfirmed Chatter Sanofi Will Sell its Seprafilm Device to Baxter for $350M,2019-12-02 07:08:00-05:00,SNY,negative
1162545.0,14 Most Shorted European Stocks,2019-11-25 15:45:00-05:00,SNY,neutral
1162546.0,19 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-11-22 07:47:00-05:00,SNY,neutral
1162547.0,"Sanofi Internal Memo Shows Co.'s head Of Strategy, Muzammil Mansuri, Will Leave Co.",2019-11-22 06:43:00-05:00,SNY,negative
1162548.0,Sanofi SA shares are trading higher after the company announced the Sutimlimab met its primary endpoint for safety and efficacy in the Phase 3 trial.,2019-11-21 11:12:00-05:00,SNY,positive
1162549.0,22 Healthcare Stocks Moving In Thursday's Pre-Market Session,2019-11-21 07:47:00-05:00,SNY,neutral
1162550.0,Sanofi Said to Consider Options for $30B Consumer-health Arm,2019-11-21 04:35:00-05:00,SNY,neutral
1162551.0,Medicines Company Shares Soar On Rumored Buyout Interest From Novartis,2019-11-19 09:50:00-05:00,SNY,positive
1162552.0,EU's CHMP Recommends Restricting Use Of Sanofi's Multiple Sclerosis Medicine Lemtrada,2019-11-15 06:34:00-05:00,SNY,negative
1162553.0,"The Week Ahead In Biotech: Adcom Test For Amarin's Fish Oil Pill, Agile Awaits FDA Verdict",2019-11-10 16:08:00-05:00,SNY,positive
1162554.0,"The Daily Biotech Pulse: FDA Nod For Sanofi, BioCryst's Edema Drug In Japan, Myriad's Q1 Disappointment",2019-11-05 06:53:00-05:00,SNY,negative
1162555.0,FDA Approves Sanofi's Fluzone Influenza Vaccine,2019-11-04 17:31:00-05:00,SNY,positive
1162556.0,WeTrader Competition: Round Four Wrap-up,2019-11-01 17:15:00-04:00,SNY,neutral
1162557.0,Sanofi shares are trading lower following Q3 results.,2019-10-31 11:17:00-04:00,SNY,neutral
1162558.0,"Sanofi  Q3 EPS €1.92, Sales €9.5B",2019-10-31 08:01:00-04:00,SNY,neutral
1162559.0,Regeneron And Sanofi Announce European Commission Approval Of A New Indication For Dupixent In Severe Chronic Rhinosinusitis With Nasal Polyposis,2019-10-29 08:18:00-04:00,SNY,positive
1162560.0,More Earnings And A Fed Decision In Week Four Of The WeTrader Competition,2019-10-28 11:56:00-04:00,SNY,neutral
1162561.0,FDA Investigating Whether Heartburn Drug Zantac Causes Carcinogens To Form In The Bodies Of Patients,2019-10-24 17:06:00-04:00,SNY,neutral
1162562.0,"Sanofi Press Release Confirms Precautionary Voluntary Recall Of Zantac OTC In US, Canada",2019-10-18 11:00:00-04:00,SNY,neutral
1162563.0,14 Healthcare Stocks Moving In Thursday's Pre-Market Session,2019-10-17 07:42:00-04:00,SNY,neutral
1162564.0,"Sanofi, Baxter Shares Volatile Over Last Few Mins. As Hearing Sanofi In Talks To Sell Seprafilm Products To Baxter",2019-10-16 14:15:00-04:00,SNY,positive
1162565.0,Innate Pharma IPO: What You Need To Know,2019-10-15 13:26:00-04:00,SNY,neutral
1162566.0,BioNTech IPO: What You Need To Know,2019-10-08 07:55:00-04:00,SNY,neutral
1162567.0,'FDA challenges testing used by lab that found a carcinogen in Zantac and other heartburn meds' -STAT,2019-10-02 14:50:00-04:00,SNY,positive
1162568.0,Health Canada Has Approved Sanofi Canada's Dupixent For Treatment Of Adolescents With Moderate To Sever Atopic Dermatits,2019-09-27 09:49:00-04:00,SNY,positive
1162569.0,"The Daily Biotech Pulse: ESMO Conference Gets Underway, J&J's Darzalex Snags Another Approval, Kaleido Biosciences CFO To Leave",2019-09-27 07:56:00-04:00,SNY,positive
1162570.0,"The Daily Biotech Pulse: PhaseBio Leaps On Trial Results, Pacira Set To Join SmallCap 600 Index, Positive Readout For Amgen's Blood Cancer Drug",2019-09-25 07:13:00-04:00,SNY,positive
1162571.0,"The Daily Biotech Pulse: Sandoz Recalls Ulcer Drug, Anchiano Strikes Agreement With ADT Pharma, Proteon Announces Reverse Merger",2019-09-24 08:12:00-04:00,SNY,positive
1162572.0,Guggenheim Upgrades Sanofi to Buy,2019-09-23 07:00:00-04:00,SNY,neutral
1162573.0,Shares of several drug companies are trading higher after Senate Majority Leader McConnell suggested a new Democratic drug price reform proposal would be dead on arrival.,2019-09-20 13:00:00-04:00,SNY,negative
1162574.0,Sanofi shares are trading higher after the company announced CHMP has recommended approval of Dupixent for severe chronic rhinosinusitis with nasal polyposis.,2019-09-20 12:15:00-04:00,SNY,positive
1162575.0,15 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-09-20 08:24:00-04:00,SNY,neutral
1162576.0,Sanofi Announces CHMP Has Recommended Approval Of Dupixent For Severe Chronic Rhinosinusitis With Nasal Polyposis,2019-09-20 06:49:00-04:00,SNY,positive
1162577.0,Sony Rejects Loeb's Proposal for Chip Business Spin-off,2019-09-17 06:07:00-04:00,SNY,negative
1162578.0,Happify Health and Sanofi Sign Global Agreement to Bring Prescription Digital Mental Health Therapeutics to Individuals with Multiple Sclerosis,2019-09-17 03:59:00-04:00,SNY,positive
1162579.0,Abbott And Sanofi Partner To Integrate Glucose Sensing And Insulin Delivery Technologies To Help Change The Way Diabetes Is Managed,2019-09-16 08:06:00-04:00,SNY,positive
1162580.0,"EMA Says, At European Commission Request, Will Review Ranitidine Medicines After Tests Showed Presence Of Impurity",2019-09-13 09:54:00-04:00,SNY,neutral
1162581.0,UPDATE: FDA Says Ranitidine Medicines Which Contain NDMA Impurity Include Some Products Commonly Known As Brand-Name Drug Zantac,2019-09-13 09:53:00-04:00,SNY,neutral
1162582.0,Sanofi Shares Fall 1% Following Reports Carcinogens Were Found In Versions Of Zantac By The FDA,2019-09-13 09:51:00-04:00,SNY,positive
1162583.0,Teva Dips Into Medical Marijuana Market With Canndoc Distribution Deal,2019-09-13 08:14:00-04:00,SNY,neutral
1162584.0,"The Daily Biotech Pulse: Lexicon Snaps Sanofi Diabetes Partnership With $260M Settlement, Celyad Offering, Multiple Sclerosis Conference Gets Underway",2019-09-11 07:09:00-04:00,SNY,neutral
1162585.0,Lexicon Pharmaceuticals Announces Termination Of Alliance and Settlement With Sanofi; Sanofi To Pay Co. $206M,2019-09-10 16:02:00-04:00,SNY,negative
1162586.0,Shares of several drugmakers are trading lower on news of a drug pricing bill being developed by House Democrats. The proposed bill would set US drug prices based on prices in other wealthy countries.,2019-09-10 10:30:00-04:00,SNY,positive
1162587.0,"Benzinga's Top Upgrades, Downgrades For September 3, 2019",2019-09-03 09:42:00-04:00,SNY,positive
1162588.0,32 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-09-03 08:42:00-04:00,SNY,neutral
1162589.0,26 Stocks Moving in Tuesday's Pre-Market Session,2019-09-03 08:09:00-04:00,SNY,neutral
1162590.0,Sanofi SA shares are trading higher after Bernstein initiated coverage on the company's stock with an Outperform rating and a $52 price target.,2019-09-03 07:07:00-04:00,SNY,positive
1162591.0,"Bernstein Initiates Coverage On Sanofi with Outperform Rating, Announces $52 Price Target",2019-09-03 06:32:00-04:00,SNY,neutral
1162592.0,"The Daily Biotech Pulse: Genmab-Novartis Multiple Sclerosis Drug Aces Late-Stage Studies, Akari Nets Orphan Drug Designation",2019-08-30 08:28:00-04:00,SNY,neutral
1162593.0,"The Daily Biotech Pulse: EC Approves Roche's Tecentriq For Breast Cancer, Trevena On Track For NDA Resubmission, Edap Earnings",2019-08-29 07:38:00-04:00,SNY,negative
1162594.0,Sanofi Press Release Confirms District Court Invalidates Amgen Patent Claims Targeting PCSK9,2019-08-28 16:39:00-04:00,SNY,neutral
1162595.0,Biotech Stock On The Radar: MyoKardia Bets On Precision Medicine For Heart Health,2019-08-28 16:00:00-04:00,SNY,neutral
1162596.0,"Biotech Stock On The Radar: Medicines Company, A Cardiovascular Pure Play With A Potential Blockbuster",2019-08-20 17:35:00-04:00,SNY,positive
1162597.0,"The Daily Biotech Pulse: Sanofi's Dupixent Found Effective For Pediatric Itchy Skin, Novavax Gets Nod For Late-Stage Study, Allakos Offering",2019-08-06 07:22:00-04:00,SNY,positive
1162598.0,Sanofi/Regeneron Dupixent Showed Positive Topline Results in Phase 3 Trial of Children Aged 6 to 11 Years With Severe Atopic Dermatitis,2019-08-06 03:32:00-04:00,SNY,positive
1162599.0,Denali Therapeutics Announces That Its Partner Sanofi Has Commenced Dosing of DNL758 In Phase 1 Study,2019-08-05 09:09:00-04:00,SNY,neutral
1162600.0,"The Week Ahead In Biotech: Focus On Earnings Deluge, Mid-Year Clinical Trial Readouts",2019-08-03 10:18:00-04:00,SNY,neutral
1162601.0,33 Healthcare Stocks Moving In Today's Pre-Market Session,2019-07-30 09:16:00-04:00,SNY,neutral
1162602.0,"The Daily Biotech Pulse: European Cheer For Merck, Legal Victory For Coherus, Medpace Picks Up On Earnings",2019-07-30 07:00:00-04:00,SNY,positive
1162603.0,54 Biggest Movers From Yesterday,2019-07-30 05:00:00-04:00,SNY,neutral
1162604.0,Mid-Afternoon Market Update: Crude Oil Up Over 1%; Lexicon Pharmaceuticals Shares Plunge,2019-07-29 14:22:00-04:00,SNY,negative
1162605.0,42 Stocks Moving In Monday's Mid-Day Session,2019-07-29 12:30:00-04:00,SNY,neutral
1162606.0,Mid-Day Market Update: On Deck Capital Falls On Downbeat Earnings; Medley Management Shares Jump,2019-07-29 12:13:00-04:00,SNY,positive
1162607.0,Sanofi 6-K Shows Co.'s US Unit Received New York Attorney General Subpoena Related to Insulin Pricing,2019-07-29 10:53:00-04:00,SNY,neutral
1162608.0,"Mid-Morning Market Update: Markets Mostly Lower; Mylan, Pfizer's Upjohn To Merge",2019-07-29 10:16:00-04:00,SNY,negative
1162609.0,"UPDATE: Stifel Downgrades Lexicon Pharmaceuticals To Hold, Lowers Target To $4 As Firm Notes 'Sanofi's Planned Sotagliflozin Exodus & P3 T2D CKD Data Clouds Visibility & Thesis'",2019-07-29 10:16:00-04:00,SNY,negative
1162610.0,Sanofi Trades Higher On Q2 Earnings Beat,2019-07-29 09:37:00-04:00,SNY,neutral
1162611.0,30 Healthcare Stocks Moving In Today's Pre-Market Session,2019-07-29 09:35:00-04:00,SNY,neutral
1162612.0,35 Stocks Moving In Monday's Pre-Market Session,2019-07-29 08:30:00-04:00,SNY,neutral
1162613.0,Sanofi shares are trading higher after the company reported better-than-expected Q2 EPS and sales results.,2019-07-29 08:16:00-04:00,SNY,positive
1162614.0,"Sanofi Q2 EPS $1.47 Beats $0.74 Estimate, Sales $9.663B Beat $9.4B Estimate",2019-07-29 08:11:00-04:00,SNY,neutral
1162615.0,Lexicon Shares Fall 47% On Termination Of License Agreement With Sanofi,2019-07-29 08:10:00-04:00,SNY,positive
1162616.0,Lexicon Shares Fall 52% on Termination of License Agreement with Sanofi,2019-07-29 07:05:00-04:00,SNY,positive
1162617.0,Lexicon Pharmaceuticals Received Written Notice from Sanofi Terminating the Collaboration and License Agreement for the Worldwide Development and Commercialization of the Company's Diabetes Drug Candidate Sotagliflozin,2019-07-29 07:04:00-04:00,SNY,positive
1162618.0,"Earnings Scheduled For July 29, 2019",2019-07-29 04:52:00-04:00,SNY,neutral
1162619.0,Sanofi's Earnings: A Preview,2019-07-28 18:02:00-04:00,SNY,neutral
1162620.0,Sanofi Says Terminating Collaboration With Lexicon,2019-07-26 16:06:00-04:00,SNY,neutral
1162621.0,"The Daily Biotech Pulse: Obseva Gets The Greenlight, Verastem Climbs On Licensing Deal, Merit Medical Earnings Disappoint",2019-07-26 07:26:00-04:00,SNY,neutral
1162622.0,"Verastem Oncology Signs An Exclusive License Agreement With Sanofi For The Development And Commercialization Of COPIKTRA In Russia And CIS, Turkey, The Middle East And Africa; Co. To Receive $5M Upfront, Up To $42M In Milestones",2019-07-25 16:46:00-04:00,SNY,positive
1162623.0,"Opiant Pharmaceuticals Expands Partnership With Sanofi, Signs Agreement For Manufacturing OPNT004 For Treatment Of Acute Cannabinoid Overdose",2019-07-23 08:05:00-04:00,SNY,positive
1162624.0,"The Daily Biotech Pulse: Acadia Schizophrenia Drug Fails, Viveve Plummets, Eisai Gets Breakthrough Therapy Designation",2019-07-23 07:26:00-04:00,SNY,negative
1162625.0,Sanofi Signs Strategic Deal with Roche for Exclusive US OTC Rights to Tamiflu in Flu Care,2019-07-23 04:08:00-04:00,SNY,positive
1162626.0,"Shares of several drug manufacturing companies are trading lower, potentially on continued weakness after the Trump Administration on Thursday rolled back a proposal to eliminate rebates from government drug plans.",2019-07-12 09:53:00-04:00,SNY,negative
1162627.0,"Mizuho Comments On News Praluent Will Be Pulled From Germany, Sees Positive Implications For Amgen's Repatha, The Medicine Co.'s Inclisiran",2019-07-11 11:46:00-04:00,SNY,positive
1162628.0,Shares of several drug manufacturing companies are trading lower. The Trump Administration earlier rolled back a proposal to eliminate rebates from government drug plans and commented on continued efforts to lower drug prices.,2019-07-11 10:36:00-04:00,SNY,negative
1162629.0,"The Daily Biotech Pulse: Jazz Buys Tumor Drug Program, Sanofi's BLA For Multiple Myeloma Drug Accepted, Positive Results For ViiV",2019-07-10 07:17:00-04:00,SNY,positive
1162630.0,Catalent Reports Agreement With  Sanofi Active Ingredient Solutions Under Which Co. Will Have Access To Spray Drying Manufacturing Services,2019-07-09 07:04:00-04:00,SNY,positive
1162631.0,Sanofi Highlights EU Approval Of Libtayo As Treatment For Advanced Cutaneous Squamous Cell Carcinoma,2019-07-01 10:05:00-04:00,SNY,positive
1162632.0,Meet The 3 Biggest Industries Investing In Cannabis,2019-06-28 15:51:00-04:00,SNY,neutral
1162633.0,Sanofi Reports CHMP Recommended Approval Of Dupixent For Moderate-To-Sever Atopic Dermatitis In Adolescents,2019-06-28 07:01:00-04:00,SNY,positive
1162634.0,"The Daily Biotech Pulse: Verrica Rallies, Aclaris Flunked Hair Loss Study, 3 Biotechs To IPO",2019-06-27 07:26:00-04:00,SNY,negative
1162635.0,Regeneron Pharmaceuticals And Sanofi Announce That The FDA Has Approved Dupixent (Dupilumab) For Use With Other Medicines To Treat Chronic Rhinosinusitis With Nasal Polyposis In Adults Whose Disease Is Not Controlled,2019-06-26 13:33:00-04:00,SNY,positive
1162636.0,"The Daily Biotech Pulse: Decision Day For Regeneron-Sanofi, Vermillion Offering, PDL BioPharma CFO to Depart",2019-06-26 07:19:00-04:00,SNY,neutral
1162637.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs",2019-06-22 15:07:00-04:00,SNY,neutral
1162638.0,"The Daily Biotech Pulse: ContraVir's Volatile Ride Continues, Late-Stage Disappointment For Exelixis, Regeneron-Sanofi Breathe Easy",2019-06-21 07:18:00-04:00,SNY,negative
1162639.0,"Sanofi, Regeneron Announce Positive Topline Phase 2 Results for IL-33 Antibody in Asthma",2019-06-21 04:36:00-04:00,SNY,positive
1162640.0,"Sanofi, Google Partner On Health Care-Focused Virtual Innovation Lab",2019-06-18 10:54:00-04:00,SNY,positive
1162641.0,"The Daily Biotech Pulse: PhaseBio Pumped Up, Eiger Exults On Breakthrough Therapy Designation, Biohaven Slips On Stock Sale",2019-06-18 07:31:00-04:00,SNY,neutral
1162642.0,"Sanofi, Google to Establish New Virtual Innovation Lab Focusing on Healthcare",2019-06-18 04:31:00-04:00,SNY,positive
1162643.0,"Voyager Therapeutics Acquires Worldwide Rights to VY-HTT01 For Huntington's Disease From Sanofi for $10M, Voyager Grants Ex-US Rights to BY-FXN01 to Neurocine Biosciences for $5M",2019-06-17 07:45:00-04:00,SNY,positive
1162644.0,Sanofi Announced On Sunday Soliqua Phase 3 Results Significantly Lowered Blood Sugar Levels Versus GLP-1 Receptor Agonist Treatments,2019-06-10 10:04:00-04:00,SNY,negative
1162645.0,60 Biggest Movers From Friday,2019-06-10 06:41:00-04:00,SNY,neutral
1162646.0,44 Stocks Moving In Friday's Mid-Day Session,2019-06-07 12:50:00-04:00,SNY,neutral
1162647.0,Sanofi's Leadership Transition: What You Need To Know,2019-06-07 12:25:00-04:00,SNY,neutral
1162648.0,Sanofi shares are trading higher after the current CEO Brandicourt announced he would step down and Paul Hudson will be the new CEO on September 1st.,2019-06-07 08:34:00-04:00,SNY,positive
1162649.0,25 Stocks Moving In Friday's Pre-Market Session,2019-06-07 08:04:00-04:00,SNY,neutral
1162650.0,"The Daily Biotech Pulse: Vertex Bets Big On Gene-Editing Therapies, Sanofi Poaches Novartis For CEO Role, Relief In Europe for Endologix",2019-06-07 07:24:00-04:00,SNY,positive
1162651.0,Sanofi CEO Brandicourt to Leave Company from September 1; Paul Hudson to become New Sanofi CEO Effective September 1,2019-06-06 18:07:00-04:00,SNY,positive
1162652.0,Hearing Sanofi Has Lost German Court Ruling in PRALUENT Dispute With Amgen,2019-06-04 11:16:00-04:00,SNY,negative
1162653.0,"'China to Audit Sanofi, Bristol-Myers in Drugmaker Accounts Probe' -Bloomberg",2019-06-04 07:45:00-04:00,SNY,neutral
1162654.0,Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates,2019-05-31 13:45:00-04:00,SNY,neutral
1162655.0,Shares of several healthcare companies are trading lower after the US state of Oklahoma filed a multi-billion dollar lawsuit against Johnson & Johnson relating to opioid abuse; Oklahoma settled an opioid lawsuit with Teva Pharmaceuticals earlier this week,2019-05-29 10:47:00-04:00,SNY,negative
1162656.0,Cegedim And Sanofi Are Engaged In An Innovative Collaboration On Real World Data For Healthcare Improvement In Europe,2019-05-21 12:06:00-04:00,SNY,positive
1162657.0,"Regeneron, Sanofi Highlight Positive Updated Data For Libtayo In Locally-Advanced, Metastatic Cutaneous Squamous Cell Carcinoma Will Be Shared At 2019 ASCO",2019-05-16 07:11:00-04:00,SNY,positive
1162658.0,Sanofi Reports Licensing Of Dupixent In EU For Treatment Of Severe Asthma With Type-2 Inflammation,2019-05-08 08:48:00-04:00,SNY,negative
1162659.0,Shares of several financial companies are trading lower in continued uncertainty of a trade war between the US and China.,2019-05-07 09:37:00-04:00,SNY,negative
1162660.0,"Regeneron, Sanofi Report Dupixent Approved For Severe Asthma By EC",2019-05-07 09:00:00-04:00,SNY,positive
1162661.0,Shares of several financial companies are trading lower following a tweet from President Trump which hinted at additional tariffs on China and China indicated it may back out of upcoming trade negotiations.,2019-05-06 09:56:00-04:00,SNY,neutral
1162662.0,Alnylam Offering By Sanofi Priced At $80.25/Share,2019-05-03 09:40:00-04:00,SNY,neutral
1162663.0,5 Biotech Stocks With Near-Term Catalysts Ahead,2019-05-02 14:18:00-04:00,SNY,neutral
1162664.0,"The Daily Biotech Pulse: FDA Nod For Sanofi's Dengue Vaccine, Veracyte Offering, Biogen Reports Positive Data",2019-05-02 08:16:00-04:00,SNY,positive
1162665.0,"The Daily Biotech Pulse: Nabriva Stumbles At FDA Hurdle, Gilead CFO To Retire, Eisai Ends Collaboration With Purdue",2019-05-01 07:39:00-04:00,SNY,neutral
1162666.0,Attention Biotech Investors: Mark Your Calendar For These May PDUFA Dates,2019-04-30 13:00:00-04:00,SNY,neutral
1162667.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs",2019-04-27 11:44:00-04:00,SNY,neutral
1162668.0,Sanofi And Lexicon Zynquista Now Approved In The European Union For Treatment Of Adults With Type 1 Diabetes,2019-04-26 16:01:00-04:00,SNY,positive
1162669.0,"Regeneron, Sanofi Report CHMP Issued Positive Opinion For Libtayo",2019-04-26 11:16:00-04:00,SNY,positive
1162670.0,Sanofi SA shares are trading higher after the company reported Q1 EPS and sales up from last year.,2019-04-26 09:27:00-04:00,SNY,positive
1162671.0,"Sanofi Q1 EPS €1.42, Up 10.9% YoY, Sales €8.39B Up 6.2% YoY",2019-04-26 08:08:00-04:00,SNY,neutral
1162672.0,"The Daily Biotech Pulse: Mixed Results For Merck's Keytruda In Stomach Cancer; Roche's Spark-Buy Delayed, Teva Recalls Hypertension Drug",2019-04-26 08:02:00-04:00,SNY,negative
1162673.0,Shares of several drug companies are trading lower amid continued efforts from Washington to curb prescription drug prices. The overall healthcare sector has seen weakness recently due to uncertainty over the future of healthcare policy.,2019-04-17 10:31:00-04:00,SNY,negative
1162674.0,Shares of several drug companies are trading lower. Weakness may be tied to uncertainty over healthcare policy going into the 2020 primaries and Washington's recent efforts to curb prescription drug prices.,2019-04-16 15:34:00-04:00,SNY,negative
1162675.0,"Alnylam, Sanofi Conclude Research and Option Phase of 2014 RNAi Therapeutics Collaboration",2019-04-08 03:49:00-04:00,SNY,neutral
1162676.0,Sangamo Soars Amid Multiple Development Pipeline Updates,2019-04-02 12:47:00-04:00,SNY,neutral
1162677.0,Attention Biotech Investors: Mark Your Calendar For These April PDUFA Dates,2019-03-29 12:45:00-04:00,SNY,neutral
1162678.0,CDC: 44 States Still Reporting High Flu Activity,2019-03-29 08:55:00-04:00,SNY,negative
1162679.0,The Genfit IPO: What You Need To Know,2019-03-26 16:41:00-04:00,SNY,neutral
1162680.0,Apple Arcade Is The Company's Newest Subscription Gaming Service,2019-03-25 16:35:00-04:00,SNY,neutral
1162681.0,Lexicon Reports FDA Issued Complete Response Letter For Zynquista,2019-03-22 14:16:00-04:00,SNY,neutral
1162682.0,"The Daily Biotech Pulse: Immutep Gets US Patent, Conatus NASH Disappointment, Eisai Moves On After Aducanumab Setback",2019-03-22 08:16:00-04:00,SNY,negative
1162683.0,Altimmune's Flu Shot Study: What You Need To Know,2019-03-19 16:05:00-04:00,SNY,negative
1162684.0,"The Daily Biotech Pulse: FDA Nod For Roche And Amphastar, Milestone Payment Kicks In For Affimed",2019-03-19 07:40:00-04:00,SNY,neutral
1162685.0,Sanofi Says it is Considering a Transition Plan for its CEO,2019-03-18 11:19:00-04:00,SNY,neutral
1162686.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings",2019-03-16 08:35:00-04:00,SNY,neutral
1162687.0,Regeneron Pharmaceuticals Announces Praluent Is Not Approved In EU,2019-03-15 16:02:00-04:00,SNY,negative
1162688.0,Regeneron And Sanofi To Present New Praluent Data At ACC.19,2019-03-13 07:09:00-04:00,SNY,neutral
1162689.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings, IPOs",2019-03-10 14:32:00-04:00,SNY,neutral
1162690.0,"The Daily Biotech Pulse: Tonix Gets European Patent, EC Nod For Roche, Insys Earnings",2019-03-08 07:38:00-05:00,SNY,neutral
1162691.0,Sanofi Announces FDA to Undertake Priority Review of Dupixent for Adults with Inadequately Controlled Severe Chronic Rhinosinusitis with Nasal Polyps,2019-03-08 03:54:00-05:00,SNY,negative
1162692.0,Attention Biotech Investors: Mark Your Calendar For These March PDUFA Dates,2019-03-04 11:50:00-05:00,SNY,neutral
1162693.0,CHMP Recommends Lexicon And Sanofi's Zynquista For The Treatment Of Adults With Type 1 Diabetes,2019-03-01 08:01:00-05:00,SNY,positive
1162694.0,Major Shareholders Team To Scuttle Bristol-Myers Squibb's $74B Celgene Buyout: What's Next?,2019-02-28 12:42:00-05:00,SNY,neutral
1162695.0,FDA Expands Indication For Sanofi's Soliqua 100/33,2019-02-27 16:18:00-05:00,SNY,positive
1162696.0,"The Daily Biotech Pulse: Immunomedics CEO Departs, Ultragenyx Offering, Karyopharm Awaits FDA Panel Vote",2019-02-26 07:56:00-05:00,SNY,positive
1162697.0,"Regeneron, Sanofi Issue Press Release Highlighting 'Strongly Disagree' With Verdict To Uphold 3 Of 5 Amgen US Patent Claims Related To PCSK9 Antibodies",2019-02-25 17:23:00-05:00,SNY,neutral
1162698.0,"Jury Finds Amgen's Patents For Repatha Are Valid; Sanofi, Regeneron Have Lost Validity Trial, Conceded Infringement",2019-02-25 15:47:00-05:00,SNY,negative
1162699.0,"Regeneron, Sanofi Highlight Detailed Results From 2 Phase 3 Trials In Adults With Recurring Severe Chronic Rhinosinusits With Nasal Polyps",2019-02-25 12:46:00-05:00,SNY,negative
1162700.0,"US Senate Finance Committee Launches Bipartisan Investigation Into Rising Insulin Prices; Sends Letters To Eli Lilly, Novo Nordisk And Sanofi",2019-02-22 15:57:00-05:00,SNY,neutral
1162701.0,Bristol-Myers Shares Spike ~0.8% Higher As Traders Circulate Speculation From Dealreporter Sanofi Interested In Takeover Of Co.,2019-02-21 09:44:00-05:00,SNY,positive
1162702.0,"'*SANOFI, REGENERON WIN IPR CHALLENGE TO AMGEN ANTIBODY PATENT' -Tweets zbiotech",2019-02-14 12:23:00-05:00,SNY,positive
1162703.0,Unum Therapeutics 13G Shows Sanofi Holds 5.91% Stake In Co.,2019-02-11 08:50:00-05:00,SNY,neutral
1162704.0,Regeneron and Sanofi Offer Praluentat a New Reduced US List Price,2019-02-11 07:00:00-05:00,SNY,neutral
1162705.0,Sanofi Sees FY19 Business EPS Growth 3-5% Year Over Year,2019-02-07 08:13:00-05:00,SNY,positive
1162706.0,"Sanofi Q4 Business EPS €1.10, IFRS EPS €0.20, Sales €8.997B",2019-02-07 08:12:00-05:00,SNY,neutral
1162707.0,"The Daily Biotech Pulse: Galapagos-Evotec Forge Fibrosis Partnership, Sanofi Earnings, Alector To Debut",2019-02-07 08:08:00-05:00,SNY,neutral
1162708.0,"14 Stocks To Watch For February 7, 2019",2019-02-07 04:18:00-05:00,SNY,neutral
1162709.0,"Earnings Scheduled For February 7, 2019",2019-02-07 04:01:00-05:00,SNY,neutral
1162710.0,"FDA Approves Sanofi's Cablivi Injection, Indicated For Treatment Of Adult Patients With Acquired Thrombotic Thrombocytopenic Purpura; FDA Grants Approval Of Cablivi To Ablynx",2019-02-06 11:30:00-05:00,SNY,positive
1162711.0,"The Daily Biotech Pulse: Gilead Earnings, Codexis Sings Pact With Merck, Eli Lilly Reports Positive Trial Results",2019-02-05 07:47:00-05:00,SNY,positive
1162712.0,Sanofi Says CHMP Recommends Approval Of Praluent To Reduce Cardiovascular Risk In People With Established Atherosclerotic Cardiovascular Disease,2019-02-04 04:14:00-05:00,SNY,positive
1162713.0,Pharma Catches Another Case Of M&A Fever,2019-02-01 10:15:00-05:00,SNY,neutral
1162714.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings",2019-01-27 16:07:00-05:00,SNY,neutral
1162715.0,Fda Approves Use Of Sanofi's 0.5 Ml Dose Of Fluzone Quadrivalent (Influenza Vaccine) In Children As Young As 6 Months Of Age,2019-01-23 14:55:00-05:00,SNY,positive
1162716.0,"Sanofi UK Marketing Authorization Granted For Sanofi Pasteur's Trivalent Influenza Vaccine (Split Virion, Inactivated) High Dose (TIV High Dose)",2019-01-21 12:38:00-05:00,SNY,positive
1162717.0,"The Daily Biotech Pulse: Regulatory Roadblock For Immunomedics, AdCom Split On Lexicon's Diabetes Drug",2019-01-18 07:49:00-05:00,SNY,neutral
1162718.0,Sanofi and Lexicon's Oral Type 1 Diabetes Drug Gets an Evenly Split FDA Advisory Panel at 8 to 8,2019-01-17 16:23:00-05:00,SNY,neutral
1162719.0,"The Daily Biotech Pulse: FDA Panel Backs Amgen's Hypertension Drug, Adamis Allergy Drug Launched In US",2019-01-17 08:06:00-05:00,SNY,positive
1162720.0,Sanofi Reports FDA Approval For Expanded Use Of Adacel Vaccine For Repeat Vaccination,2019-01-14 16:49:00-05:00,SNY,positive
1162721.0,From JP Morgan Conference: Sanofi CFO Says Co. Will Still Face Headwind From Diabetes Segment In 2019,2019-01-08 13:44:00-05:00,SNY,positive
1162722.0,US Supreme Court Rejects Amgen Bid To Reinstate Patent Verdict Against Sanofi And Regeneron Over Cholesterol Medication,2019-01-07 09:41:00-05:00,SNY,positive
1162723.0,"Sanofi,Regeneron Restructure Immuno-Oncology Collaboration for Discovery and Development Programs; Sanofi to Pay Regeneron $462M Plus Up to $120M in Development Costs",2019-01-07 03:52:00-05:00,SNY,negative
1162724.0,Acer Therapeutics Reports In-License Of Osanetant From Sanofi,2019-01-02 08:31:00-05:00,SNY,neutral
1162725.0,MyoKardia Regains Global Rights To Mavacamten And MYK-491 Programs From Sanofi,2019-01-02 08:01:00-05:00,SNY,neutral
1162726.0,Attention Biotech Investors: Mark Your Calendar For These January PDUFA Dates,2018-12-31 09:00:00-05:00,SNY,neutral
1162727.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials",2018-12-30 15:27:00-05:00,SNY,neutral
1162728.0,"The Daily Biotech Pulse: Tracon Aces Early-Stage Trials, Boston Scientific To Buy Out Millipede",2018-12-27 07:51:00-05:00,SNY,neutral
1162729.0,Sanofi Receives FDA Approval For Pediatric Hexavalent Combination Vaccine,2018-12-26 14:32:00-05:00,SNY,positive
1162730.0,Opiant Pharmaceuticals Licenses Novel CB-1 Receptor Antagonist For Treatment Of Acute Cannabinoid Overdose From Sanofi,2018-12-26 08:02:00-05:00,SNY,negative
1162731.0,The Week Ahead In Biotech: Focus Shifts To Year-End Clinical Trial Results,2018-12-23 10:37:00-05:00,SNY,neutral
1162732.0,"Competition Bureau Has Closed Abuse-Of-Dominance Investigation Into Celgene, Pfizer, Sanofi Practices",2018-12-20 16:00:00-05:00,SNY,neutral
1162733.0,"The Daily Biotech Pulse: Pfizer-Glaxo Set Up Consumer Health Care Venture, New Patent For Adamas",2018-12-19 07:46:00-05:00,SNY,positive
1162734.0,Sanofi Reports EC Granted Marketing Authorization For Dengvaxia As Dengue Vaccine,2018-12-19 07:08:00-05:00,SNY,positive
1162735.0,Sanofi To Transfer Its US Stock Listing From NYSE To Nasdaq,2018-12-18 16:32:00-05:00,SNY,neutral
1162736.0,Morgan Stanley Initiates Coverage On Sanofi with Equal-Weight Rating,2018-12-14 09:58:00-05:00,SNY,neutral
1162737.0,"Mylan Reports US Patent, Trademark Appeal Board Ruled In Favor Of Co. In IPR Proceedings, Found All Claims Of Sanofi's Lantus Unpatentable",2018-12-13 07:33:00-05:00,SNY,positive
1162738.0,"UPDATE: Gabelli On Clovis Says Continues 'to believe Bristol, Sanofi and Roche to be the most interested buyers'",2018-12-11 10:39:00-05:00,SNY,positive
1162739.0,5 Biotech Companies To Keep On Your M&A Watchlist For 2019,2018-12-10 12:32:00-05:00,SNY,neutral
1162740.0,"Immune Design Says On Dec 6, Received Notice From Sanofi US Services, That It Elected To Terminate License Agreement Dated As Of August 6, 2014",2018-12-10 06:14:00-05:00,SNY,positive
1162741.0,9 Policy Catalysts For Health Care Investors To Watch Before Year's End,2018-11-25 09:35:00-05:00,SNY,positive
1162742.0,"The Daily Biotech Pulse: Denali's Positive Results, Novartis' Substance Abuse Therapy Launch, Medtronic Earnings",2018-11-20 08:29:00-05:00,SNY,negative
1162743.0,UPDATE: Denali Says Sanofi Intends To Initiate Clinical Trials With DNL758 In 2019,2018-11-19 16:34:00-05:00,SNY,neutral
1162744.0,"Denali Says Co., Sanofi Are Pursuing Several Compounds Including DNL758 For Systemic Inflammatory Diseases",2018-11-19 16:33:00-05:00,SNY,neutral
1162745.0,Sanofi Reports EMA Recommended Fexinidazole For Sleeping Sickness,2018-11-16 07:11:00-05:00,SNY,positive
1162746.0,13F From Buffett's Berkshire Shows Liquidated ~3.7M Share Stake In Sanofi,2018-11-14 16:15:00-05:00,SNY,positive
1162747.0,Regulus Licenses miR-21 to Sanofi for $7M Upfront and Up to $40M in Development Milestones,2018-11-06 08:24:00-05:00,SNY,neutral
1162748.0,Sanofi Reports FDA Accepted For Priority Review For Supplemental Biologics License Application For Dupixent In Adolescent Patients 12-17 Years Of Age,2018-11-06 08:03:00-05:00,SNY,positive
1162749.0,"The Daily Biotech Pulse: EyePoint Licenses Eye Inflammation Drug, Insys Strategic Review Of Opioid Assets, Neos Offering",2018-11-06 07:04:00-05:00,SNY,positive
1162750.0,"The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs",2018-11-04 13:35:00-05:00,SNY,neutral
1162751.0,"Benzinga's Top Upgrades, Downgrades For November 1, 2018",2018-11-01 09:48:00-04:00,SNY,positive
1162752.0,"The Daily Biotech Pulse: AbbVie's Leukemia Drug Trial Meets Endpoint, Denali Strikes Collaboration Deal",2018-11-01 07:30:00-04:00,SNY,negative
1162753.0,Barclays Upgrades Sanofi to Equal-Weight,2018-11-01 07:11:00-04:00,SNY,neutral
1162754.0,Denali Therapeutics Announces Collaboration with Sanofi to Develop RIPK1 Inhibitors for Treatment of Neurological and Inflammatory Diseases,2018-11-01 04:27:00-04:00,SNY,negative
1162755.0,"The Daily Biotech Pulse: KemPharm, FDA Nod For Merck, Clovis Q3 Miss, 3 Stocks To Debut",2018-10-31 08:20:00-04:00,SNY,negative
1162756.0,"Earnings Scheduled For October 31, 2018",2018-10-31 04:06:00-04:00,SNY,neutral
1162757.0,FDA Has Granted Priority Review For Sanofi's Dengue Vaccine Candidate,2018-10-30 17:12:00-04:00,SNY,positive
1162758.0,Sanofi Reports Received Positive CHMP Opinion For Dengue Vaccine,2018-10-19 07:45:00-04:00,SNY,positive
1162759.0,"Sanofi, Novo Nordisk, Lilly Shares Unaffected Amid Report State Of Minnesota Filed Suit Accusing Insulin Manufacturers Of Deceptive Drug Pricing Practices",2018-10-16 15:06:00-04:00,SNY,positive
1162760.0,"The Daily Biotech Pulse: Enzo's Q4 Loss, Sanofi's Positive Trial Results, ImmunoCellular To Delist",2018-10-16 08:52:00-04:00,SNY,positive
1162761.0,"Sanofi, Regeneron Announce Dupixent Showed Positive Topline Results in Two Phase 3 Trials of Patients With Chronic Rhinosinusitis With Nasal Polyps",2018-10-16 04:02:00-04:00,SNY,positive
1162762.0,Aimmune Therapeutics Announces Initiation of Phase 2 Study With Regeneron and Sanofi of AR101 With Adjunctive Dupilumab in Peanut-Allergic Patients,2018-10-15 08:02:00-04:00,SNY,neutral
1162763.0,"The Week Ahead In Biotech: ESMO Conference, PDUFA Dates, Clinical Trial Results And IPOs",2018-10-14 13:21:00-04:00,SNY,neutral
1162764.0,Altimmune Shares Volatile After Presentation of Positive Flu Vaccine Data at IDWeek,2018-10-08 09:50:00-04:00,SNY,positive
1162765.0,FDA Approves Regeneron And Sanofi's Libtayo (cemiplimab-rwlc) As First And Only Treatment for Advanced Cutaneous Squamous Cell Carcinoma,2018-09-28 16:40:00-04:00,SNY,positive
1162766.0,Attention Biotech Investors: Mark Your Calendar For These October PDUFA Dates,2018-09-26 16:41:00-04:00,SNY,neutral
1162767.0,"Sanofi, Regeneron Report FDA Will Review Supplemental Biologics License Application For Praluent For Treatment To Reduce Major Adverse Cardiovascular Events",2018-09-12 08:10:00-04:00,SNY,negative
1162768.0,"Sanofi, Regeneron Announces FDA to Review Supplemental Biologics License Application for Praluent Injection as Potential Treatment to Reduce Major Adverse Cardiovascular Events",2018-09-12 04:24:00-04:00,SNY,negative
1162769.0,"BofA Upgrades Sanofi, Names 3 Growth Drivers For Pharma Stock",2018-09-10 15:58:00-04:00,SNY,positive
1162770.0,Bank of America Upgrades Sanofi to Buy,2018-09-10 09:42:00-04:00,SNY,neutral
1162771.0,"Sanofi PR Confirms Earlier Reports That The Co. Reached A Deal With The SEC Regarding Possible Violations Of FCPA, Will Pay $25.206M",2018-09-04 12:17:00-04:00,SNY,negative
1162772.0,"Sanofi Charged With FCPA Violations, Will Pay $25M To Resolve Charges",2018-09-04 11:44:00-04:00,SNY,negative
1162773.0,"Sanofi on Monday Announced European Commission Has Approved Cablivi For Adults With aTTP, A Rare Blood-Clotting Disoder",2018-09-04 08:39:00-04:00,SNY,positive
1162774.0,"The Daily Biotech Pulse: Immunomedics' Bottom-Line Miss; Kala, Regeneron Await FDA Verdict",2018-08-24 08:47:00-04:00,SNY,positive
1162775.0,"UPDATE: Alnylam PDUFA Date Related To Patisiran APOLLO Is Sat., Aug. 11; A Decision Ahead Of The Date Could Come Today; Sanofi Is Working With Alnylma Related To Patisiran",2018-08-10 12:26:00-04:00,SNY,neutral
1162776.0,"Benzinga's Top Upgrades, Downgrades For August 10, 2018",2018-08-10 09:17:00-04:00,SNY,positive
1162777.0,Citigroup Upgrades Sanofi to Buy,2018-08-10 07:23:00-04:00,SNY,neutral
1162778.0,REMINDER: Alnylam and Sanofi Have FDA PDUFA Date for Patisiran APOLLO Saturday Aug. 11th,2018-08-09 15:15:00-04:00,SNY,neutral
1162779.0,Attention Biotech Investors: Mark Your Calendar For These August PDUFA Dates,2018-08-01 07:38:00-04:00,SNY,neutral
1162780.0,UPDATE: Sanofi's Drug Inventory Increased To Total Of 14 Weeks For All Therapeutics Areas,2018-07-31 14:45:00-04:00,SNY,positive
1162781.0,UPDATE: Sanofi's Brexit-Related Preparations Began About A Year Ago,2018-07-31 14:44:00-04:00,SNY,neutral
1162782.0,Sanofi Has Been Stockpiling Drugs For 6 Months For No-Deal Brexit,2018-07-31 14:44:00-04:00,SNY,neutral
1162783.0,"Sanofi Shares Unaffected As Co. Discloses Shipping Of 25M Doses Of Flublok Quadrivalent, Fluezone High-Dose Vaccine For This Year's Flu Season",2018-07-30 13:39:00-04:00,SNY,negative
1162784.0,"UPDATE: Sanofi, Revolution Will Jointly Develop SHP2 Inhibitors",2018-07-18 06:08:00-04:00,SNY,negative
1162785.0,UPDATE: Sanofi Says Revolutions Medicine To Receive Upfront Payment OF $50M From Sanofi,2018-07-18 06:08:00-04:00,SNY,neutral
1162786.0,UPDATE: Sanofi Sees Beginning First-In-Human Trials With RMC-4630 In 2H'18,2018-07-18 06:07:00-04:00,SNY,neutral
1162787.0,"Sanofi, Revolution Medicines Report Launch Of Global Partnership To Develop Potential First-In-Class Targeted Treatments For Multiple Cancers",2018-07-18 06:07:00-04:00,SNY,neutral
1162788.0,"Benzinga's Daily Biotech Pulse: AbbVie Files sNDA For Leukemia Drug, AcelRx Offering, Aurinia Starts Mid-Stage Trial",2018-07-12 08:37:00-04:00,SNY,neutral
1162789.0,BofA Revives Myokardia With New Buy Rating,2018-07-10 14:06:00-04:00,SNY,positive
1162790.0,Sanofi Genzyme Is Disappointed With Recent Recommendation By Cadth To Not Reimburse Dupixent,2018-07-10 07:08:00-04:00,SNY,negative
1162791.0,"UPDATE: RG-012 Recruitment Is Paused While Discussions With Sanofi To Restructure The Cos.' Partnership Are Ongoing; Regulus Will Also Reduce Workforce By ~60%, Expects Actions To Yield $20M In Annualized Savings",2018-07-05 17:02:00-04:00,SNY,neutral
1162792.0,"Trade Wars Aside, First Half Of 2018 Sees Highest Value Of Cross-Border M&A In A Decade",2018-07-05 13:30:00-04:00,SNY,negative
1162793.0,A Look At Biotech In 2018 And The Biggest Catalysts Coming Up In The Second Half Of The Year,2018-07-05 12:25:00-04:00,SNY,neutral
1162794.0,Sanofi Announces CHMP Recommends Approval of Cablivi,2018-06-29 03:56:00-04:00,SNY,positive
1162795.0,"Sanofi, Advent Finalize Negotiations for Acquisition of Zentiva",2018-06-28 04:05:00-04:00,SNY,neutral
1162796.0,Sanofi's Toujeo Met its Primary Endpoint,2018-06-25 08:03:00-04:00,SNY,neutral
1162797.0,Watching Shares of Regeneron After Traders Circulate Unconfirmed Chatter Of Offer From Sanofi,2018-06-20 13:52:00-04:00,SNY,positive
1162798.0,Sanofi Completes Acquisition of Ablynx Following Expiration of the Squeeze-out Procedure,2018-06-19 04:27:00-04:00,SNY,neutral
1162799.0,Sanofi appoints Jean-Baptiste Chasseloup de Chatillon CFO,2018-06-19 04:26:00-04:00,SNY,neutral
1162800.0,"Benzinga's Daily Biotech Pulse: vTv Swoons On Failed Alzheimer's Trial, Regenxbio Gets FDA Fast Track For RGX-111",2018-06-13 07:48:00-04:00,SNY,negative
1162801.0,Sanofi Shares Unaffected As Traders Circulate Word France's National Agency For Medicines And Health Products Said Co.'s Valproate Is Forbidden From Usage During Pregnancy,2018-06-12 13:48:00-04:00,SNY,negative
1162802.0,Translate Bio Announces 3-Year Collaboration Agreement With Sanofi To Develop Vaccines For Up To 5 Infectious Diseases Using mRNA Technology; Sanofi Will Make $45M Upfront Payment To Translate Bio,2018-06-11 07:03:00-04:00,SNY,positive
1162803.0,"Regeneron, Sanofi Report New England Journal of Medicine Publishes Pivotal Cemiplimab Trials Showing Results in Advanced Cutaneous Squamous Cell Carcinoma",2018-06-04 14:18:00-04:00,SNY,positive
1162804.0,The Week Ahead In Biotech: ASCO Presentations Dominate The Headlines,2018-06-03 19:27:00-04:00,SNY,negative
1162805.0,"Jim Cramer Shares His Thoughts On Lululemon, Regeneron And More",2018-06-01 07:38:00-04:00,SNY,positive
1162806.0,"The Market In 5 Minutes: Right To Try, Uber, Buffett, Jobless Claims And More",2018-05-31 09:00:00-04:00,SNY,neutral
1162807.0,"Benzinga's Daily Biotech Pulse: Clinical Hold For Crispr, Gilead Study Meets Endpoint, Akers Gets Grace Time",2018-05-31 08:22:00-04:00,SNY,positive
1162808.0,"After Roseanne Blames Ambien For Tweet, Sanofi Says Sleep Aid's Side Effects Don't Include Racism",2018-05-30 10:56:00-04:00,SNY,positive
1162809.0,"'People of all races, religions and nationalities work at Sanofi every day to improve the lives of people around the world. While all pharmaceutical treatments have side effects, racism is not a known side effect of any Sanofi medication' - Sanofi Tweets",2018-05-30 10:12:00-04:00,SNY,negative
1162810.0,FDA To Review Sanofi's Zynquista™ (Sotagliflozin) As Potential Treatment For Type 1 Diabetes,2018-05-22 08:08:00-04:00,SNY,neutral
1162811.0,"Sanofi, Regeneron Announce New England Journal of Medicine Published 2 Positive Phase 3 Trials Showing Dupixent (dupilumab) Improved Moderate-to-Severe Asthma",2018-05-21 14:15:00-04:00,SNY,positive
1162812.0,UPDATE: Sanofi Says US Regulatory Submission For Patients Aged 12-17 Planned For Q3'18,2018-05-16 08:03:00-04:00,SNY,neutral
1162813.0,"Sanofi Reports Dupixent Phase 3 Trial Results Met Primary, Key Secondary Endpoints",2018-05-16 08:02:00-04:00,SNY,neutral
1162814.0,"Bioverativ, Sangamo Announce FDA Acceptance of IND Application for Gene-Edited Cell Therapy BIVV003 to Treat Sickle Cell Disease",2018-05-16 07:31:00-04:00,SNY,positive
1162815.0,"Sanofi, Regeneron Announce Dupixent Phase 3 Trial in Adolescents With Inadequately Controlled Moderate-to-severe Atopic Dermatitis Met Primary, Secondary Endpoints",2018-05-16 03:52:00-04:00,SNY,negative
1162816.0,"Sanofi, Ablynx Announce Successful Results of Initial Tender Offer Period for Ablynx; Commencement of Squeeze-out Tender Period",2018-05-14 03:39:00-04:00,SNY,positive
1162817.0,"Benzinga's Daily Biotech Pulse: ARMO Skyrockets On Eli Lilly Deal, Akcea Meets FDA Panel, vTv Alzheimer's Trial Results",2018-05-10 09:44:00-04:00,SNY,neutral
1162818.0,"Regeneron and Sanofi to Lower the Price of Praluent Injection in Exchange for 'Straightforward, More Affordable' Patient Access for Express Scripts Patients",2018-05-01 07:03:00-04:00,SNY,negative
1162819.0,Sanofi Announces FDA to Conduct Priority Review of Cemiplimab as Potential Treatment for Advanced Cutaneous Squamous Cell Carcinoma,2018-04-30 03:52:00-04:00,SNY,positive
1162820.0,"Benzinga's Daily Biotech Pulse: Intra-cellular Moves On Poster Presentation, Earnings Beats From Vertex, Exact Sciences",2018-04-27 07:25:00-04:00,SNY,neutral
1162821.0,Zealand Pharma Announces Q1 2018 Net Sales by Sanofi from Soliqua 100/33/ Suliqua of $11.1M; From Lyxumia/Adlyxin $6.7M,2018-04-27 04:18:00-04:00,SNY,neutral
1162822.0,Sanofi 'sHead of Global R&D Elias Zerhouni to Retire; John Reed to Succeed Zerhouni on July 1,2018-04-24 03:47:00-04:00,SNY,positive
1162823.0,"The Week Ahead In Biotech: PDUFA Dates, IPOs And More",2018-04-20 14:00:00-04:00,SNY,neutral
1162824.0,"WHO Says Sanofi's Dengue Vaccine Should Be Dealt With 'In Safer Way' By Using It Exclusively In People Already Infected, Recommends Testing Before Individuals Are Given Co.'s Dengue Vaccine",2018-04-19 10:14:00-04:00,SNY,positive
1162825.0,Sanofi Shares Unch Following Report CFO Jerome Contamine To Leave Co. Later In '18,2018-04-17 14:45:00-04:00,SNY,positive
1162826.0,"Alnylam's President Talks Strategy To Become A Top Biotech Company, 'Developing An Entirely New Class Of Medicine'",2018-04-17 11:21:00-04:00,SNY,positive
1162827.0,"Advent in Talks to Acquire Zentiva, Sanofi's European Generics Business for €1.9B",2018-04-17 04:12:00-04:00,SNY,neutral
1162828.0,Sanofi to Invest €350M in Canadian Vaccine Facility,2018-04-12 03:59:00-04:00,SNY,neutral
1162829.0,"Regeneron, Sanofi Announce EMA to Review DUPIXENT as Potential Treatment for Inadequately Controlled Moderate-to-Severe Asthma",2018-04-03 04:02:00-04:00,SNY,negative
1162830.0,"Regeneron, Sanofi Announce EMA to Review Cemiplimab as Potential Treatment for Advanced Cutaneous Squamous Cell Carcinoma",2018-04-03 04:00:00-04:00,SNY,positive
1162831.0,Lexicon Pharmaceuticals Announces EMA Acceptance of Marketing Authorization Application for Sotagliflozin to Treat Adults With Type 1 Diabetes,2018-03-29 04:05:00-04:00,SNY,positive
1162832.0,Sanofi Reports EMA to Review Sotagliflozin as Potential Treatment for Type 1 Diabetes,2018-03-29 04:01:00-04:00,SNY,neutral
1162833.0,The FDA Approves Sanofi's Toujeo Insulin Pen,2018-03-27 08:08:00-04:00,SNY,positive
1162834.0,Torrent Pharma May Raise 15B Rupees in Preparation of Bid for Sanofi Generics Business -Live Mint,2018-03-14 04:31:00-04:00,SNY,neutral
1162835.0,"Regeneron And Sanofi On Saturday Announced Plan To Expand Accessibility And Affordability Of Praluent, Will Offer Reduced Net Price To Payers Willing To Reduce Access Barriers For Highest-Risk Patients",2018-03-12 08:24:00-04:00,SNY,positive
1162836.0,"Sanofi, Regeneron Announce ODYSSEY OUTCOMES Trial Met Primary Endpoint",2018-03-10 19:32:00-05:00,SNY,neutral
1162837.0,Height Casts 65% Odds That Congress Rolls Back Pharma Discounts,2018-03-07 11:31:00-05:00,SNY,neutral
1162838.0,"Sanofi Says It'll Decide Within 2 Months Whether To File Application For Dengvaxia In U.S., Is In Talks With External Partners To Develop Dengue Infection Test",2018-03-07 11:13:00-05:00,SNY,neutral
1162839.0,Torrent Pharma to Submit €2B Binding Offer for Sanofi's Generic Drug Unit-LiveMint,2018-03-07 04:01:00-05:00,SNY,neutral
1162840.0,An Eventful February Took Its Toll On TD Ameritrade's Investor Index,2018-03-06 16:17:00-05:00,SNY,neutral
1162841.0,7 Biotech Stocks With Clinical Trial Outcomes In March,2018-03-05 12:01:00-05:00,SNY,neutral
1162842.0,"Regeneron, Sanofi Announce FDA to Review DUPIXENT as Potential Treatment for Moderate-to-Severe Asthma",2018-03-02 04:07:00-05:00,SNY,neutral
1162843.0,"Novavax Shares Rise 30% On Positive Data, But Risks Remain",2018-03-01 08:47:00-05:00,SNY,positive
1162844.0,Benzinga Pro's 4 Stocks To Watch Today,2018-03-01 08:41:00-05:00,SNY,neutral
1162845.0,Sanofi Receives Antitrust Clearances in Connection with the Acquisition of Ablynx,2018-03-01 04:37:00-05:00,SNY,neutral
1162846.0,"CDC Still Recommends Sanofi, GlaxoSmithKline Vaccines As Flu-Related Deaths Rise",2018-02-12 16:26:00-05:00,SNY,positive
1162847.0,25 Stocks Moving In Monday's Pre-Market Session,2018-02-12 08:06:00-05:00,SNY,neutral
1162848.0,"Sanofi and SK Chemicals Announce an Agreement for Cell Culture Technology, Worth up to $155M of Milestone Payments",2018-02-12 06:41:00-05:00,SNY,positive
1162849.0,Sanofi Commences Tender Offer for Acquisition of Bioverativ for $105/Share in Cash,2018-02-08 05:59:00-05:00,SNY,neutral
1162850.0,"UPDATE: Sanofi Reports Q4 $1.31, Sales $13.25B",2018-02-07 07:45:00-05:00,SNY,neutral
1162851.0,"Sanofi Report Q4 EPS EUR 1.06, Sales EUR 8.69B",2018-02-07 07:43:00-05:00,SNY,neutral
1162852.0,Sanofi Sees FY18 Business EPS Up 2-5%,2018-02-07 07:43:00-05:00,SNY,neutral
1162853.0,"Earnings Scheduled For February 7, 2018",2018-02-07 04:52:00-05:00,SNY,neutral
1162854.0,"UPDATED: Carlyle, BC Partners, Advent And A Consortium Of Blackstone And Nordic Capital Are Among Financial Investors Shortlisted By Sanofi For Generic Drugs Sale",2018-02-05 12:44:00-05:00,SNY,neutral
1162855.0,"Brazil's EMS, India's Torrent Pharma Among Firms On Shortlist To Submit Final Bids For Sanofi's Generic Drugs Unit",2018-02-05 12:41:00-05:00,SNY,neutral
1162856.0,Partner Therapeutics (PTx) Acquires Leukine from Sanofi,2018-02-01 07:16:00-05:00,SNY,neutral
1162857.0,Attention Biotech Investors: February PDUFA Catalysts Come Calling,2018-01-31 15:30:00-05:00,SNY,neutral
1162858.0,"Sanofi, DNDi Seek European Medicines Agency Review for Sleeping Sickness Treatment",2018-01-31 04:00:00-05:00,SNY,neutral
1162859.0,Sanofi On A Buyout Spree This Month: Announces Ablynx Acquisition For $4.8 Billion,2018-01-30 10:45:00-05:00,SNY,neutral
1162860.0,38 Biggest Movers From Yesterday,2018-01-30 04:37:00-05:00,SNY,neutral
1162861.0,35 Stocks Moving In Monday's Mid-Day Session,2018-01-29 12:21:00-05:00,SNY,neutral
1162862.0,"The Market In 5 Minutes: Steve Wynn, Sanofi-Ablynx, Trump's Infrastructure Plan",2018-01-29 09:10:00-05:00,SNY,neutral
1162863.0,28 Stocks Moving In Monday's Pre-Market Session,2018-01-29 08:00:00-05:00,SNY,neutral
1162864.0,A Peek Into The Markets: U.S. Stock Futures Down Ahead Of Consumer Spending Data,2018-01-29 07:07:00-05:00,SNY,neutral
1162865.0,Sanofi to Acquire Ablynx for €3.9B,2018-01-29 03:44:00-05:00,SNY,neutral
1162866.0,Argus: Bioverativ Shares Fully Valued After Sanofi Buyout Offer,2018-01-24 11:40:00-05:00,SNY,positive
1162867.0,Pharma M&A Picks Up Momentum,2018-01-23 13:56:00-05:00,SNY,neutral
1162868.0,Biotech M&A Off To A Strong Start In 2018: More Deals To Follow?,2018-01-23 10:58:00-05:00,SNY,positive
1162869.0,"Benzinga's Top Upgrades, Downgrades For January 23, 2018",2018-01-23 09:18:00-05:00,SNY,positive
1162870.0,Barclays Downgrades Sanofi to Underweight,2018-01-23 06:52:00-05:00,SNY,neutral
1162871.0,38 Biggest Movers From Yesterday,2018-01-23 04:55:00-05:00,SNY,neutral
1162872.0,Mid-Afternoon Market Update: Bioverativ Climbs Following $105/Share Offer From Sanofi; Recon Technology Shares Drop,2018-01-22 14:33:00-05:00,SNY,neutral
1162873.0,Bioverativ Shares Up 61.6% Following $105/Share Offer From Sanofi,2018-01-22 13:11:00-05:00,SNY,positive
1162874.0,32 Stocks Moving In Monday's Mid-Day Session,2018-01-22 12:46:00-05:00,SNY,neutral
1162875.0,Mid-Day Market Update: Juno Therapeutics Surges On Acquisition News; Sanmina Shares Plummet,2018-01-22 12:02:00-05:00,SNY,positive
1162876.0,Mid-Morning Market Update: Markets Gain; Halliburton Profit Beats Estimates,2018-01-22 10:29:00-05:00,SNY,positive
1162877.0,Benzinga Pro's 6 Stocks To Watch Today,2018-01-22 08:55:00-05:00,SNY,neutral
1162878.0,30 Stocks Moving In Monday's Pre-Market Session,2018-01-22 07:58:00-05:00,SNY,neutral
1162879.0,A Peek Into The Markets: U.S. Stock Futures Drop After Government Shutdown,2018-01-22 06:42:00-05:00,SNY,negative
1162880.0,"8 Stocks To Watch For January 22, 2018",2018-01-22 04:22:00-05:00,SNY,neutral
1162881.0,"Sanofi to Acquire Bioverativ for $11.6B, $105/Share in Cash",2018-01-22 04:01:00-05:00,SNY,neutral
1162882.0,"Friday U.S. CDC Announced America At Peak Of Flue Season With Flu Outbreak Across Entire Continental U.S. For First Time; Potential Positive For Flu Vaccine Manufacturers e.g. Sanofi, GlaxoSmithKline",2018-01-16 09:28:00-05:00,SNY,negative
1162883.0,Sanofi Makes 1st Milestone Payment Of To €3M Evotec And Apeiron,2018-01-08 09:55:00-05:00,SNY,neutral
1162884.0,"Regeneron, Sanofi To Accelerate and Expand Investment for Cemiplimab and Dupilumab Development Programs From $1B To $1.64B",2018-01-08 07:08:00-05:00,SNY,positive
1162885.0,"Sanofi, Alnylam Enter into Strategic Restructuring of RNAi Therapeutics Rare Disease Alliance; Sanofi to Pay Alnylam $50M Milestone Following Dosing of First Patient in ATLAS Phase 3 Program for itusiran",2018-01-07 15:40:00-05:00,SNY,negative
1162886.0,Alnylam and Sanofi Submit Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for Patisiran for the Treatment of Hereditary ATTR (hATTR) Amyloidosis,2017-12-18 07:09:00-05:00,SNY,neutral
1162887.0,Sanofi Issues Release Highlighting FDA's Lifting Of Clinical Hold On Fitusiran,2017-12-15 07:03:00-05:00,SNY,neutral
1162888.0,Mylan Reports US Patent And Trademark Appeal Board Instituted Inter Partes Review Proceedings On All Claims Against Sanofi's Lantus Patents,2017-12-14 07:33:00-05:00,SNY,neutral
1162889.0,"Regeneron, Sanofi Announce Positive Topline Pivotal Results for PD-1 Antibody Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma",2017-12-13 03:56:00-05:00,SNY,positive
1162890.0,PR Confirms FDA Approves Sanofi's Admelog,2017-12-11 13:11:00-05:00,SNY,positive
1162891.0,3 Stocks In Focus As Biotech M&A Hopes For 2018 Rise,2017-12-11 12:52:00-05:00,SNY,positive
1162892.0,FDA Reports Approval Of Sanofi's Admelog,2017-12-11 12:47:00-05:00,SNY,positive
1162893.0,Sanofi Explores Combination Treatments For Multiple Myeloma In New Late-Stage Trials,2017-12-07 08:12:00-05:00,SNY,neutral
1162894.0,EMA Says Sanofi's Dengue Vaccine Currently Being Reviewed For Authorization,2017-12-04 13:17:00-05:00,SNY,neutral
1162895.0,"WHO To Conduct Full Review Of Data On Revised Guidance For The Use Of  Dengvaxia, Philippines Ordered A Probe Following An Announcement By Sanofi Saying The Drug Could Worsen Disease In Some Cases, Co. Says Most Doses Were Sold In Philippines And Brazil",2017-12-04 11:11:00-05:00,SNY,negative
1162896.0,Sanofi's Toujeo Met Primary Study Objective in Head-to-head Study vs Insulin Degludec,2017-12-04 04:15:00-05:00,SNY,neutral
1162897.0,Sanofi Ends Development Of Clostridium Difficile Vaccine,2017-12-01 16:06:00-05:00,SNY,neutral
1162898.0,"Benzinga's Top Upgrades, Downgrades For December 1, 2017",2017-12-01 09:11:00-05:00,SNY,positive
1162899.0,UPDATE: Sanofi Release Updating Info On Dengue Vaccine Included Affirmed Guidance Which Was Provided On Nov. 2: Sees 'broadly stable Business EPS(1) at CER in 2017 versus 2016',2017-11-29 11:49:00-05:00,SNY,positive
1162900.0,UPDATE: Sanofi Says 'will ask regulators to update product label to reflect new information',2017-11-29 11:39:00-05:00,SNY,neutral
1162901.0,Sanofi Offers Update On Dengue Vaccine: 'New analysis of long-term Dengvaxia® data found differences in vaccine performance based on prior dengue infection',2017-11-29 11:38:00-05:00,SNY,neutral
1162902.0,Barclays Upgrades Sanofi American Depositary Shares (Each repstg one-half of one ordinary share) to Equal-Weight,2017-11-15 09:36:00-05:00,SNY,positive
1162903.0,Sanofi Reports Will Develop Principia Biopharma's Experimental Oral Treatment Which Shows Promise In MS And Potentially Other Central Nervous System Diseases,2017-11-09 07:40:00-05:00,SNY,positive
1162904.0,Regeneron Pharmaceuticals Gains A Bull Ahead Of Earnings,2017-11-03 13:52:00-04:00,SNY,positive
1162905.0,"Alnylam And Sanofi Present 'Positive' Results From Phase 3 APOLLO Study Of Patisiran, Met Primary Endpoint",2017-11-02 10:47:00-04:00,SNY,neutral
1162906.0,Sanofi Reaffirms FY17 Guidance,2017-11-02 08:22:00-04:00,SNY,neutral
1162907.0,"Sanofi Reports Q3 IFRS EPS €1.25, Down 3.8%, Sales €9.053B, Up 0.3% On Reported Basis",2017-11-02 08:22:00-04:00,SNY,neutral
1162908.0,"Earnings Scheduled For November 2, 2017",2017-11-02 05:08:00-04:00,SNY,neutral
1162909.0,"Sanofi Reports Dupilumab Significantly Reduced Steroid Use, Asthma Attacks, Improved Lung Function In Phase 3 Study Of People With Severe Steroid-Dependent Asthma",2017-10-31 07:56:00-04:00,SNY,negative
1162910.0,"Regeneron Reports Results From Phase 3 Study Of Dupilumab In People With Severe Steroid-Dependent Asthma: 'Significantly Reduced Steroid Use, Asthma Attacks, and Improved Lung Function'",2017-10-31 07:23:00-04:00,SNY,negative
1162911.0,Voyager Therapeutics Gains Full Worldwide Rights To VY-AADC,2017-10-30 16:33:00-04:00,SNY,positive
1162912.0,"Sanofi Reports Filing Of US Suit To Defend Patent Rights On Lantus, Lantus SoloStar",2017-10-24 16:09:00-04:00,SNY,neutral
1162913.0,Sanofi and Regeneron Announce 'Positive' Phase 2 Study Results for Dupilumab in Patients With Active Moderate-to-Severe Eosinophilic Esophagitis,2017-10-16 08:03:00-04:00,SNY,positive
1162914.0,Three Ways To Approach The Cannabis Trade,2017-10-12 12:33:00-04:00,SNY,neutral
1162915.0,Sanofi Invests €170M in New Vaccine Production Facility in France,2017-10-12 04:03:00-04:00,SNY,neutral
1162916.0,Sanofi Issues Pre-Quarterly Results Communication:,2017-10-11 16:33:00-04:00,SNY,neutral
1162917.0,A Deep Dive Into MannKind's Big Bet On Afrezza,2017-10-11 11:45:00-04:00,SNY,neutral
1162918.0,New Label For Afrezza Could Turn Things Around At MannKind,2017-10-10 10:21:00-04:00,SNY,neutral
1162919.0,Amgen 'Disappointed' In Court Decision To Reverse Praluent Sales Ban,2017-10-05 12:40:00-04:00,SNY,negative
1162920.0,Regeneron PR Confirms Appellate Court Orders a New Trial and Vacates Permanent Injunction in Ongoing Patent Case Regarding Praluent,2017-10-05 12:31:00-04:00,SNY,neutral
1162921.0,"UPDATE: Amgen Highlights To Benzinga, In Process Of Lifting Ban, U.S. Appeals Court Also Rejected A Main Argument Brought By Sanofi & Regeneron; Co. States 'We look forward to reasserting our rights in court'",2017-10-05 12:16:00-04:00,SNY,negative
1162922.0,"Amgen Responds To U.S. Appeals Court Decision to Reverse District Court Ban On Sales Of Sanofi/Regnereron's Praluent, Tells Benzinga: 'We are disappointed by the Court's action,' Ability To Deliver New Medicines Depends On 'Meaningful patent protection'",2017-10-05 12:16:00-04:00,SNY,negative
1162923.0,"Regeneron Shares Halted Up 1.8% Following Earlier Report Appeals Court Has Thrown Out Ban On Sanofi, Regeneron's Praluent Brought By Amgen",2017-10-05 11:04:00-04:00,SNY,negative
1162924.0,UPDATE: Court Filing Confirms Earlier Rumor Of Sanofi Winning New Trial vs Amgen In Case Over Praluent,2017-10-05 10:12:00-04:00,SNY,positive
1162925.0,Hearing Sanofi Wins New Trial In Amgen Case Over Praluent,2017-10-05 09:56:00-04:00,SNY,positive
1162926.0,"Regeneron, Sanofi Announce Approval of DUPIXENT in EU to Treat Adult Patients with Moderate-to-Severe Atopic Dermatitis",2017-09-28 04:32:00-04:00,SNY,positive
1162927.0,"Sputnik News Reports 'Anti-HIV Fight: 'New Method Doesn't Give Virus a Chance to Resist Treatment', Mentions Sanofi In Study Of New Antibody",2017-09-26 11:29:00-04:00,SNY,negative
1162928.0,What's Next For L'Oreal After The Death Of Billionaire Liliane Bettencourt?,2017-09-22 13:20:00-04:00,SNY,negative
1162929.0,Alnylam Pharmaceutical Surges After Rare Disease Drug Met Key Endpoints,2017-09-20 08:25:00-04:00,SNY,neutral
1162930.0,Alnylam and Sanofi APOLLO Phase 3 Study Met Primary and All Secondary Endpoints,2017-09-20 07:01:00-04:00,SNY,neutral
1162931.0,"Sanofi, Regeneron Announce Positive Study Results for Dupixent in Patients With Moderate-to-Severe Atopic Dermatitis",2017-09-17 10:00:00-04:00,SNY,positive
1162932.0,Sanofi Reports Soliqua 100/33 Provided Earlier Blood Sugar Control vs Insulin Glargine 100 Units/mL,2017-09-12 07:03:00-04:00,SNY,neutral
1162933.0,"Regeneron, Sanofi Announce Positive Dupilumab Topline Results from Phase 3 Trial in Uncontrolled Persistent Asthma",2017-09-11 04:09:00-04:00,SNY,positive
1162934.0,What Pharmaceuticals Spend On Lobbying To Influence Trump,2017-09-09 16:28:00-04:00,SNY,negative
1162935.0,Sanofi Issues Release Highlighting Update On Alnylam's Fitusiran Development Program,2017-09-07 07:21:00-04:00,SNY,neutral
1162936.0,Sanofi Receives Tentative FDA Approval of Admelog,2017-09-01 14:00:00-04:00,SNY,positive
1162937.0,"The Pullback In Sanofi Is A Buying Opportunity, Says Argus",2017-09-01 09:54:00-04:00,SNY,positive
1162938.0,"Benzinga's Top Upgrades, Downgrades For August 30, 2017",2017-08-30 09:17:00-04:00,SNY,positive
1162939.0,HSBC Upgrades Sanofi American Depositary Shares (Each repstg one-half of one ordinary share) to Hold,2017-08-30 06:54:00-04:00,SNY,positive
1162940.0,Assessing The Eligible Suitors For Estee Lauder If Acquisition Rumors Are True,2017-08-28 12:30:00-04:00,SNY,positive
1162941.0,Mylan's Stock Is No Longer A Buy According To Analysts At Argus,2017-08-22 09:07:00-04:00,SNY,negative
1162942.0,"Sanofi, Aventis To Receive $38.7M As Share Of Federal Recovery As Whistleblower In Mylan Case According To DoJ",2017-08-17 13:12:00-04:00,SNY,positive
1162943.0,"Democrats On House Committe On Oversight & Govt. Reform Say Launching Into MS Drug Pricing, Committee Send Letters To Biogen, Teva, Sanofi, Roche, Novartis, And Bayer",2017-08-17 11:17:00-04:00,SNY,neutral
1162944.0,Where Does Zika Virus Vaccine Research Stand Now?,2017-08-12 14:51:00-04:00,SNY,neutral
1162945.0,"Pfizer, Sanofi, Glaxo Shares Unaffected Amid Comment From Mexican Anti-Trust Agency Official Suggesting Drugs Sold By Those Cos. Do Not Face Competition From Generics Readily Available Elsewhere",2017-08-09 10:56:00-04:00,SNY,positive
1162946.0,Sanofi Issues Release Highlighting Filing Of Suit In US To Defend Its Patent Rights On Lantus,2017-08-08 15:33:00-04:00,SNY,neutral
1162947.0,"This Week's Pharma, Energy IPOs",2017-08-07 12:32:00-04:00,SNY,positive
1162948.0,Expectations For Regeneron No Longer Realistic; Analyst Downgrades,2017-08-01 09:58:00-04:00,SNY,negative
1162949.0,"Sanofi Raises FY 2017 Guidance, Sees FY EPS EUR 1.35",2017-07-31 07:31:00-04:00,SNY,neutral
1162950.0,"Earnings Scheduled For July 31, 2017",2017-07-31 04:42:00-04:00,SNY,neutral
1162951.0,"Regeneron, Sanofi Report Received Positive CHMP Opinion For Dupixent To Treat Adult Patients With Moderate-To-Severe Atopic Dermatitis",2017-07-21 07:30:00-04:00,SNY,positive
1162952.0,Sanofi and Regeneron's Dupixent for Severe Eczema Recommended for Approval by the EU Medicines Agency,2017-07-21 07:22:00-04:00,SNY,positive
1162953.0,"AstraZeneca CEO Rumor Reportedly Ends, Shares Rise",2017-07-18 13:34:00-04:00,SNY,positive
1162954.0,"Foreign Stock Roundup: Infosys Beats, Taiwan Semiconductor Misses",2017-07-18 13:33:00-04:00,SNY,negative
1162955.0,Sanofi to acquire Protein Sciences for $650M Upfront; Up to $100M in Milestones,2017-07-11 03:55:00-04:00,SNY,neutral
1162956.0,Adam Feuerstein Tweets: Experimental gene-silencing drug from $ALNY and $SNY shows strong results in hemophilia —> statnews.com/2017/07/10/aln…,2017-07-10 09:33:00-04:00,SNY,positive
1162957.0,"UPDATE: Alnylam, Sanofi Report 2 Serious Adverse Events Were Possibly Related To The Drug",2017-07-10 09:32:00-04:00,SNY,negative
1162958.0,"UPDATE: Alnylam, Sanofi Report Once Monthly, Subcutaneous Fitusiran Achieves Median Annualized Bleeding Rate (ABR) of One for All Patients and Zero for Patients with Inhibitors in Exploratory Post-hoc Analysis",2017-07-10 09:31:00-04:00,SNY,negative
1162959.0,"Alnylam, Sanofi Genzyme Report Positive Results from Ongoing Phase 2 Open-Label Extension Study",2017-07-10 09:30:00-04:00,SNY,positive
1162960.0,"Alnylam, Sanofi Genzyme Report Initiation Of ATLAS Phase 3 Program With Fitusiran In Patients With Hemophilia A, B With Or Without Inhibitors",2017-07-07 07:30:00-04:00,SNY,positive
1162963.0,"Regeneron, Sanofi Announce EU Approval of Kevzara to Treat Adult Patients with Moderately to Severely Active RA",2017-06-27 04:40:00-04:00,SNY,positive
1162964.0,Dan Loeb's Activist Campaign Against Nestle Goes Against Decades Of History,2017-06-26 08:41:00-04:00,SNY,neutral
1162966.0,How Altimmune Is Trying To Get Ahead Of A Potentially Fatal 'Flu Pandemic',2017-06-23 08:15:00-04:00,SNY,negative
1162970.0,"Wall Street's M&A Chatter From June 20: Calpine, Parexel, Gilead, Spherix-Hoth Therapeutics, Norsat-Hytera",2017-06-21 07:10:00-04:00,SNY,neutral
1162972.0,Sanofi-Aventis US Receives FDA Orphan Designation for Tybost in Treatment of Homozygous Familial Hypercholesterolemia,2017-06-18 22:16:00-04:00,SNY,neutral
1162974.0,PAREXEL Reports Collaboration With Sanofi For Advancement Of Wearable Devices In Life Science Industry,2017-06-15 08:00:00-04:00,SNY,neutral
1162976.0,"Wall Street's M&A Chatter From June 13: Brookdale, Etsy, Roche-Tesaro",2017-06-14 06:53:00-04:00,SNY,neutral
1162977.0,Tesaro Is A Top Rumor Mill Stock Right Now; Here Is A Timeline Of The Chatter,2017-06-13 12:24:00-04:00,SNY,positive
1162979.0,"Wall Street's M&A Chatter From June 12: Neuroderm, Penn Virginia, Tesaro, Synaptics-Conexant",2017-06-13 07:03:00-04:00,SNY,neutral
1162984.0,"Sanofi Reports Data Show Switching to Toujeo, Halved Hypoglycemia Risk in Senior Adults Treated with Basal Insulin",2017-06-11 11:05:00-04:00,SNY,negative
1162985.0,Sanofi Announces New Analysis Shows Soliqua 100/33 Lowered HbA1c by 2%+ in Patients with Screening Levels Greater than 9%,2017-06-11 10:54:00-04:00,SNY,positive
1162986.0,"Sanofi, Regeneron Present Positive Study Results for Investigational PD-1 Antibody REGN2810 #ASCO17",2017-06-04 17:43:00-04:00,SNY,positive
1162987.0,Regeneron and Sanofi Report FDA Approval of Kevzara for Treatment of Moderately to Severely Active RA in Adult Patients,2017-05-22 17:46:00-04:00,SNY,positive
1162988.0,Regeneron And Sanofi Have A Near-Term FDA Catalyst,2017-05-22 14:08:00-04:00,SNY,neutral
1162989.0,REMINDER: Regneron And Sanofi Have Sarilumab FDA PDUFA Date Today,2017-05-22 08:58:00-04:00,SNY,neutral
1162990.0,Sanofi Reports CHMP Recommendation for Approval of Insulin Lispro Biosimilar,2017-05-19 07:12:00-04:00,SNY,positive
1162991.0,"Sanfoi Says Price Increases In U.S. Will Be At Or Below Independent Standard Measure Of Health Care Inflation, NHE Growth Projection",2017-05-09 07:49:00-04:00,SNY,positive
1162992.0,Sanofi Says It Has Decided Not To Sell Cepia Division According To Spokeswoman,2017-05-05 07:30:00-04:00,SNY,neutral
1162993.0,Hearing Sanofi spokesperson Has Said Co. Has Decided Not to Sell Its Cepia Unit,2017-05-05 07:11:00-04:00,SNY,neutral
1162994.0,"Regeneron, Sanofi Issue Results of 'Honestly RA,' Show 80% of RA Patients Report Life-Altering Pain Daily or Multiple Times/Week Despite Treatment",2017-05-02 08:32:00-04:00,SNY,negative
1162995.0,Sanofi Genzyme Reports Approval Of Cerdelga By Health Canada,2017-05-01 08:04:00-04:00,SNY,positive
1162996.0,"Wall Street's M&A Chatter From April 28-30: Walgreens-Rite Aid, Anthem-Cigna, Fox-Tribune Media, Sarepta",2017-05-01 06:55:00-04:00,SNY,neutral
1162997.0,"Exondys Sales, Takeover Speculation Fuel Sarepta Therapeutics",2017-04-28 11:31:00-04:00,SNY,neutral
1162998.0,"Adam Feuerstein Tweets: $SRPT CEO Exits Along With a $SNY Director, So Let's Speculate About a Possible Deal —> thestreet.com/story/14109187…",2017-04-28 08:36:00-04:00,SNY,neutral
1162999.0,Sanofi Reaffirms FY 2017 Guidance,2017-04-28 07:35:00-04:00,SNY,neutral
1163000.0,"Sanofi Q1 EPS EUR 1.42 vs EUR 1.34 YoY, Sales EUR 8.65B vs EUR 7.78B Est",2017-04-28 07:34:00-04:00,SNY,neutral
1163001.0,"Earnings Scheduled For April 28, 2017",2017-04-28 05:00:00-04:00,SNY,neutral
1163002.0,Sanofi's Sanofi Genzyme Reports Data on 6-Year Efficacy of Co.'s Lemtrade in MS Patients Who Experienced  Relapse Between Treatment Courses: Results Observed Were Similar to Those Who Did Not Replace Between Courses,2017-04-25 08:12:00-04:00,SNY,neutral
1163003.0,"Regeneron, Sanofi Report FDA Approval of Once-Monthly Dosing Option for Praluent Injection",2017-04-25 08:02:00-04:00,SNY,positive
1163004.0,Hearing A Court Filing Has Shown Sanofi-Aventis Filed Antitrust Suit Against Mylan Related to Latter's EpiPen,2017-04-24 11:02:00-04:00,SNY,neutral
1163005.0,UPDATE: FT Article Says Investor Argued That Sanofi Should Focus Efforts On Smaller Acquisitions Or Target A Co. That's Unlikely To Draw Rival Bidders Such As Alexion,2017-04-24 09:50:00-04:00,SNY,negative
1163006.0,Hearing FT Reporting Sanofi May Be In Talks With Alexion Pharma,2017-04-24 09:47:00-04:00,SNY,neutral
1163007.0,Sanofi Reports Received FDA Approval of Thymoglobulin for Prevention of Acute Kidney Transplant Rejection,2017-04-24 08:52:00-04:00,SNY,negative
1163008.0,"Regeneron, Sanofi Receive Positive CHMP Opinion for Marketing of Kevzara to Treat Adult Patients with Moderately to Severely Active Rheumatoid Arthritis",2017-04-24 04:21:00-04:00,SNY,positive
1163009.0,EMA Recommends Approval Of Sanofi And Regeneron's Kevzara For Rheumatoid Arthritis Treatment,2017-04-21 13:27:00-04:00,SNY,positive
1163010.0,Financial Times Reporting Sanofi Epilepsy Drug Caused Birth Defects In Children,2017-04-20 10:24:00-04:00,SNY,negative
1163011.0,"Hearing Sanofi's Head of Diabetes Unit Has Said Co. is Considering Diabetes Device Assets Which May Come to Market, is Not Positive a Any Deal Will Happen",2017-04-20 06:30:00-04:00,SNY,negative
1163012.0,Cardiovascular Players Could Be Eyeing Esperion,2017-04-10 11:53:00-04:00,SNY,neutral
1163013.0,Anthrax And Government Contracts: PharmAthene And Altimmune Ahead Of Merger,2017-04-06 16:01:00-04:00,SNY,neutral
1163014.0,"Sanofi May Now Have Moved Past Its Most Challenging Period, Analyst Initiates At Buy",2017-04-06 13:08:00-04:00,SNY,positive
1163015.0,"Benzinga's Top Upgrades, Downgrades For April 6, 2017",2017-04-06 09:28:00-04:00,SNY,positive
1163016.0,"Argus Initiates Coverage On Sanofi American With Buy, Announces $50 Price Target",2017-04-06 07:15:00-04:00,SNY,neutral
1163017.0,Sanofi Announces Toujeo Showed Significant Reductions in Blood Sugar and Significantly Lower Incidence of Hypoglycemia in a Real-World Observational Study Presented at Endo 2017,2017-04-02 19:45:00-04:00,SNY,negative
1163018.0,Sanofi Hires Advisors for Sale of European Generic Drug Business -Reuters,2017-03-29 06:59:00-04:00,SNY,neutral
1163019.0,Watch These 8 Huge Put Purchases In Wednesday Trade,2017-03-29 04:23:00-04:00,SNY,positive
1163020.0,Benzinga's Option Alert Recap From March 28,2017-03-28 16:26:00-04:00,SNY,positive
1163021.0,"Regeneron, Sanofi To Host Conference Call To Discuss Dupixent FDA Approval Today 4pm ET",2017-03-28 13:51:00-04:00,SNY,positive
1163022.0,Regeneron's Dupixent Passes The FDA Muster; Baird Sees Strong Launch,2017-03-28 12:41:00-04:00,SNY,positive
1163023.0,Option Alert: Sanofy Apr $44 Put; 2642 @Bid @$0.27; Ref=$45.72,2017-03-28 11:40:00-04:00,SNY,positive
1163024.0,TheStreet's Adam Feuerstein Tweets '$REGN $SNY Dupixent approved.',2017-03-28 11:35:00-04:00,SNY,neutral
1163025.0,"Adam Feuerstein Tweets: Tomorow's FDA drug approval decision will be Roche Ocrevus in MS. (Also affecting $BIIB)

Wednesday — $REGN $SNY Dupixent in eczema.",2017-03-27 16:31:00-04:00,SNY,positive
1163026.0,"Wall Street's M&A Chatter From March 23: Citrix, Dow-Dupont, TripAdvisor",2017-03-24 07:15:00-04:00,SNY,neutral
1163027.0,FiercePharma Says Sanofi On Verge Of $1B-Plus Deal For Flexion According To Sources,2017-03-23 10:26:00-04:00,SNY,neutral
1163028.0,"Watching Shares of Regeneron, Sanofi Amid Expectation for Amgen News Related to Repatha at 9 a.m. EDT",2017-03-17 08:15:00-04:00,SNY,positive
1163030.0,Your Guide To Patent Play Exposure,2017-03-11 19:34:00-05:00,SNY,positive
1163031.0,"Regeneron, Sanofi Report Will Present New Phase 3 Praluent Injection Clinical Trial Analyses at ACC.17 Scientific Sessions",2017-03-07 08:03:00-05:00,SNY,neutral
1163032.0,"Regeneron, Sanofi Announce Presentation of Positive Data from Long-Term Pivotal Phase 3 CHRONOS Study of DUPIXENT in Moderate-to-Severe Atopic Dermatitis",2017-03-05 17:51:00-05:00,SNY,positive
1163033.0,Icahn's (Potential) Move Into Biotech,2017-03-04 19:25:00-05:00,SNY,neutral
1163034.0,"Sanofi Pasteur, MedImmune Collaborate on Monoclonal Antibody to Prevent Illnesses Associated with RSV; Sanofi Pasteur to Make Upfront Payment of €120M, Pay up to €495M upon Achievement of Certain Milestones",2017-03-03 04:26:00-05:00,SNY,negative
1163035.0,Sanofi's Kevzara Now Available In Canada For Treatment of Patients With Moderate to Severe Rheumatoid Arthritis,2017-02-28 08:16:00-05:00,SNY,negative
1163036.0,U.S. FTC Approves Final Order Settling Charges That Boehringer Ingelheim $13.53B Asset Swap With Sanofi Would Likely Be Anticompetitive,2017-02-24 13:39:00-05:00,SNY,positive
1163037.0,Carl Icahn's Track Record In Big Pharma,2017-02-24 09:40:00-05:00,SNY,neutral
1163038.0,Breaking Down The Multiple Sclerosis 2017 Formularies: 'Stability Fares Well For The Market',2017-02-23 14:06:00-05:00,SNY,positive
1163039.0,Icahn Takes Bristol-Myers Stake With M&A In Mind; Who Could Be The Acquirer?,2017-02-21 16:48:00-05:00,SNY,neutral
1163040.0,Sanofi Reports Initiation of Phase 2 Trial to Evaluate Therapy for Genetic Form of Parkinson's Disease,2017-02-14 08:03:00-05:00,SNY,neutral
1163041.0,The Market In 5 Minutes: Hello... Can You Hear Me?,2017-02-13 09:29:00-05:00,SNY,neutral
1163042.0,Ipsen to Acquire a Portfolio of Select Consumer Healthcare Products from Sanofi for  €83M in Cash,2017-02-13 04:17:00-05:00,SNY,neutral
1163043.0,Sanofi Near Deal to Sell Some OTC Products to Ipsen for ~€100M -Bloomberg,2017-02-12 20:58:00-05:00,SNY,neutral
1163044.0,Stay Of Court Injunction A Mild Positive For Regeneron,2017-02-09 12:02:00-05:00,SNY,positive
1163045.0,"Regeneron Gets 'Encouraging' Judicial Decision, Could Still Lose Appeal",2017-02-09 11:18:00-05:00,SNY,negative
1163046.0,"Regeneraon and Sanofi PR Confirms Reports Appeals Court Grants Stay of Permanent Injunction for Praluent During Appeals Process, Drug Continues To Be Available To Patients In U.S.",2017-02-08 17:31:00-05:00,SNY,positive
1163047.0,"UPDATE: Court of Appeals in Regeneron, Sanofi, Amgen Case Related to Praluent Issued Order Granting Emergency Motion to Stay Pending Appeal",2017-02-08 16:26:00-05:00,SNY,negative
1163048.0,"Hearing Sanofi, Regeneron Won Order Allow Praluent Sales to Continue",2017-02-08 16:19:00-05:00,SNY,positive
1163049.0,Q4 2016 Real-Time Call Brief,2017-02-08 09:18:00-05:00,SNY,neutral
1163050.0,"Sanofi Sees FY17 EPS To Be Flat To Down 3%, Consistent With Previous Guidance For 2016-2017 Period",2017-02-08 07:32:00-05:00,SNY,neutral
1163051.0,"Sanofi Reports Q4 Business EPS €1.25, Sales €8.867B",2017-02-08 07:32:00-05:00,SNY,neutral
1163052.0,"Earnings Scheduled For February 8, 2017",2017-02-08 04:40:00-05:00,SNY,neutral
1163053.0,Your Guide To 2017's Emerging Pharmaceuticals Catalysts,2017-02-07 14:39:00-05:00,SNY,neutral
1163054.0,Sanofi Reports Xyzal Allergy 24HR Approved for OTC Use in US,2017-02-01 08:07:00-05:00,SNY,positive
1163055.0,"Regeneron, Sanofi Announce First Approval of Kevzara for Treatment of Moderately to Severely Active RA in Adults by Health Canada",2017-02-01 04:14:00-05:00,SNY,positive
1163056.0,"Recent Weakness In Eli Lilly, Novo Nordisk, Sanofi Due To New York Times Reporting Drug Makers Accused Of Fixing Drug Prices On Insulin",2017-01-30 14:45:00-05:00,SNY,negative
1163057.0,"The Market In 5 Minutes: Google And Microsoft And Intel, Oh My!",2017-01-27 09:03:00-05:00,SNY,neutral
1163058.0,Wall Street's M&A Chatter From January 26,2017-01-27 06:58:00-05:00,SNY,neutral
1163059.0,2 New ETFs Worth A Gander,2017-01-20 08:21:00-05:00,SNY,positive
1163060.0,Orphan Drugs Among 2015's Top 10 Best-Selling Medications,2017-01-18 10:40:00-05:00,SNY,positive
1163061.0,Sanofi Reports Suliqua Approved in EU for Treatment of Adults with Type 2 Diabetes,2017-01-17 13:24:00-05:00,SNY,positive
1163062.0,"Form 4 Shows Sanofi Buys 87,298 Shares Of Regeneron Pharmaceutical",2017-01-13 16:20:00-05:00,SNY,positive
1163063.0,Catalyst Alert: Amgen/Regeneron Patent Case Appeal Could Be Decided By April,2017-01-10 09:06:00-05:00,SNY,positive
1163064.0,Why The Amgen/Regeneron Patent Saga Is Far From Over,2017-01-09 12:27:00-05:00,SNY,neutral
1163065.0,Legal Experts Weigh In On The Amgen/Regeneron Patent Case,2017-01-09 10:12:00-05:00,SNY,positive
1163066.0,"Sanofi and ImmuNext Enter into Agreement to Develop Treatments for Autoimmune Diseases, Potential Milestone Payments to ImmuNext up to $500M",2017-01-09 08:06:00-05:00,SNY,positive
1163067.0,Low Odds Court Ruling Against Regeneron Get Reversed On Appeal,2017-01-06 11:48:00-05:00,SNY,negative
1163068.0,Amgen Higher After Favorable Court Ruling,2017-01-06 11:02:00-05:00,SNY,positive
1163069.0,"5 Key Takeaways In Regeneron's Praluent Suit, Steps Forward",2017-01-06 09:04:00-05:00,SNY,neutral
1163070.0,Regeneron Falls As Court Grants Permanent Injunction For Infringement Of Amgen's Repatha Patents,2017-01-06 08:54:00-05:00,SNY,negative
1163071.0,UPDATE: Court Grants Permanent Injunction for Infringement of Amgen's Repatha Patents,2017-01-06 04:37:00-05:00,SNY,negative
1163072.0,Amgen Wins Ban On Sanofi's Sales Of Praluent Cholestrol Drug,2017-01-05 16:46:00-05:00,SNY,neutral
1163073.0,"Regeneron, Sanofi Shares Indicated Lower, Amgen Shares Higher as Hearing Bid to Overturn Amgen's Win in Cholesterol Drug Patent Case Was Lost",2017-01-03 16:50:00-05:00,SNY,positive
1163074.0,Myokardia Reports Sanofi Has Notified Co. That It Elects To Continue Global Cardiomyopathy Research Partnership Formed Aug. 2014,2017-01-03 08:38:00-05:00,SNY,neutral
1163075.0,"Hearing Sanofi Spokesperson Has Said FTC Statement on Divestitures Was 'No Surprise,' and That the Required Sale of Assets Concerns a Small Portfolio of Products",2016-12-28 15:15:00-05:00,SNY,negative
1163076.0,"FTC Will Require Boehringer Ingelheim To Make Divestitures To Eli Lilly, Bayer AG As Conditions For Sanofi Deal",2016-12-28 14:14:00-05:00,SNY,neutral
1163077.0,What You Need To Know About Cempra's 2 PDUFA Dates This Week,2016-12-27 11:08:00-05:00,SNY,neutral
1163078.0,Positive Zika Vaccine Update May Ignite Inovio Short Squeeze,2016-12-21 11:05:00-05:00,SNY,positive
1163079.0,Reasons To Stay Bullish On Alnylam In The New Year,2016-12-19 09:39:00-05:00,SNY,neutral
1163080.0,"The Market In 5 Minutes: Adobe, Oracle Take The Earnings Stage",2016-12-16 09:15:00-05:00,SNY,neutral
1163081.0,Sanofi in Advanced Talks to Acquire Actelion for ~$275/Share -Bloomberg,2016-12-16 04:21:00-05:00,SNY,positive
1163082.0,Wall Street's M&A Chatter From December 14,2016-12-15 06:57:00-05:00,SNY,neutral
1163083.0,Who Else Might Johnson & Johnson Seek To Acquire With Actelion Now Out Of Its Crosshairs?,2016-12-14 13:56:00-05:00,SNY,neutral
1163084.0,"CNBC Now Tweets: LATEST: Sanofi in talks with Actelion, potential deal not seen as imminent - sources",2016-12-14 09:39:00-05:00,SNY,neutral
1163085.0,The Market In 5 Minutes: All Eyes On The Fed,2016-12-14 09:02:00-05:00,SNY,neutral
1163086.0,Sanofi Said to be in Talks with Actelion Pharmaceuticals for Potential Deal -Wall Street Journal,2016-12-14 05:07:00-05:00,SNY,neutral
1163087.0,What We Know About Trump's Potential Pick To Head The FDA,2016-12-12 14:08:00-05:00,SNY,neutral
1163088.0,"Chardan Upgrades Regeneron; Cites Fovista Failure, Stock's Recent Underperformance",2016-12-12 08:28:00-05:00,SNY,negative
1163089.0,"Regeneron, Sanofi Announce Marketing Authorization Application for Dupixent Accepted for Review by EMA",2016-12-08 04:03:00-05:00,SNY,positive
1163090.0,Sanofi Said To Explore Actelion Counterbid To Johnson & Johnson,2016-12-05 16:12:00-05:00,SNY,neutral
1163091.0,Sanofi's Sanofi Genzyme Announces Initiation of ICARIA-MM Phase III Trial of Isatuximab,2016-12-05 12:51:00-05:00,SNY,neutral
1163092.0,Sanofi Genzyme Says Govt. Of Nova Scotia Added Lemtrada To Its Pharmcare Program,2016-12-02 10:13:00-05:00,SNY,neutral
1163093.0,Sanofi Announces Plans To Stop Production Of Bladder-Cancer Drugs TheraCys And ImmuCyst In Mid-2017,2016-11-18 10:55:00-05:00,SNY,negative
1163094.0,Alnylam Pharmaceuticals Announces Sanofi Genzyme Opt-in Decision for Co-Development and Co-Commercialization of Fitusiran in Hemophilia and Rare Bleeding Disorders,2016-11-14 08:02:00-05:00,SNY,neutral
1163095.0,"MannKind, Sanofi Reach Agreement on AFREZZA; Sanofi to Purchase $10.2M Worth of Insulin from MannKind",2016-11-09 19:40:00-05:00,SNY,positive
1163096.0,8-K from MannKind Shows Settlement Deal with sanofi-aventis; Sanofi Will Buy $10.2M on Insulin from Co.,2016-11-09 17:14:00-05:00,SNY,neutral
1163097.0,"Pharma Stocks Up Post Election: Ariad 16%, Infinity Up 13%, Allergan, Progenics, Endo 10%, Pfizer, Regeneron 8%, AbbVie 7%, Mylan, Medicines Co. 6%, Perrigo, Merck 5%, Bristol-Myers, Eli Lilly, Sanofi, Novartis 3.5%",2016-11-09 09:41:00-05:00,SNY,neutral
1163098.0,Sanofi Genzyme Reports Began Pivotal Phase 3 Trial of NeoGAA Investigational Second-Generation Therapy for Pompe Disease,2016-11-04 08:03:00-04:00,SNY,neutral
1163099.0,Can Cempra Clear Solithera Hurdle After FDA Reveal?,2016-11-02 14:55:00-04:00,SNY,positive
1163100.0,"BZ NOTE: Regeneron Disclosed In Press Release Earlier That Sanofi Was In Discussions With The FDA Regarding Deficiencies In Its French Facility, The Street's Adam Feuerstein Highlights This In A Recent Tweet",2016-10-28 14:48:00-04:00,SNY,positive
1163101.0,"UPDATE: Sanofi Says Co., Regeneron Remain Committed to Development of Sarilumab",2016-10-28 14:38:00-04:00,SNY,positive
1163102.0,Regeneron And Sanofi Receive Complete Response Letter From FDA; Refers To Certain Deficiencies In Mfg Practice At Sanofi Facility; Satisfactory Resolution Of These Deficiencies Is Required Before The FDA Will Grant Approval For Sarilumab,2016-10-28 14:37:00-04:00,SNY,positive
1163103.0,20 Biggest Mid-Day Gainers For Friday,2016-10-28 12:24:00-04:00,SNY,neutral
1163104.0,18 Stocks Moving In Friday's Pre-Market Session,2016-10-28 08:37:00-04:00,SNY,neutral
1163105.0,"Sanofi Earlier Reports Q3 EPS $1.00 vs. Est. $0.85, Rev. $10.07B vs. Est. $10.28B",2016-10-28 08:14:00-04:00,SNY,neutral
1163106.0,"Regeneron Says Advised By Collaborator, Sanofi, That Manufacturing Deficiencies have been Raised by FDA During Inspection of  Sanofi Facility",2016-10-28 06:30:00-04:00,SNY,neutral
1163107.0,"Earnings Scheduled For October 28, 2016",2016-10-28 04:02:00-04:00,SNY,neutral
1163108.0,6 Big Pharma Companies Left To Report September Quarterly Figures,2016-10-25 13:45:00-04:00,SNY,neutral
1163109.0,Lexicon Pharma Offers 'A 2-Part Story With Upside Prospects',2016-10-07 10:45:00-04:00,SNY,positive
1163110.0,Sanofi Reports Purchase Of 450K Shaes Of Myokardia,2016-10-06 16:01:00-04:00,SNY,neutral
1163111.0,"Chardan Rates Regeneron A Sell, Advises Caution",2016-09-30 14:37:00-04:00,SNY,neutral
1163112.0,A Reason To Say Oui To The France ETF,2016-09-29 16:19:00-04:00,SNY,neutral
1163113.0,"Bass Pro Shops, Regarding Cabela's Takeout Bid Reports, Tells Benzinga ""We Are Aware  Of Recent Media Speculation And Our Policy Is Not To Comment On Market Rumors""",2016-09-29 15:53:00-04:00,SNY,neutral
1163114.0,"vTv Therapeutics Shares Initiated With Buy Rating, $13 Target",2016-09-26 11:46:00-04:00,SNY,positive
1163115.0,"Regeneron, Sanofi Announce Dupilumab Biologics License Application Accepted for Priority Review by FDA",2016-09-26 04:34:00-04:00,SNY,positive
1163116.0,Benzinga's Top Initiations,2016-09-23 08:54:00-04:00,SNY,positive
1163117.0,PiperJaffray Initiates Coverage on Sanofi at Neutral,2016-09-23 07:50:00-04:00,SNY,neutral
1163118.0,The 5 Top-Selling Drugs In The World,2016-09-20 12:09:00-04:00,SNY,neutral
1163119.0,Sanofi's Specialty Care Unit Sanofi Genzyme Reports Treatment Effects Maintained Over Six Years in Patients with Relapsing Remitting Multiple Sclerosis who Received Sanofi Genzyme's Lemtrada in Clinical Trials,2016-09-16 10:31:00-04:00,SNY,positive
1163120.0,Watch These 5 Huge Put Purchases In Thursday Trade,2016-09-15 04:54:00-04:00,SNY,positive
1163121.0,Option Alert: SNY Oct16 38.0 Puts: 3500 @  ASK  $0.75: 3500 traded vs 172 OI:  Earnings 11/3  $39.19 Ref,2016-09-14 15:50:00-04:00,SNY,positive
1163122.0,"Sanofi, Alphabet Announce Diabetes  JV -Reuters",2016-09-12 04:15:00-04:00,SNY,neutral
1163123.0,Novogen Names Gordon Hirsch as Chief Medical Officer,2016-08-29 07:05:00-04:00,SNY,neutral
1163124.0,"Regeneron, Sanofi Present Positive Phase 3 Investigational Data for Praluent Injection in Patients Undergoing LDL Apheresis Therapy at ESC Congress 2016",2016-08-29 03:55:00-04:00,SNY,positive
1163125.0,"Mylan Is Offering An EpiPen Savings Card, But A Lot Of People Will Still Get Screwed",2016-08-26 14:19:00-04:00,SNY,negative
1163126.0,5-Month Timeline: A Look Back At Medivation's Takeover Story,2016-08-22 08:46:00-04:00,SNY,neutral
1163127.0,"Must Watch Stocks for August 22, 2016",2016-08-22 05:05:00-04:00,SNY,neutral
1163128.0,Benzinga's Weekend M&A Chatter,2016-08-21 20:59:00-04:00,SNY,neutral
1163129.0,"UPDATE: Reuters Says Merck, Sanofi, Pfizer, Gilead, Celgene Have Each Submitted Expressions of Interest for Medivation",2016-08-17 12:55:00-04:00,SNY,positive
1163130.0,Watch These Huge Put Purchases In Monday Trade,2016-08-15 02:37:00-04:00,SNY,positive
1163131.0,Option Alert: SNY Sep16 39.0 Puts Sweep: 961 @  ASK  $0.65: 1265 traded vs 2045 OI: $40.19 Ref,2016-08-12 10:06:00-04:00,SNY,positive
1163132.0,"UPDATE: Pfizer, Sanofi, German Bidder Said to be Competing for Medivation",2016-08-11 10:18:00-04:00,SNY,neutral
1163133.0,EU Antitrust Regulators Approve Sanofi Bid for Boehringer Ingelheim's Consumer Health Business,2016-08-04 10:02:00-04:00,SNY,neutral
1163134.0,"Sanofi, Regeneron Announce EMA Acceptance for Review of Marketing Authorisation Application for Sarilumab",2016-08-01 05:58:00-04:00,SNY,positive
1163135.0,"Sanofi Reports Q2 EPS E$1.31 Does Not Compare To Est. $0.72, Rev. E$8.868B vs. Est. $10B",2016-07-29 08:01:00-04:00,SNY,neutral
1163136.0,"Earnings Scheduled For July 29, 2016",2016-07-29 04:03:00-04:00,SNY,neutral
1163137.0,Zealand Pharma Announces FDA Approves Lixisenatide as Adlyxintm for Treatment of Adults With Type 2 Diabetes in U.S.; Triggers $5M Milestone Payment from Sanofi,2016-07-28 04:21:00-04:00,SNY,positive
1163138.0,The Market In 5 Minutes: The Dow's Win Streak Comes To An End,2016-07-22 08:55:00-04:00,SNY,positive
1163139.0,"Benzinga's M&A Chatter for Thursday July 21, 2016:",2016-07-21 16:46:00-04:00,SNY,neutral
1163140.0,Medivation Bidders Will Have To Price In Talazoparib; BMO Sees $68-$76 Takeout Price,2016-07-07 15:33:00-04:00,SNY,neutral
1163141.0,Credit Suisse Says Medivation Market Value Is Approaching Its Target,2016-07-07 08:11:00-04:00,SNY,positive
1163142.0,The Market In 5 Minutes: Gold Hits Highest Level Since 2014,2016-07-06 08:56:00-04:00,SNY,neutral
1163143.0,Sanofi Genzyme Begins Pivotal Phase 2/3 Trial of Olipudase Alfa for Adult Patients with Acid Sphingomyelinase Deficiency,2016-07-06 08:02:00-04:00,SNY,neutral
1163144.0,Sanofi Pasteur Signs Research Agreement for Zika Vaccine,2016-07-06 04:48:00-04:00,SNY,positive
1163145.0,"Stocks To Watch For July 6, 2016",2016-07-06 04:19:00-04:00,SNY,neutral
1163146.0,"Benzinga's M&A Chatter for Tuesday July 5, 2016",2016-07-05 20:36:00-04:00,SNY,neutral
1163147.0,UPDATE: Medivation Expresses Interest In Exploring a Potential Transaction And Demonstrated Interest To Board's Satisfaction,2016-07-05 16:18:00-04:00,SNY,positive
1163148.0,"Medivation Enters into Confidentiality Agreements, Including with Sanofi; Sanofi To Terminate Its Consent Solictation",2016-07-05 16:16:00-04:00,SNY,positive
1163149.0,Medivations in Talks With Sanofi Following Sweetened Offer,2016-07-05 14:45:00-04:00,SNY,neutral
1163150.0,Sanofi Says Milestone #1 for Lemtrada has Not been Met -8K,2016-07-05 13:10:00-04:00,SNY,neutral
1163151.0,"Regeneron, Sanofi Announce Approval of Praluent for Treatment of Hypercholesterolemia in Japan",2016-07-05 03:54:00-04:00,SNY,positive
1163152.0,Sanofi Sounding Out Medivation Shareholder; Preparing to Raise Offer -CNBC,2016-06-28 09:55:00-04:00,SNY,neutral
1163153.0,Betaville's Ben Harrington Says Sanofi Could bid for Biomarin if Medivation Bid Fails,2016-06-27 09:51:00-04:00,SNY,negative
1163154.0,Glass Lewis Urges Medivation Shareholders To Vote For Current Board,2016-06-24 08:31:00-04:00,SNY,neutral
1163155.0,Medivation Sends Letter to Stockholders to Set Record Straight on Sanofi's Misleading Claims,2016-06-23 17:52:00-04:00,SNY,negative
1163156.0,The Market In 5 Minutes: It's Brexit Time,2016-06-23 08:56:00-04:00,SNY,neutral
1163157.0,Sanofi Announces VaxigripTetra Gets Positive End of Procedure From German Reference Member State Paul Ehrlich Institute,2016-06-23 07:58:00-04:00,SNY,positive
1163158.0,"Benzinga's M&A Chatter for Wednesday June 22, 2016",2016-06-22 19:04:00-04:00,SNY,neutral
1163159.0,Hearing Sanofi Will Consider Adding Contingent Value Right Payments to Offer for Medivation,2016-06-22 13:49:00-04:00,SNY,positive
1163160.0,Wedbush Analyst Says Sanofi Could Not Feasibly Drop Its Bid For Medivation To Shift Sight To Biomarin,2016-06-17 12:40:00-04:00,SNY,positive
1163161.0,Medivation Prescription Growth And Potential Price Increases Could Drive Upside This Year,2016-06-16 10:17:00-04:00,SNY,positive
1163162.0,Sanofi Announces Expiration of Hart-Scott-Rodino Waiting Period Regarding Proposed Acquisition of Medivation,2016-06-14 07:57:00-04:00,SNY,neutral
1163164.0,The Market In 5 Minutes: Crude Oil Hits Highest Level In Nearly A Year,2016-06-08 09:06:00-04:00,SNY,negative
1163165.0,"Sanofi Says if Medivation Were to Engage and Provide Additional Information, It Would be in a Position to Increase Offer",2016-06-08 06:28:00-04:00,SNY,positive
1163166.0,Sanofi Releases Presentation of Proposed Medivation Acquisition,2016-06-08 06:26:00-04:00,SNY,neutral
1163167.0,"Regeneron, Sanofi Announce that Dupilumab Used with Topical Corticosteroids was Superior to Treatment with TCS Alone in Long-term Phase 3 Trial in Inadequately Controlled Moderate-to-Severe Atopic Dermatitis Patients",2016-06-06 04:12:00-04:00,SNY,positive
1163168.0,"Medivation Sets June 1, 2016 as Record Date for Sanofi Consent Solicitation",2016-06-01 18:46:00-04:00,SNY,positive
1163169.0,"UPDATE: Sanofi Says Latest Medivation Board Can Set Record Date is Jun. 22, 2016",2016-06-01 14:21:00-04:00,SNY,neutral
1163170.0,Sanofi Issues Release Disclosing It Has Submitted Written Notice to Secretary of Medivation Requesting Fix of Record Date,2016-06-01 14:20:00-04:00,SNY,neutral
1163171.0,CNBC Now Tweets: Sanofi expected to request record date from Medivation today - sources (via @davidfaber),2016-06-01 09:44:00-04:00,SNY,neutral
1163172.0,"UPDATE: Medivation Says Sanofi Hand-Picked Nominees Have Minimal Biotech Experience, Medivation Says Board Of Directors Has Rewarded Stockholders With Extraordinary  Returns",2016-05-27 08:10:00-04:00,SNY,positive
1163173.0,UPDATE: Medivation Urges Holders to Mail GREEN Consent Solicitation Card,2016-05-27 08:09:00-04:00,SNY,positive
1163174.0,Medivation Reports Filing of Prelim. Proxy Statement to Contested Solicitation,2016-05-27 08:07:00-04:00,SNY,neutral
1163175.0,Could Rally Cool Off Ahead Of Friday's GDP Data and Yellen Speech?,2016-05-26 13:38:00-04:00,SNY,positive
1163176.0,"Benzinga's M&A Chatter for Wednesday May 25, 2016",2016-05-25 21:47:00-04:00,SNY,neutral
1163177.0,FDA Panel Recommends FDA Approval of Sanofi's Combo Diabetes Drug Iglarlixi,2016-05-25 16:24:00-04:00,SNY,positive
1163178.0,Medivation Advises Its Shareholders To Spurn Sanofi's Move To Replace Entire Board,2016-05-25 10:48:00-04:00,SNY,neutral
1163179.0,The Market In 5 Minutes: Bold Moves,2016-05-25 09:28:00-04:00,SNY,positive
1163180.0,"Sanofi Names Candidates, Committed To Replacing Medivation's Entire Board",2016-05-25 09:04:00-04:00,SNY,positive
1163181.0,Medivation Urges Stockholders to Reject Sanofi's Attempt to Replace Medivation Board of Directors,2016-05-25 08:47:00-04:00,SNY,negative
1163182.0,"Sanofi Reports Filing of Consent Solicitation to Remove, Replace Medivation Board",2016-05-25 07:12:00-04:00,SNY,positive
1163183.0,"UPDATE: Sanofi Nominees for Medivation Board Include Michael Campbell, Barbara Deptula, Wendy Lane, Ronald Rolfe, Steven Shulman, Charles Slacik, James Tyree, David Wilson",2016-05-25 06:52:00-04:00,SNY,neutral
1163184.0,Sanofi Says Soliciting Consents from Medivation Shareholders to Take Actions Including 8 Directors Elected By Board Before Proposal Effectiveness Is Removed,2016-05-25 06:50:00-04:00,SNY,positive
1163185.0,Sanofi to Increase Efforts in China -Reuters,2016-05-25 05:58:00-04:00,SNY,positive
1163186.0,Sanofi to Name Nominees to Replace Medivation Board as Soon as Wednesday,2016-05-25 05:29:00-04:00,SNY,neutral
1163187.0,Sanofi Announces Executive Committee Changes Aligned to Strategic Roadmap 2020,2016-05-23 08:28:00-04:00,SNY,neutral
1163188.0,"Sanofi, in Email to Benzinga, Says 6M+ Doses of Yellow Fever Vaccine Stamaril Shipped to Angola Between January and April 2016",2016-05-20 08:30:00-04:00,SNY,neutral
1163189.0,Sanofi Files for Premerger Notification Under HSR for Medivation Acquisition,2016-05-12 14:25:00-04:00,SNY,neutral
1163190.0,The Market In 5 Minutes: Nothing's Impossible,2016-05-12 09:59:00-04:00,SNY,neutral
1163191.0,Benzinga's Top Upgrades,2016-05-12 09:16:00-04:00,SNY,positive
1163192.0,"Barclays Upgrades Sanofi, Not Too Concerned About Praluent Risks",2016-05-12 07:46:00-04:00,SNY,negative
1163193.0,Barclays Upgrades Sanofi to Overweight,2016-05-12 06:14:00-04:00,SNY,negative
1163194.0,The Market In 5 Minutes: Better Late Than Never,2016-05-10 10:04:00-04:00,SNY,positive
1163195.0,Report: Medivation Committed To Selling Itself,2016-05-10 08:42:00-04:00,SNY,positive
1163196.0,"Benzinga's M&A Chatter for Monday May 9, 2016",2016-05-09 20:40:00-04:00,SNY,neutral
1163197.0,Medivation's Take-Out Price Raised To $68-$78 At Citi,2016-05-06 10:48:00-04:00,SNY,neutral
1163198.0,"If Medivation Is Sold, Brean Thinks It'll Be For Far More Than Sanofi's Bid",2016-05-06 10:29:00-04:00,SNY,neutral
1163199.0,What's M&A Like In The Biotech Sector Right Now?,2016-05-06 08:40:00-04:00,SNY,positive
1163200.0,"Medivation Execs Making A Strong Case For Independent Growth Vs. Sale, Credit Suisse Says",2016-05-06 08:28:00-04:00,SNY,positive
1163201.0,"Benzinga's M&A Chatter for Thursday May 5, 2016",2016-05-05 20:02:00-04:00,SNY,neutral
1163202.0,Medivation Reiterates Rejection Of Sanofi's Inadequate Proposal To Buy It,2016-05-05 13:21:00-04:00,SNY,negative
1163203.0,"Medivation Reiterating Rejection of Sanofi Offer, Says Board Believes It Can Deliver Shareholder Value Above And Beyond What Sanofi Is Offering",2016-05-05 12:59:00-04:00,SNY,negative
1163204.0,"UPDATE: Sanofi CEO to Medivation Board: 'If you are not prepared to engage with us, we have no choice but to go directly to your shareholders.'",2016-05-05 08:36:00-04:00,SNY,negative
1163205.0,UPDATE: Sanofi's Letter to Medivation's Board of Directors,2016-05-05 08:34:00-04:00,SNY,neutral
1163206.0,UPDATE: Sanofi Says Could be in Position to Revise Offer for Medivation,2016-05-05 08:30:00-04:00,SNY,neutral
1163207.0,UPDATE:  Sanofi Says Acquisition of Medivation is a Priority,2016-05-05 08:29:00-04:00,SNY,neutral
1163208.0,Sanofi Sends Letter to Medivation's Board of Directors,2016-05-05 08:27:00-04:00,SNY,neutral
1163209.0,"Mizuho Downgrades Relypsa, Says Near-Term Takeout 'Unlikely'",2016-05-04 13:30:00-04:00,SNY,neutral
1163210.0,"Benzinga's M&A Chatter for Tuesday May 3, 2016",2016-05-03 18:52:00-04:00,SNY,neutral
1163211.0,The Market In 5 Minutes: Do Or Die,2016-05-03 09:44:00-04:00,SNY,negative
1163212.0,Benzinga's Top Downgrades,2016-05-03 09:23:00-04:00,SNY,positive
1163213.0,HSBC Downgrades Sanofi to Hold,2016-05-03 08:06:00-04:00,SNY,neutral
1163214.0,Stifel Lays Out 3 Scenarios For Medivation Takeover,2016-05-02 14:49:00-04:00,SNY,neutral
1163215.0,Jefferies Lifts Target On Medivation To $52 From $39 As 'Xtandi Looking Better',2016-05-02 14:28:00-04:00,SNY,positive
1163216.0,Benzinga's Weekend M&A Chatter,2016-05-01 20:36:00-04:00,SNY,neutral
1163217.0,$45 Billion Thursday For M&A Shows There Are Still Plenty Of Buyers Out There,2016-04-29 16:14:00-04:00,SNY,neutral
1163218.0,Here's What Medivation Said In Its Rejection Letter To Sanofi,2016-04-29 14:38:00-04:00,SNY,negative
1163219.0,"Earnings Scheduled For April 29, 2016",2016-04-29 04:07:00-04:00,SNY,neutral
1163220.0,"Benzinga's M&A Chatter for Thursday April 28, 2016",2016-04-28 18:17:00-04:00,SNY,neutral
1163221.0,Why Medivation Will Likely Reject Sanofi's $52.50/Share Buyout Offer,2016-04-28 16:37:00-04:00,SNY,negative
1163222.0,Why Are Medivation Shares Trading Sharply Above The $52.50 Offer?,2016-04-28 13:45:00-04:00,SNY,positive
1163223.0,Goldman Sees Potential Medivation Buyout Value Near $70/Share,2016-04-28 13:13:00-04:00,SNY,positive
1163224.0,Citi On Medivation-Sanofi Buyout Offer: More Bidders Likely Coming,2016-04-28 10:51:00-04:00,SNY,neutral
1163225.0,Benzinga's Volume Movers,2016-04-28 10:28:00-04:00,SNY,neutral
1163226.0,Sanofi Wants To Acquire Medivation For $52.50 Per Share,2016-04-28 10:11:00-04:00,SNY,positive
1163227.0,12 Stocks Moving In Thursday's Pre-Market Session,2016-04-28 08:21:00-04:00,SNY,neutral
1163228.0,"Must Watch Stocks for April 28, 2016",2016-04-28 05:38:00-04:00,SNY,neutral
1163229.0,Sanofi Offers to Acquire Medivation for $52.50/Share in Cash,2016-04-28 04:38:00-04:00,SNY,neutral
1163230.0,"Leerink: Medivation Buyout 'Inevitable,' AstraZeneca And AbbVie Most Likely Buyers",2016-04-25 10:51:00-04:00,SNY,neutral
1163231.0,"Biomarin Shares Spiking, DealReporter Says Co May Be Attractive To Sanofi",2016-04-22 15:28:00-04:00,SNY,positive
1163232.0,Sanofi Announces €300M Investment to Expand Biologics Site in Belgium,2016-04-19 04:45:00-04:00,SNY,positive
1163233.0,"Medivation Ticks Up 3%, AstraZeneca Said To Be Also Interested In Acquisition",2016-04-18 08:31:00-04:00,SNY,positive
1163234.0,Mid-Afternoon Market Update: Dow Rises Over 1%; Medivation Shares Gain On Reported Pushback Of Sanofi Takeover Effort,2016-04-13 15:47:00-04:00,SNY,positive
1163235.0,"SunTrust: Medivation M&A Chatter Highlights Value, Company's 'Unique' Industry Position",2016-04-13 13:44:00-04:00,SNY,positive
1163236.0,Mid-Day Market Update: Repros Therapeutics Jumps Following Encouraging Study Results; Clovis Oncology Shares Drop,2016-04-13 12:00:00-04:00,SNY,positive
1163237.0,"The Market In 5 Minutes: JPMorgan, Too Big To Fail, And Paul Carey",2016-04-13 10:20:00-04:00,SNY,negative
1163238.0,Mid-Morning Market Update: Markets Open Higher; JPMorgan Beats Q1 Expectations,2016-04-13 10:07:00-04:00,SNY,neutral
1163239.0,10 Stocks Moving In Wednesday's Pre-Market Session,2016-04-13 08:18:00-04:00,SNY,neutral
1163240.0,"Must Watch Stocks for April 13, 2016",2016-04-13 04:51:00-04:00,SNY,neutral
1163241.0,Medivation Surges On Reported Pushback Of Sanofi Takeover Effort,2016-04-12 17:48:00-04:00,SNY,neutral
1163242.0,"After-Hours Recap: Medivation, Valeant, CSX & More",2016-04-12 17:17:00-04:00,SNY,neutral
1163243.0,Cancer Drug Stocks Are The Picture Of Health,2016-04-12 17:12:00-04:00,SNY,negative
1163244.0,Chardan Analyst: Amicus Therapeutics Could Be Bought For $22.50/Share,2016-04-12 09:44:00-04:00,SNY,neutral
1163245.0,"BZ NOTE: Relypsa Has Been Mentioned In Rumors Over Past 7 Months In Possible M&A Talk With Sanofi, Merck, Astra Zeneca",2016-04-07 13:05:00-04:00,SNY,positive
1163246.0,SocGen Picks New Favorites In Big Pharma,2016-04-06 13:44:00-04:00,SNY,positive
1163247.0,WHO Says Number of Adults with Diabetes has Quadrupled Since 1980 -AFP,2016-04-06 04:52:00-04:00,SNY,positive
1163248.0,Sanofi Shares Rise After Company Agrees To Sell Nichi-Iko Pharma Stake,2016-04-04 10:23:00-04:00,SNY,positive
1163249.0,"Regeneron, Sanofi Announce Positive Dupilumab Topline Results from Two Phase 3 Trials in Inadequately Controlled Moderate-to-Severe Atopic Dermatitis Patients",2016-04-01 04:11:00-04:00,SNY,positive
1163250.0,"Credit Suisse: Medivation Could Be Worth $54 To $75 In Takeout, But Management Won't Sell",2016-03-31 11:27:00-04:00,SNY,positive
1163251.0,"Benzinga's M&A Chatter for Wednesday March 30, 2016",2016-03-30 20:28:00-04:00,SNY,neutral
1163252.0,"FBB Capital's Mike Bailey Earlier Questioned Medivation Deal Timing, Says Deal Would Raise Questions Amid Congressional Examination",2016-03-30 17:20:00-04:00,SNY,negative
1163253.0,Why Goldman Is Still Selling Mannkind,2016-03-30 14:53:00-04:00,SNY,neutral
1163254.0,"Benzinga's M&A Chatter for Wednesday March 23, 2016",2016-03-23 20:57:00-04:00,SNY,neutral
1163255.0,Medivation Spikes to High of $40.80 on Chatter Sanofi Bid,2016-03-23 14:36:00-04:00,SNY,neutral
1163256.0,Medivation Up As Triple M&A Interest Rumor Circulates,2016-03-22 11:47:00-04:00,SNY,positive
1163257.0,"The Market In 5 Minutes: Tuesday, March 22, 2016",2016-03-22 11:15:00-04:00,SNY,neutral
1163258.0,Why Regeneron's Praluent Is Likely To Be Removed From The U.S. Market This Year,2016-03-21 11:08:00-04:00,SNY,neutral
1163259.0,"The Market In 5 Minutes: Thursday, March 17, 2016",2016-03-17 10:40:00-04:00,SNY,neutral
1163260.0,"Goldman Sachs Considers Implications For Regeneron, Amgen, Sanofi Following PCSK9 Ruling",2016-03-17 07:45:00-04:00,SNY,neutral
1163261.0,Chardan Downgrades Regeneron To Sell,2016-03-16 16:12:00-04:00,SNY,neutral
1163262.0,The Plot Thickens At Amgen; Piper Still Overweight,2016-03-16 15:25:00-04:00,SNY,negative
1163263.0,"Jury In Repatha Patent Case Ruled In Favor Of Amgen, Against Regeneron And Sanofi",2016-03-16 15:05:00-04:00,SNY,positive
1163264.0,"Piper Jaffray Says Street Downplaying What Regeneron And Sanofi Owe Amgen, May Be Substantially Higher Than Street Expectations Without Treble Damages or Willful Infringement",2016-03-16 14:26:00-04:00,SNY,negative
1163265.0,Amgen Wins Patent Case On Repatha,2016-03-16 14:03:00-04:00,SNY,positive
1163266.0,"UPDATE: Regeneron, Sanofi Say Ongoing Litigation Does Not Impact Praluent Injection",2016-03-16 12:32:00-04:00,SNY,negative
1163267.0,Sanofi Shares Are Down 2% On The Day At $40.34/Share Off U.S. Jury Praluent Verdict,2016-03-16 12:31:00-04:00,SNY,positive
1163268.0,"UPDATE: Regeneron, Sanofi Say Jury Verdict Asserted Claims of Two Amgen Patents for Antibodies Targeting PCSK9 as Valid",2016-03-16 12:31:00-04:00,SNY,positive
1163269.0,"Regeneron, Sanofi Issue Release Saying 'Strongly Disagree' with US Jury Verdict in Ongoing Patent Litigation Related to Praluent, Will Appeal",2016-03-16 12:30:00-04:00,SNY,negative
1163270.0,Jefferies Says SNY/REGN Had A Win Today When Judge Robinson Determined SNY/REGN Praluent Infringes And Ruled Co's Are Liable For Damages And Royalties To AMGN,2016-03-16 12:22:00-04:00,SNY,positive
1163271.0,"Wild Price Action in Amgen Shares Implies Some Trader Confusion on Report of Ruling in Repatha Patent Case; Stock Spiked to High of $147, Came Back Down to Below $144 Shortly After",2016-03-16 12:13:00-04:00,SNY,neutral
1163272.0,"Hearing Federal Judge Has Issued Ruling Against Amgen, Said Co. Has Not Shown Clear, Convincing Evidence Defendant's Invalidity Defenses Were Objectively Baseless",2016-03-16 12:11:00-04:00,SNY,negative
1163273.0,Spike Higher in Amgen Ahead of Verdict for Repatha Patent Case Likely Indicates Loss for Regeneron,2016-03-16 12:06:00-04:00,SNY,negative
1163274.0,Sanofi Files for Potential Debt Shelf Offering; Size Not Disclosed,2016-03-15 11:08:00-04:00,SNY,negative
1163275.0,JMP: MannKind Investors Need 'Clarity',2016-03-15 10:36:00-04:00,SNY,neutral
1163276.0,UPDATE: Hearing Jefferies Has Highlighted Decision by Judge Moving Forward Jury in Regeneron/Sanofi/Amgen Case Would Not Consider One of Three Defense Arguments Proposed as for Invalidiation,2016-03-14 14:46:00-04:00,SNY,negative
1163277.0,Regeneron  Says Phase 3 Monotherapy Study Met Primary Endpoint Demonstrating That Sarilumab Was Superior To Adalimumab,2016-03-11 04:27:00-05:00,SNY,positive
1163278.0,"Sanofi Pasteur, Merck Report Intent to End Joint Vaccines Operations in Europe, Sanofi Pasteur MSD, to Pursue Their Own Distinct Growth Strategies",2016-03-08 08:04:00-05:00,SNY,positive
1163279.0,"JP Morgan Expects Sony CIS And Camera Module Operations To See NT Headwinds, Says LT Growth Prospects Remain Intact",2016-03-08 06:31:00-05:00,SNY,positive
1163280.0,US Appeals Court Upholds Dismissal of Shareholder Securities Fraud Lawsuit vs Sanofi; Plaintiffs Accused Sanofi of Making Materially False or Misleading Statements Regarding MS Drug Lemtrada -Reuters,2016-03-04 09:31:00-05:00,SNY,negative
1163281.0,"Sanofi To Begin Preclinical Studies Of Zika Vaccine In Coming Months, See HUman Trials Starting In 2017",2016-03-03 12:05:00-05:00,SNY,neutral
1163282.0,25 Headlines Moving The Markets This Week,2016-02-29 12:36:00-05:00,SNY,neutral
1163283.0,"Sanofi Is Looking For Rare Disease Acquisitions, FT Says",2016-02-29 09:21:00-05:00,SNY,neutral
1163284.0,"Benzinga's M&A Chatter for Thursday February 25, 2016",2016-02-25 20:58:00-05:00,SNY,neutral
1163285.0,PTC Therapeutics Mounts Tepid Comeback,2016-02-25 16:27:00-05:00,SNY,neutral
1163286.0,Sanofi Spokesperson on Word of PTC Therapeutics Interest Tells Benzinga Co. 'Does Not Comment on Market Rumors',2016-02-25 13:35:00-05:00,SNY,positive
1163287.0,EXCLUSIVE: Sanofi In Talks To Buy PTC Therapeutics,2016-02-25 13:32:00-05:00,SNY,positive
1163288.0,Street Insider Reports Sanofi Could Bid for PTC Therapeutics,2016-02-25 13:22:00-05:00,SNY,neutral
1163289.0,Sanofi To Reutrn Auvi-Q Rights To kaleo,2016-02-23 16:13:00-05:00,SNY,neutral
1163290.0,"Merus Announces Inaugural Deal with Sanofi To Acquire The Rights To Surgestone, Provames, Speciafoldine, And Tredemine, Merus Increases EBITDA Guidance To $47-$50M",2016-02-23 07:32:00-05:00,SNY,neutral
1163291.0,"FDA Accepts Sanofi New Drug Application for Once-Daily Fixed-Ratio Combination of Insulin Glargine and Lixisenatide, Decision Anticipated Aug 2016",2016-02-22 08:04:00-05:00,SNY,positive
1163292.0,Chardan Upgrades Regeneron Amid Relative Underperformance To Amgen Shares,2016-02-16 08:33:00-05:00,SNY,positive
1163293.0,Chardan: Sell Regeneron After Sanofi Drops Patent Infringement Bombshell,2016-02-10 09:30:00-05:00,SNY,negative
1163294.0,Chardan Believes Sanofi/Regeneron Invalidation Of Amgen Patents In Entirety Is Unlikely,2016-02-10 07:21:00-05:00,SNY,neutral
1163295.0,Sanofi's Stock Dips Lower Following Q4 Print,2016-02-09 08:11:00-05:00,SNY,negative
1163296.0,Sanofi Reports Q4 Rev €9.28B Vs. €9.07B; Increases Dividend to €2.93 from €2.85,2016-02-09 05:02:00-05:00,SNY,neutral
1163297.0,"Merck, Sanofi Exploring Potential End To Joint Venture In Europe",2016-02-02 10:18:00-05:00,SNY,neutral
1163298.0,"Sanofi, Merck Considering Ending JV to Sell Vaccines in Europe -Bloomberg",2016-02-02 04:21:00-05:00,SNY,neutral
1163299.0,"EXCLUSIVE: Inovio Plans On Producing Zika Vaccine By Q3 2016, Ready For Phase 1 Study By Q4",2016-01-29 13:38:00-05:00,SNY,positive
1163300.0,7 Biotech Traders Pick Their Favorite Stocks For 2016,2016-01-28 16:53:00-05:00,SNY,positive
1163301.0,Regeneron Is Now A Sell For Chardan,2016-01-25 08:40:00-05:00,SNY,neutral
1163302.0,"Sanofi CEO, at JP Morgan Healthcare Conference, Says Aims to Return Diabetes Business to Growth In 2019",2016-01-12 13:10:00-05:00,SNY,positive
1163303.0,"Sanofi, Innate Pharma Collaborate on New Bispecific NK Cell Engagers in Immuno-Oncology",2016-01-11 05:25:00-05:00,SNY,positive
1163304.0,"Sanofi, Warp Drive Bio to Collaborate on Development of Novel Oncology Therapies and Antibiotics Based on Proprietary Platforms",2016-01-11 04:20:00-05:00,SNY,positive
1163305.0,"Regeneron, Sanofi Announce FDA Has Accepted For Review BLA For Sarilumab",2016-01-08 10:36:00-05:00,SNY,positive
1163306.0,U.S. Stock Futures Surge After Jobs Data; El-Erian To Discuss Economic Situation,2016-01-08 08:50:00-05:00,SNY,neutral
1163307.0,"Regeneron, Sanofi Announce Sarilumab Biologics License Application Accepted for Review FDA",2016-01-08 04:01:00-05:00,SNY,positive
1163308.0,Mid-Afternoon Market Update: Crude Oil Slides Over 2%; MannKind Shares Dip On Termination Of Afrezza Deal With Sanofi,2016-01-05 15:07:00-05:00,SNY,negative
1163309.0,Mid-Day Market Update: Dow Falls 50 Points; Smith & Wesson Shares Gain Following Strong Guidance,2016-01-05 12:03:00-05:00,SNY,positive
1163310.0,Hearing Sanofi Spokesperson Has Said Co. Decided to End Deal with Mannkind Due to Low Level of Scrips Amid Substantial Sales Effort,2016-01-05 10:22:00-05:00,SNY,negative
1163311.0,Mid-Morning Market Update: Markets Edge Higher; Commercial Metals Posts Lower Q1 Earnings,2016-01-05 09:56:00-05:00,SNY,negative
1163312.0,MannKind Is Plummeting,2016-01-05 09:19:00-05:00,SNY,neutral
1163313.0,"MannKind Corporation Reports Termination of License, Collaboration Agreement With Sanofi",2016-01-05 09:00:00-05:00,SNY,positive
1163314.0,US Stock Futures Signal Lower Start On Wall Street,2015-12-28 07:44:00-05:00,SNY,negative
1163315.0,Sanofi Announces Dengvaxia Dengue Vaccine Approved in Brazil,2015-12-28 05:33:00-05:00,SNY,positive
1163316.0,Here's What's Been Going On With Relypsa,2015-12-24 10:06:00-05:00,SNY,neutral
1163317.0,"Sanofi Reports Submission of NDA for Once-Daily Fixed-Ratio Combo of Insulin Glargine, Lixisenatide",2015-12-23 08:03:00-05:00,SNY,neutral
1163318.0,Watch Stocks of Co.'s with Flu-Related Solutions; Macquarie Note Earlier Highlighted 'Early Flu Results Lagging,2015-12-22 12:06:00-05:00,SNY,negative
1163319.0,Wedbush Hikes Relypsa Target To $86 On Edge Of U.S. Veltassa Launch,2015-12-22 09:50:00-05:00,SNY,neutral
1163320.0,"Analyst Sees Relypsa's Valtassa Becoming 'The Standard Of Care,' Initiates With Buy, $63 Target",2015-12-17 08:03:00-05:00,SNY,neutral
1163321.0,Sanofi Enters Negotiations to Swap Merial for Boehringer Ingelheim's Consumer Healthcare Business,2015-12-15 04:19:00-05:00,SNY,neutral
1163322.0,"Regeneron, Sanofi Announce UnitedHealth Group to Provide Preferred Access Praluent Injection",2015-12-11 04:13:00-05:00,SNY,neutral
1163323.0,Stocks Hitting 52-Week Lows,2015-12-10 10:14:00-05:00,SNY,negative
1163324.0,Benzinga's Top Downgrades,2015-12-10 08:53:00-05:00,SNY,positive
1163325.0,Exane BNP Paribas Downgrades Sanofi to Underperform,2015-12-10 08:05:00-05:00,SNY,neutral
1163326.0,EXCLUSIVE: Relypsa Being Evaluated By 3-4 Potential Acquirers; Sanofi Seen As 'Natural Buyer',2015-12-04 13:14:00-05:00,SNY,positive
1163327.0,EXCLUSIVE: Wedbush's Liana Moussatos Tells Benzinga Sanofi 'is a natural buyer of Relypsa',2015-12-04 12:43:00-05:00,SNY,positive
1163328.0,Sanofi Informs Canadian Clients Should Return All AllerJect Devices To Local Pharmacy,2015-12-02 08:04:00-05:00,SNY,neutral
1163329.0,Morgan Stanley Downgrades Sanofi to Equalweight,2015-12-01 11:45:00-05:00,SNY,neutral
1163330.0,"Must Watch Stocks for November 30, 2015",2015-11-30 04:16:00-05:00,SNY,neutral
1163331.0,Benzinga's Weekend M&A Chatter,2015-11-29 19:44:00-05:00,SNY,neutral
1163332.0,"Early Global News: Judge Dismisses Yelp Lawsuit, Boston Scientific Recall, Brazil Suing BHP & Vale",2015-11-28 11:42:00-05:00,SNY,negative
1163333.0,"Lazard Said to be Working With Sanofi on Sale of Merial Animal Health Unit, Which Could be Valued at $12.7B -Reuters",2015-11-27 13:39:00-05:00,SNY,positive
1163334.0,Pfizer Canada Reports Securing of Sufficient Quantities of Eipin Injectors for Replacing All Remaining Allerject Devices Impacted by Sanofi Recall,2015-11-27 07:03:00-05:00,SNY,positive
1163335.0,"Regeneron, Sanofi Announce 18,000-Patient ODYSSEY OUTCOMES Trial of Praluent Injection Fully Enrolled",2015-11-24 04:21:00-05:00,SNY,neutral
1163336.0,US Stock Futures Gain Ahead Of Macy's Earnings,2015-11-11 07:55:00-05:00,SNY,positive
1163337.0,"MannKind's Future Looks 'Grim,' Has 37% Downside Warns Piper Jaffray",2015-11-10 09:03:00-05:00,SNY,negative
1163338.0,Bryan Garnier Downgraded Sanofi to Neutral,2015-11-09 11:36:00-05:00,SNY,neutral
1163339.0,UBS Downgrades Sanofi to Neutral,2015-11-09 08:27:00-05:00,SNY,neutral
1163340.0,Bernstein Downgrades Sanofi to Market Perform,2015-11-09 07:58:00-05:00,SNY,neutral
1163341.0,"Regeneron, Sanofi Present Positive Results from Pivotal Phase 3 Study of Sarilumab at ACR Annual Meeting",2015-11-08 08:29:00-05:00,SNY,positive
1163342.0,Mid-Morning Market Update: Markets Decline; Humana Earnings Beat Estimates,2015-11-06 10:03:00-05:00,SNY,neutral
1163343.0,Morning Market Gainers,2015-11-06 09:43:00-05:00,SNY,neutral
1163344.0,"Sanofi, Lexicon to Collaborate on Sotagliflozin, a Potential Diabetes Treatment",2015-11-06 04:21:00-05:00,SNY,neutral
1163345.0,ISIS Pharma Called A 'Sleeper Awakening' At Piper Jaffray,2015-11-05 10:25:00-05:00,SNY,neutral
1163346.0,Novo Nordisk +4% Premarket Following Announcement of Sanofy Diabetes License Agreement With Hanmi,2015-11-05 08:25:00-05:00,SNY,positive
1163347.0,"Sanofi, Regeneron Report Will Present Results from Phase 3 Trials at AHA Sessions '15",2015-11-05 08:07:00-05:00,SNY,neutral
1163348.0,US Stock Futures Surge Ahead Of Jobless Claims Data,2015-11-05 07:22:00-05:00,SNY,neutral
1163349.0,"Sanofi,Hanmi Announce License Agreement to Develop Portfolio Of Long-Acting Diabetes Treatments",2015-11-05 05:55:00-05:00,SNY,positive
1163350.0,Watch Out Below: 'Sluggish' MannKind Double-Downgraded By RBC Analyst,2015-11-04 09:26:00-05:00,SNY,neutral
1163351.0,"94,613 Dengue Fever Cases Reported in Malaysia in 2015, Including 262 Deaths -Bernama",2015-11-01 09:29:00-05:00,SNY,neutral
1163352.0,Mylan Confirms Availability of EpiPen Auto-Injector for U.S. Patients Affected by Sanofi's Auvi-Q Recall,2015-10-29 13:24:00-04:00,SNY,negative
1163353.0,"Sanofi Reports €0.61, Sales €9.591B",2015-10-29 08:50:00-04:00,SNY,neutral
1163354.0,"Sanofi Reports Q3 EPS E$1.61, Rev. E$9.591B",2015-10-29 08:40:00-04:00,SNY,neutral
1163355.0,Sanofi US Issues Voluntary Nationwide Recall of Auvi-Q Due to Potential Inaccurate Dosage Delivery,2015-10-28 16:17:00-04:00,SNY,neutral
1163356.0,Relypsa Plunges After Veltassa FDA Approval; Wedbush Says 'Misunderstanding' Creates Buying Opportunity,2015-10-22 12:58:00-04:00,SNY,positive
1163357.0,"Regeneron Trading Up To $517/Share Up 2.6% Premarket On Eli Lilly Evacetraqib Development Discontinuation, Watch Regenron Partner Sanofi",2015-10-12 08:26:00-04:00,SNY,neutral
1163358.0,Sanofi's Genzyme Reports Treatment Effects Maintained Over Five Years in Majority of Patients with Relapsing Remitting MS who Received Genzyme's Lemtrada,2015-10-08 05:00:00-04:00,SNY,neutral
1163359.0,Sanofi's Genzyme Announces New Analysis Suggests Aubagio Slows Brain Atrophy in People with Relapsing MS,2015-10-07 05:17:00-04:00,SNY,neutral
1163360.0,"Alnylam, Genzyme Report that Genzyme Opts into ALN-AT3 Hemophilia Program for Development and Commercialization Outside of North America and Western Europe",2015-10-01 07:00:00-04:00,SNY,neutral
1163361.0,Diabetic Investor On MannKind: 'There's A Reason Why So Many People Are Short This Stock',2015-09-29 15:11:00-04:00,SNY,neutral
1163362.0,"UPDATE: Kliff Thinks That Sanofi Could Let Afrezza Die Slowly, Or Terminate MannKind Partnership Publicly To Publicly Distance Themselves From Former CEO Chris Viehbacher",2015-09-29 12:44:00-04:00,SNY,negative
1163363.0,"Diabetic Investor David Kliff Speculates By Time JPM Healthcare Conference Rolls Around In January, Sanofi Will Be ""Done With"" MannKind's Afrezza Inhalable Insulin",2015-09-29 12:39:00-04:00,SNY,neutral
1163364.0,"Diabetic Investor David Kliff On MannKind, Says Feedback That He Is Getting From Sanofi Reps. Say (Afrezza) Is ""going nowhere"", ""so many issues with it""",2015-09-29 12:35:00-04:00,SNY,neutral
1163365.0,Sanofi Announces NDA for Lixisenatide Will Be Accepted for Review by FDA,2015-09-29 08:01:00-04:00,SNY,positive
1163366.0,"Regeneron, Sanofi Announce Approval of Praluent for Treatment of Hypercholesterolemia in EU",2015-09-28 05:20:00-04:00,SNY,positive
1163367.0,Chardan's Amusa Is Downgrading Amicus Therapeutics: Here's Why,2015-09-16 11:40:00-04:00,SNY,neutral
1163368.0,Sanofi Offers Topline Results from Second PIVOTAL LixiLan Phase III Study,2015-09-14 08:04:00-04:00,SNY,neutral
1163369.0,Piper Jaffray Drops Hammer On MannKind,2015-09-09 11:47:00-04:00,SNY,neutral
1163370.0,Regeneron and Sanofi Report New Positive Praluent Phase 3 Data Presented at ESC Congress 2015,2015-09-01 09:01:00-04:00,SNY,positive
1163371.0,Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes,2015-08-31 09:02:00-04:00,SNY,positive
1163372.0,"Relypsa, Sanofi Enter 2 Year Detailing Agreement For Patiromer FOS",2015-08-10 16:07:00-04:00,SNY,positive
1163373.0,US Stock Futures Drop; All Eyes On Jobs Report,2015-08-07 07:57:00-04:00,SNY,negative
1163374.0,"Sanofi, Evotec Announce Strategic Collaboration for Diabetes",2015-08-07 04:48:00-04:00,SNY,neutral
1163375.0,Calls Of Note: The Research Moving Stocks Today,2015-08-06 12:03:00-04:00,SNY,neutral
1163376.0,MannKind Triples Production Capacity for Afrezza,2015-07-31 09:02:00-04:00,SNY,neutral
1163377.0,"Sanofi Reports Q2 EPS E$1.41, Rev. E$9.378B; Estimates Not Available",2015-07-30 07:32:00-04:00,SNY,neutral
1163378.0,Sanofi Announces First LixiLan Phase III Study Met Primary Endpoint,2015-07-29 07:25:00-04:00,SNY,neutral
1163379.0,Sanofi Reports that First LixiLan Phase III Study Met Primary Endpoint,2015-07-29 07:09:00-04:00,SNY,neutral
1163380.0,Sanofi Shares Move to High on Volume,2015-07-28 15:24:00-04:00,SNY,positive
1163381.0,Regeneron Shares Rising After Sanofi Collaboration Revealed: Good News For Shareholders?,2015-07-28 13:57:00-04:00,SNY,positive
1163382.0,Experimental MERS Vaccine Shows Potential in Animal Experiments -Reuters,2015-07-28 11:01:00-04:00,SNY,neutral
1163383.0,US Stock Futures Surge Ahead Of Fed Meeting,2015-07-28 07:02:00-04:00,SNY,neutral
1163384.0,"Regeneron, Sanofi Announce Immuno-Oncology Collaboration",2015-07-28 04:39:00-04:00,SNY,neutral
1163385.0,New England Journal Of Medicine Publishes Analyses Confirming Sanofi Vaccine Candidate Safely Protects Pre-Adolescents to Adults Against Dengue,2015-07-27 12:03:00-04:00,SNY,positive
1163386.0,AstraZeneca to Sell Caprelsa to Sanofi's Genzyme for Up to $300M,2015-07-27 05:29:00-04:00,SNY,neutral
1163387.0,"UBS 'Looking Elsewhere,' Says To Sell Regeneron",2015-07-09 08:55:00-04:00,SNY,neutral
1163388.0,JMP Sees A 'Negative Market Tone' In Biotechnology,2015-06-15 13:31:00-04:00,SNY,negative
1163389.0,Genzyme Initiates Phase 1/2 Clinical Trial to Evaluate Olipudase Alfa in Pediatric Patients,2015-06-15 08:01:00-04:00,SNY,neutral
1163390.0,MannKind Corporation Sinks: CFO Says 'We're Not There Yet' With Afrezza,2015-06-10 16:30:00-04:00,SNY,neutral
1163391.0,"FDA Panel Clears Product Path For Sanofi, Regeneron Pharmaceuticals",2015-06-10 10:52:00-04:00,SNY,positive
1163392.0,"FDA Advisory Panel Recommends Approval of Regeneron, Sanofi's Praluent",2015-06-09 16:52:00-04:00,SNY,positive
1163393.0,"Afrezza Feedback 'Largely Positive' For MannKind, Jefferies Says",2015-06-09 09:55:00-04:00,SNY,positive
1163394.0,"Sanofi Study Says No Increased Risk Of Heart Problems, Pancreatitis, Cancer, Or Severe Hypoglycemia In Lixisenatide",2015-06-08 14:17:00-04:00,SNY,negative
1163395.0,Wedbush: Regulus Therapeutics Will Quadruple In Price Within 12 Months,2015-06-04 15:44:00-04:00,SNY,neutral
1163396.0,Jefferies: MannKind's Consumer Ads For Afrezza May Increase Awareness,2015-06-04 13:36:00-04:00,SNY,positive
1163397.0,Genzyme Announces FDA Grants Breakthrough Therapy Designation for Olipudase Alfa,2015-06-04 03:34:00-04:00,SNY,positive
1163398.0,Stocks Hitting 52-Week Highs,2015-05-27 10:10:00-04:00,SNY,neutral
1163399.0,Morning Market Gainers,2015-05-27 09:44:00-04:00,SNY,neutral
1163400.0,"Regeneron, Sanofi Announce Positive Topline Results from Phase 3 Studies with Sarilumab in Patients with RA",2015-05-21 04:36:00-04:00,SNY,positive
1163401.0,Adam Feuerstein @adamfeuerstein $MNKD — I'm told $SNY will disclose Afrezza Q1 sales tomorrow,2015-04-29 16:36:00-04:00,SNY,neutral
1163402.0,FDA Grants Fast Track Designation to Genzyme's  GZ/SAR402671 for Treatment of Fabry Disease,2015-04-28 04:42:00-04:00,SNY,positive
1163403.0,Genzyme Initiates Phase 2a Clinical Trial to Evaluate Oral Therapy for Fabry Disease,2015-04-21 09:03:00-04:00,SNY,neutral
1163404.0,"Innate Pharma, Sanofi Announce Collaboration on Development of new Antibody Drug Conjugates",2015-04-16 04:47:00-04:00,SNY,neutral
1163405.0,SocGen Initiates Big Drug/Pharma Names,2015-04-15 12:07:00-04:00,SNY,neutral
1163406.0,Hearing Sanofi Will Launch Toujeo Diabtes Drug in US at End of Mar.,2015-03-27 11:24:00-04:00,SNY,neutral
1163407.0,Sanofi's Genzyme Announces Positive Results from Cerdelga Study Published in Lancet,2015-03-25 21:28:00-04:00,SNY,positive
1163408.0,Sanofi Pasteur Announces FDA Approval of Quadracel DTaP-IPV Vaccine for Children 4 through 6 Years of Age,2015-03-25 12:16:00-04:00,SNY,positive
1163409.0,CVS Says New Cholesterol Drug Types Could Be Costly,2015-03-20 12:58:00-04:00,SNY,negative
1163410.0,Evotec Sanofi Sign Agreement for Major Multi-Component Strategic Alliance Vlaued @€250M,2015-03-19 21:29:00-04:00,SNY,positive
1163411.0,"Sanofi Cardiovascular Study Shows Lyxumia Non-Inferior, Not Superior to Placebo",2015-03-19 04:39:00-04:00,SNY,negative
1163412.0,Leerink Swann Upgrades Sanofi to Outperform,2015-03-17 07:09:00-04:00,SNY,neutral
1163413.0,"Sanofi, Regeneron Announce 18-Month Results of ODYSSEY LONG TERM Trial with Praluent Published in NEJM",2015-03-15 18:03:00-04:00,SNY,neutral
1163414.0,"Regeneron, Sanofi Announce Positive 18-Month Results of ODYSSEY LONG TERM Trial with Praluent Published in NEJM",2015-03-15 11:03:00-04:00,SNY,positive
1163415.0,8 Healthcare Names Cowen & Co Are Talking About,2015-03-10 18:02:00-04:00,SNY,neutral
1163416.0,Regeneron Signs Amended Collaboration Agreement with Sanofi-Aventis; Will No Longer Be Required to Reimburse Sanofi for 50% of Development Expenses,2015-02-27 07:13:00-05:00,SNY,positive
1163417.0,Sanofi Receives FDA Approval of Once-Daily Basal Insulin Toujeo,2015-02-25 21:29:00-05:00,SNY,positive
1163418.0,Sanofi Announces Naming of Olivier Brandicourt as CEO,2015-02-19 16:47:00-05:00,SNY,neutral
1163419.0,ENGAGE Randomized Clinical Trial Evaluating Cerdelgafor Treatment-Naïve Patients with Gaucher Disease Type 1 Published in The Journal of the American Medical Association,2015-02-17 11:36:00-05:00,SNY,positive
1163420.0,Genzyme Presents Phase 3 Clinical Trial Extension Results for Cerdelga Lysosomal Disease Network WORLD Symposium,2015-02-12 08:47:00-05:00,SNY,neutral
1163421.0,Sanofi Posts Higher Q4 Profit,2015-02-05 05:22:00-05:00,SNY,positive
1163422.0,"Sanofi, MannKind Announce Afrezza Now Available in the U.S.",2015-02-03 05:34:00-05:00,SNY,neutral
1163423.0,US Stock Futures Signal Lower Start On Wall Street,2015-01-26 07:14:00-05:00,SNY,negative
1163424.0,"Regeneron, Sanofi Announce Praluent Biologics License Application Accepted for Priority Review by FDA",2015-01-26 04:46:00-05:00,SNY,positive
1163425.0,Sanofi's Genzyme Announces EC Grants Marketing Authorization for Cerdelga for Gaucher Disease Type 1,2015-01-22 04:47:00-05:00,SNY,positive
1163426.0,10 Biotech Stories You Might've Missed This Week,2015-01-15 13:18:00-05:00,SNY,negative
1163427.0,"Why The New MannKind Management Could Focus On R&D, Not A Potential Sanofi Merger",2015-01-12 15:44:00-05:00,SNY,neutral
1163428.0,From Webcast Presentation: Sanofi M&A Strategy Is Unchanged; Continues Looking For 'Bolt-On Deals;' Not Looking At Sizable Transactions,2015-01-12 13:54:00-05:00,SNY,neutral
1163429.0,"Regeneron, Sanofi Report Alirocumab Trials Met Primary Efficacy Endpoints",2015-01-09 05:38:00-05:00,SNY,neutral
1163430.0,Germany's Bayer to Sell Equine Unit to Sanofi's Animal Health Unit; Terms Not Disclosed -Reuters,2014-12-17 05:11:00-05:00,SNY,neutral
1163431.0,Sanofi Pasteur Announces FDA Approval of Fluzone® Intradermal Quadrivalent (Influenza Vaccine) for Adults,2014-12-12 08:04:00-05:00,SNY,positive
1163432.0,Zoetis Inc. Spikes Briefly On Remarks From Sanofi CEO,2014-12-09 15:02:00-05:00,SNY,neutral
1163433.0,Shares of PTC Therapeutics Up Nearly 10% Over Last Hour as Hearing Traders Discussing DealReporter Alert Suggesting Shire or Sanofi Could Be Potential Suitors,2014-12-09 12:55:00-05:00,SNY,positive
1163434.0,Zoetis Declines Comment on Talks with Sanofi,2014-12-09 12:29:00-05:00,SNY,neutral
1163435.0,Sanofi Trades Lower Following Spike Higher,2014-12-09 11:35:00-05:00,SNY,negative
1163436.0,Sanofi Spiking Higher,2014-12-09 11:34:00-05:00,SNY,neutral
1163437.0,Sanofi's Weinberg Says Ready To Make Acquisitions In Vet Medicine,2014-12-09 11:18:00-05:00,SNY,positive
1163438.0,Zoetis Spikes Higher; May be Attributed to Comments from Sanofi,2014-12-09 11:16:00-05:00,SNY,neutral
1163439.0,"CNBC Now Tweets: 'BREAKING: New lawsuit claims recently ousted Sanofi CEO, other execs. conducted scheme in violation of federal law. http://cnb.cx/1vMPvRq'",2014-12-03 15:31:00-05:00,SNY,negative
1163440.0,Evotec Announces Co. Sanofi Entered Into Exclusive Talks for Major Multi-Component Strategic Collaboration,2014-12-02 12:44:00-05:00,SNY,positive
1163441.0,Sanofi Reports FDA Approval of Priftin Tablets for Treatment of Latent Tuberculosis Infection,2014-12-02 08:36:00-05:00,SNY,positive
1163442.0,Mid-Day Market Update: ON Semiconductor Surges On $1 Billion Buyback Plan; POZEN Shares Slip,2014-12-01 13:43:00-05:00,SNY,positive
1163443.0,"Mid-Morning Market Update: Markets Open Lower; Weatherford To Sell Engineered Chemistry, Drilling Fluid Operations to Berkshire's Lubrizol",2014-12-01 10:23:00-05:00,SNY,negative
1163444.0,Morning Market Losers,2014-12-01 09:53:00-05:00,SNY,negative
1163445.0,"POZEN, Sanofi Mutually Agree to End U.S. Partnership for PA8140/PA32540",2014-12-01 06:04:00-05:00,SNY,positive
1163446.0,"POZEN, Sanofi Mutually Agree to Terminate US Partnership for PA8140/PA32540",2014-12-01 06:02:00-05:00,SNY,positive
1163447.0,EMA Recommends Sanofi's Gaucher Disease Drug Eliglustat,2014-11-21 07:08:00-05:00,SNY,positive
1163448.0,Sanofi Declines Comment on Potential Candidates for CEO Job -Reuters,2014-11-20 14:25:00-05:00,SNY,neutral
1163449.0,"Regeneron, Sanofi Announce Dupilumab Receives FDA Breakthrough Therapy Designation in Atopic Dermatitis",2014-11-20 05:39:00-05:00,SNY,neutral
1163450.0,Regeneron and Sanofi Announce New Results from Six Phase 3 Trials Showing that Alirocumab Significantly Reduced LDL Cholesterol,2014-11-19 08:16:00-05:00,SNY,neutral
1163451.0,Sanofi Board Preparing Shortlist for New CEO -Reuters,2014-11-18 08:20:00-05:00,SNY,neutral
1163452.0,"Regulus, Sanofi Present New Data Enhancing Preclinical Profile of RG-012 for Treatment of Renal Dysfunction in Alport Syndrome at ASN",2014-11-15 18:29:00-05:00,SNY,negative
1163453.0,"Regeneron, Sanofi Announce Positive Results from Phase 2b Study of Dupilumab in Patients with Moderate-to-Severe Asthma",2014-11-11 04:59:00-05:00,SNY,positive
1163454.0,Sanofy's Genzyme Enrolls First Patient in Phase II Vatelizumab Trial in Relapsing Remitting MS,2014-11-04 06:06:00-05:00,SNY,neutral
1163455.0,Sanofi Reports New England Journal of Medicine Reports Publish of Results of Final Landmark Phase III Efficacy Clinical Study of Co.'s Dengue Vaccine Candidate,2014-11-03 14:48:00-05:00,SNY,positive
1163456.0,"Benzinga's M&A Chatter for Thursday October 30, 2014",2014-10-30 21:24:00-04:00,SNY,neutral
1163457.0,CNBC's Stock Pops & Drops From October 29,2014-10-29 20:29:00-04:00,SNY,neutral
1163458.0,QE Finally Ends,2014-10-29 16:56:00-04:00,SNY,neutral
1163459.0,Deutsche Bank Downgrades Sanofi SA,2014-10-29 12:29:00-04:00,SNY,neutral
1163460.0,Mid-Morning Market Update: Markets Mixed; Goodyear Earnings Beat Estimates,2014-10-29 10:43:00-04:00,SNY,neutral
1163461.0,Deutsche Bank Downgrades Sanofi to Hold,2014-10-29 09:15:00-04:00,SNY,neutral
1163462.0,Sanofi Board of Directors Fires CEO Christopher A. Viehbacher ,2014-10-29 05:23:00-04:00,SNY,neutral
1163463.0,Sanofi's Board Will Meet Wednesday at 9 a.m. EDT Related to Speculation on CEO,2014-10-28 17:39:00-04:00,SNY,neutral
1163464.0,"Markets Continue To Rally As The Dow Closes Above 17,000",2014-10-28 16:44:00-04:00,SNY,neutral
1163465.0,Mid-Afternoon Market Update: Dow Rises Over 150 Points; Kohl's Shares Decline On Weak Forecast,2014-10-28 15:39:00-04:00,SNY,negative
1163466.0,Mid-Day Market Update: Integrated Device Technology Jumps On Upbeat Earnings; Twitter Shares Decline,2014-10-28 13:50:00-04:00,SNY,positive
1163467.0,"Midday Losers From October 28: Twitter, Kohl's, Amkor Technologies And More",2014-10-28 13:27:00-04:00,SNY,negative
1163468.0,Mid-Morning Market Update: Markets Open Higher; Pfizer Profit Tops Street View,2014-10-28 11:06:00-04:00,SNY,positive
1163469.0, Sanofi Reports Q3 Revenue €8.78B vs €8.43B Last Year,2014-10-28 05:59:00-04:00,SNY,neutral
1163470.0,"Earnings Scheduled For October 28, 2014",2014-10-28 05:25:00-04:00,SNY,neutral
1163471.0,"Sanofi CEO Viehbacher Wrote to Board on September4, Citing Rumour Chairman Was Seeking to Replace Him, Says Replacing him Could be Detrimental to Shareholder Interests -Les Echos",2014-10-27 09:59:00-04:00,SNY,positive
1163472.0,Ferring Pharmaceuticals Acquires Marketing Rights for DDAVP from Sanofi -Reuters,2014-10-22 09:19:00-04:00,SNY,neutral
1163473.0,"Report: Actavis, Sanofi To Bid On Over-The-Counter Drug Maker",2014-10-20 20:15:00-04:00,SNY,neutral
1163474.0,"Benzinga's M&A Chatter for Monday October 20, 2014",2014-10-20 19:27:00-04:00,SNY,neutral
1163475.0,UPDATE: Omega Pharma Valued at €4B,2014-10-20 17:17:00-04:00,SNY,positive
1163476.0,"Actavis May Have Joined Bidding for Omega Pharma, Sanofi, Perrigo, Boehringer Also Considering Offer",2014-10-20 17:15:00-04:00,SNY,neutral
1163477.0,"Regeneron, Sanofi Report Commencement of Phase 3 Study of Dupilumab in Patients with AD",2014-10-20 07:04:00-04:00,SNY,neutral
1163478.0,"Amgen Reports Filing of Suit Against Sanofi, Regeneron for Patent Infrigement, Seeking Injunction Related to PCSK9 Inhibitor",2014-10-17 09:01:00-04:00,SNY,negative
1163479.0,NASDAQ Dips 1.5%; HB Fuller Shares Decline On Downbeat Results,2014-09-25 12:09:00-04:00,SNY,positive
1163480.0,Markets Tumble; Scholastic Posts Wider Fiscal-First Quarter Loss,2014-09-25 11:12:00-04:00,SNY,negative
1163481.0,Morning Market Movers ,2014-09-25 09:39:00-04:00,SNY,neutral
1163482.0,Genzyme Collaborates On Gene Therapy For Rare Disease That Causes Childhood Blindness,2014-09-24 08:03:00-04:00,SNY,neutral
1163483.0,Could European Funds Offer An Opportunity Now?,2014-09-23 10:04:00-04:00,SNY,positive
1163484.0,"Sanofi, MyoKardia Report Collaboration to Develop Targeted Therapies for Patients with Generic Heart Disease, Up to $200M Collaboration",2014-09-17 08:35:00-04:00,SNY,neutral
1163485.0,Sanofi Shares Up ~1% Following Earlier FDA Alert Co. Has Received Orphan Drug Designation for Gaucher Disease Treatment,2014-09-12 13:36:00-04:00,SNY,positive
1163486.0,Sanofi Says Study Shows Postive Results from Lemtrada Trials' 2nd Year Extension,2014-09-11 06:09:00-04:00,SNY,neutral
1163487.0,Sanofi Announces Vaccines Unit Has Reported FDA Approval for Use of Menactra Vaccine,2014-09-08 14:19:00-04:00,SNY,positive
1163488.0,ECB Decision Boosts ETFs,2014-09-04 16:02:00-04:00,SNY,positive
1163489.0,"Regeneron, Sanofi Announce Four Pivotal Alirocumab Trials All Met Primary Efficacy Eendpoint",2014-08-31 08:01:00-04:00,SNY,neutral
1163490.0,The 4 Companies Teaming Up For A New Tool To Fight Cancer,2014-08-25 16:03:00-04:00,SNY,negative
1163491.0,"Illumina Announces Strategic Partnerships with AstraZeneca, Janssen, Sanofi",2014-08-21 05:21:00-04:00,SNY,neutral
1163492.0,"Benzinga's M&A Chatter for Wednesday August 13, 2014",2014-08-13 17:39:00-04:00,SNY,neutral
1163493.0,Sanofi Launches Authorized Generic Version of Eloxatin Through Winthrop US,2014-08-12 08:53:00-04:00,SNY,neutral
1163494.0,Sanofi Reports First Antimalarial Treatments Produced with Semisynthetic Artemisinin Enter Market,2014-08-12 07:05:00-04:00,SNY,neutral
1163495.0,Markets Marginally Higher On Light Volume And Encouraging Geopolitical Developments,2014-08-11 16:46:00-04:00,SNY,positive
1163496.0,US Stock Futures Signal Higher Start On Wall Street,2014-08-11 07:44:00-04:00,SNY,neutral
1163497.0,UPDATE: MannKind Shares Rise 35% Premarket on Afrezza Licensing Deal ,2014-08-11 05:31:00-04:00,SNY,positive
1163498.0,"Sanofi, MannKind Announce Global Licensing Agreement for Afrezza Rapid-Acting Inhaled Insulin",2014-08-11 05:26:00-04:00,SNY,positive
1163499.0,Pfizer To Buy Baxter's Vaccines For $635 Million: The Positives & Negatives,2014-08-05 09:16:00-04:00,SNY,positive
1163500.0,"Glaxo, Sanofi Trend Up On Potential Deal For Established Brands",2014-08-04 12:55:00-04:00,SNY,neutral
1163501.0,"Amended 13D Filing from Sanofi on Regeneron Shows Co. Has Confirmed 22.5% Stake in REGN as of Jul. 30th, Planning to Buy 30% Stake This Year and Next",2014-07-31 17:18:00-04:00,SNY,neutral
1163502.0,"UPDATE: Sanofi Posts Upbeat Q2 Earnings, Lifts Profit Outlook",2014-07-31 06:20:00-04:00,SNY,positive
1163503.0,Regenero and Sanofi Announces Positive Top Line Results For Alirocumab Phase 3 Trials,2014-07-30 08:05:00-04:00,SNY,positive
1163504.0,Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With The Highest Dividend Yield,2014-07-11 04:14:00-04:00,SNY,positive
1163505.0,"Watch Sanofi Shares as Bloomberg Reporting the Co.'s Dengue Vaccine Were Reported in Lancet, Showed Promise Against Three Out of Four Viruses",2014-07-10 18:32:00-04:00,SNY,positive
1163506.0,Benzinga's Top #PreMarket Gainers,2014-07-10 08:09:00-04:00,SNY,positive
1163507.0,"UPDATE: Regeneron, Sanofi Offer Positive Results from Phase 2b Study of Dupilum, All Doses Met Primary Endpoint",2014-07-09 17:02:00-04:00,SNY,positive
1163508.0,"Regeneron, Sanofi Offer Positive Results from Phase 2b Study of Dupilum, All Doses Met Primary Endpoint",2014-07-09 17:00:00-04:00,SNY,positive
1163509.0,"Regeneron Pharmaceuticals Shareholder Sanofi Buys 356,700 Shares @$312.37/Share -Form 4",2014-07-08 17:45:00-04:00,SNY,positive
1163510.0,FDA Reports Acceptance of Sanofi's NDA for Basal Insulin Toujeo,2014-07-08 08:02:00-04:00,SNY,positive
1163511.0,Amended 13D from Sanofi on Regeneron Pharma Shows Firm to Raise Ownership Stake from 20.44% as of May 19th to 22.5%,2014-07-01 07:59:00-04:00,SNY,neutral
1163512.0,"Merrimack Pharmaceuticals Reaches Agreement With Sanofi, Regains Rights to Develop And Commercialize MM-121 ",2014-06-19 16:16:00-04:00,SNY,positive
1163513.0,Sanofi's Lyxumia Met Primary Endpoint in 8-Week Head-toHead Pharmacodynamic Study vs Liraglutide,2014-06-14 17:16:00-04:00,SNY,neutral
1163514.0,"Sanofi, Medtronic Announce Strategic Alliance in Diabetes",2014-06-14 16:47:00-04:00,SNY,neutral
1163515.0,Sanofi Announces Positive Phase 3 Results for Toujeo,2014-06-14 16:46:00-04:00,SNY,positive
1163516.0,"US Stock Futures Edge Higher Ahead Of Jobless Claims, Retail Sales Data",2014-06-12 07:28:00-04:00,SNY,neutral
1163517.0,Sanofi and Regeneron Announce Sarilumab Met All Three Co-Primary Endpoints,2014-06-12 05:44:00-04:00,SNY,neutral
1163518.0,"Sanofi CEO Says Relocating to Boston from Paris for Personal Reasons, Sanofi HQ to Remain in Paris -DJ",2014-06-03 07:13:00-04:00,SNY,neutral
1163519.0,ImmunoGen Announces Favorable STARLYTE Phase II Clinical Data with Sanofi's SAR3419 in Diffuse Large B-Cell Lymphoma ,2014-06-01 15:52:00-04:00,SNY,positive
1163520.0,Market Wrap For May 30: 'Sell In May And Go Away' Proves To Be Bad Advice,2014-05-30 16:30:00-04:00,SNY,negative
1163521.0,Sanofi's Genzyme Announces Lemtrada Resubmission Accepted for Review by FDA ,2014-05-30 05:29:00-04:00,SNY,positive
1163522.0,Genzyme's Lemtrada Recommended for Reimbursement on NHS by NICE,2014-05-28 05:33:00-04:00,SNY,positive
1163523.0,"Sanofi, Lilly Announce Licensing Agreement for Nonprescription Cialis ",2014-05-28 05:31:00-04:00,SNY,positive
1163524.0,Sanofi Reports Orphan Drug Designation for Treatment of Multiple Myeloma - Bloomberg,2014-05-23 14:02:00-04:00,SNY,neutral
1163525.0,Benzinga's Weekend M&A Chatter,2014-05-11 22:28:00-04:00,SNY,neutral
1163526.0,"Sanofi Rumored Not to Be Interested in Allergan, J&J Said to Demur on Co.'s Breast Implant Business - Bloomberg",2014-05-09 14:03:00-04:00,SNY,negative
1163527.0,Sanofi Announces Pentavalent Pediatric Vaccine Shan5 Prequalified by WHO,2014-05-05 05:40:00-04:00,SNY,neutral
1163528.0,"Sanofi, Merck Rumored to Each Weigh Sale of Mature-Drug Portfolios - Bloomberg",2014-05-02 15:05:00-04:00,SNY,neutral
1163529.0,Market Wrap For April 30: Markets Positive Despite Fed Tapering and GDP Rising Less Than Expected,2014-04-30 16:35:00-04:00,SNY,positive
1163530.0,"Benzinga's M&A Chatter for Tuesday April 29, 2014",2014-04-29 20:07:00-04:00,SNY,neutral
1163531.0,"Retuers Reports Sanofi Exploring Sale of Mature Drugs That Could be Valued at $7B-8B, According to Sources",2014-04-29 18:47:00-04:00,SNY,positive
1163532.0,"UPDATE: JNJ, Sanofi Spokespersons Decline Comment on Rumored Contact from Allergan",2014-04-29 10:02:00-04:00,SNY,neutral
1163533.0,"Allergan Could Explore Sale to Sanofi, J&J Instead of Valeant - Bloomberg",2014-04-29 09:23:00-04:00,SNY,neutral
1163534.0,Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With The Highest Dividend Yield ,2014-04-08 04:50:00-04:00,SNY,positive
1163535.0,UPDATE: Sanofi Value Rights Rise 30% Premarket as Genzyme to Resubmit Lemtrada Application for FDA Review ,2014-04-07 08:58:00-04:00,SNY,positive
1163536.0,Sanofi Announces Genzyme to Resubmit Lemtrada Application for FDA Review ,2014-04-07 05:38:00-04:00,SNY,neutral
1163537.0,"Sanofi Ceo Says Company Looking for Acquisitions, Will Consider Share Buybacks -Reuters",2014-04-02 11:15:00-04:00,SNY,positive
1163538.0,Sanofi Pasteur Reports FDA Has Expanded Age Indication of Adacel TDAP Vaccine,2014-04-01 09:14:00-04:00,SNY,neutral
1163539.0,"Sanofi, Regeneron Announce Primary Endpoint in Phase 2 Japanese Study of Alirocumab Met, PCSK0 Significantly Reduced LDL-C",2014-04-01 08:08:00-04:00,SNY,neutral
1163540.0,Sanofi Names Dr. Anne C. Beal Chief Patient Officer ,2014-03-31 05:35:00-04:00,SNY,neutral
1163541.0,"US Stock Futures Rise; GDP, Jobless Claims Data In Focus",2014-03-27 07:33:00-04:00,SNY,neutral
1163542.0,"Sanofi, Regeneron to Present Alirocumab Clinical Data at ACCs 63rd Annual Scientific Session ",2014-03-27 05:40:00-04:00,SNY,neutral
1163543.0,Market Wrap For March 25: Markets Snap Two-Day Losing Steak On Confidence Data,2014-03-25 16:24:00-04:00,SNY,positive
1163544.0,"Reckitt Benckiser a Frontrunner for Merck's OTC Segment, Sanofi Rumored to Join Bidders, Final Bids Are Due Next Week - Bloomberg",2014-03-24 15:49:00-04:00,SNY,positive
1163545.0,"UPDATE: Sanofi and Regeneron Unaware of Neurocognitive Adverse Event Signal Related to Alirocumab, Sanofi Says",2014-03-07 15:02:00-05:00,SNY,negative
1163546.0,Regeneron 10-K Filing from February 13 Mentions Adverse Events Related to PCSK9,2014-03-07 13:26:00-05:00,SNY,negative
1163547.0,Adam Feuerstein Tweet: '$REGN 10-K filed Feb. 13 contains exact same language used by $SNY in 20-F. No one seemed to notice.',2014-03-07 13:21:00-05:00,SNY,negative
1163548.0,UPDATE: Sanofi's 20-F Filing Was Out Just After 11AM EST,2014-03-07 13:07:00-05:00,SNY,neutral
1163549.0,"UPDATE: Bloomberg Reporting on Adverse Events Related to PCSK9, Says News Was Out in Sanofi's Form 20-F Filing Earlier",2014-03-07 13:06:00-05:00,SNY,negative
1163550.0,Downside in Regeneron Could Related to FDA Advisory on Adverse Events Related to PCSK9,2014-03-07 13:05:00-05:00,SNY,negative
1163551.0,Sanofi Says Nasacort Spray Now Available without Prescription in the US,2014-02-04 11:46:00-05:00,SNY,neutral
1163552.0,Market Wrap For January 31: Markets End January On Sour Note,2014-01-31 16:38:00-05:00,SNY,neutral
1163553.0,"Bloomberg Reporting Sanofi Has Said Co. Received Reports of Jevtana Drug Preparation Error, Says Hospitals Did Not Follow Preparation Protocol",2014-01-31 15:39:00-05:00,SNY,negative
1163554.0,"Sanofi Files Suit in US to Defend Lantus, Lantus SoloStar Patent Rights ",2014-01-30 17:13:00-05:00,SNY,neutral
1163555.0,"Sanofi, Transgene Launch Construction Phase of Bioproduction Platform ",2014-01-29 05:47:00-05:00,SNY,neutral
1163556.0,FDA Says Sanofi's Multaq Receives Paragraph IV Patent Challenge,2014-01-24 12:08:00-05:00,SNY,positive
1163557.0,Citigroup Downgrades Sanofi to Neutral,2014-01-23 12:17:00-05:00,SNY,neutral
1163558.0,"Zealand Announces Advance by Sanofi of LixiLan, the Single Injection Lyxumia(R)/Lantus(R) Combination Product, Towards Phase III Development and a Related Milestone Payment ",2014-01-15 11:22:00-05:00,SNY,neutral
1163559.0,Regeneron Pharmaceuticals CEO Schleifer: 'We have a Great Relationship with Sanofi',2014-01-14 18:20:00-05:00,SNY,positive
1163560.0,"UPDATE: Sanofi CEO Says Expecting Co. to Continue Taking Equity Stakes in its Partners, Calls 50% Dividend Payout a Target Not a Ceiling",2014-01-14 11:56:00-05:00,SNY,neutral
1163561.0,"Sanofi CEO Viehbacher at JP Morgan Healthcare Conf. Says Co. Seeking M&A Possibilities in the Consumer Health Sector, in Emerging Market Regions",2014-01-14 11:53:00-05:00,SNY,positive
1163562.0,"Benzinga's M&A Chatter for Monday January 13, 2014",2014-01-13 18:05:00-05:00,SNY,neutral
1163563.0,Alnylam Crosses Above $100 on Sanofi/Genzyme 12% Stake,2014-01-13 10:04:00-05:00,SNY,neutral
1163564.0,UPDATE: Alnylam Shares Rise 29% Pre-Market Following Announcement Sanofi's Genzyme Unit Buying 12% Of the Biotech Co,2014-01-13 09:04:00-05:00,SNY,positive
1163565.0,US Stock Futures Fall Ahead Of Federal Budget,2014-01-13 06:41:00-05:00,SNY,neutral
1163566.0,"Genzyme, Alnylam Expand Collaboration on Rare Genetic Diseases ",2014-01-13 05:54:00-05:00,SNY,positive
1163567.0,S&P Capital IQ Downgrades Sanofi to Hold,2014-01-09 12:45:00-05:00,SNY,neutral
1163568.0,JP Morgan Downgrades Sanofi to Neutral,2014-01-06 08:09:00-05:00,SNY,positive
1163569.0,"Stocks To Watch For December 30, 2013",2013-12-30 06:09:00-05:00,SNY,neutral
1163570.0,Genzyme Receives CRL from FDA on Lemtrada Application ,2013-12-30 05:49:00-05:00,SNY,neutral
1163571.0,Genzyme's Lemtrada Approved in Canada for Treatment of MS,2013-12-13 08:02:00-05:00,SNY,positive
1163572.0,"UPDATE: Vivus Eligible to Receive Up to $61M in Upfront Payments, Regulatory and Sales Milestones; Will Also Receive Escalating Royalties Based Net Sales During Agreement",2013-12-12 07:06:00-05:00,SNY,positive
1163573.0,"VIVUS Announces License and Commercialization Agreement With Sanofi for Avanafil in Africa, Middle East, Turkey and CIS/Russia ",2013-12-12 07:01:00-05:00,SNY,positive
1163574.0,FDA Grants Priority Review for Genzyme's Cerdelga for Gaucher Disease ,2013-12-11 05:54:00-05:00,SNY,positive
1163575.0,Alnylam Earns $7M Milestone Payment from Partner Genzyme for Phase II Success with Patisiran,2013-11-25 07:02:00-05:00,SNY,positive
1163576.0,"Sanofi, Regeneron Report Positive Results with Sarilumab in First Phase 3 Rheumatoid Arthritis Registration Trial ",2013-11-22 01:13:00-05:00,SNY,positive
1163577.0,2013 3Q 13F Roundup,2013-11-18 13:27:00-05:00,SNY,neutral
1163578.0,Kepler Upgrades Sanofi to Buy,2013-11-18 07:32:00-05:00,SNY,neutral
1163579.0,Mirabaud Upgrades Sanofi to Buy,2013-11-15 08:36:00-05:00,SNY,neutral
1163580.0,"13F from Buffett's Berkshire Shows Lowered Stakes in GlaxoSmithKline, Sanofi, ConocoPhilips, DirecTV, Raised Stakes in Suncor Energy, VeriSign, Bank of NY Mellon, US Bancorp",2013-11-14 16:34:00-05:00,SNY,positive
1163581.0,FDA Says Outcomes Trials Are Not Needed for PCSK9 Approval,2013-11-14 15:43:00-05:00,SNY,positive
1163582.0,FDA Panel Votes 17-0 Risks of Lemtrada Do Not Preclude Approval,2013-11-13 16:21:00-05:00,SNY,negative
1163583.0,FDA Panel Votes 14-2 Sanofi's Lemtrade Does Not Show Disability Help,2013-11-13 16:00:00-05:00,SNY,negative
1163584.0,FDA Panel Votes 12-6 Sanofi's Lemtrade is Effective,2013-11-13 15:40:00-05:00,SNY,positive
1163585.0,FDA Panel Votes 11-6 Sanofi's Lemtrade Trials Were Not Adequate,2013-11-13 15:31:00-05:00,SNY,negative
1163586.0,Food Allergy Bill Offers Financial Incentives for States That Have Emergency Meds at Schools,2013-11-13 14:22:00-05:00,SNY,negative
1163587.0,Sanofi Says Lemtrada Follow-Up Data Consistent with Trials,2013-11-08 09:31:00-05:00,SNY,neutral
1163588.0,Orexigen Reports Deal with Sanofi to Manufacture Contrave Outside of US,2013-11-06 16:31:00-05:00,SNY,neutral
1163589.0,Bloomberg Highlighting Sanofi Has Said Could Issue as Many as 6.6M New Shares for Employee Sale Running Nov. 7th-24th,2013-10-29 12:40:00-04:00,SNY,positive
1163590.0,UPDATE: Leerink Swann Downgrades Sanofi Based on Low Visibility,2013-10-18 12:14:00-04:00,SNY,negative
1163591.0,Sanofi Regeneron Report Phase 3 ODYSSEY MONO trial with Alirocumab Met Primary Efficacy Endpoint,2013-10-16 06:07:00-04:00,SNY,neutral
1163592.0,FDA Approves Sanofi's Nasacort Allergy 24HR Nasal Spray as OTC Treatment,2013-10-11 14:32:00-04:00,SNY,positive
1163593.0,MainFirst Initiates Coverage on Sanofi at Underperform,2013-10-09 06:57:00-04:00,SNY,neutral
1163594.0,Genzyme Reports Positive Data from Topic Study of Aubagio,2013-10-03 05:50:00-04:00,SNY,positive
1163595.0,"Hearing Renewed Unconfirmed Takeover Chatter in Questcor, Sanofi Rumored Buyer at $78/Share",2013-09-30 11:54:00-04:00,SNY,negative
1163596.0,US Stock Futures Flat Ahead Of Economic Data,2013-09-24 07:21:00-04:00,SNY,neutral
1163597.0,Sanofi Announces Data Show Lyxumia Added to Basal Insulin Lowered Blood Sugar in Patients with Type 2 Diabetes,2013-09-24 06:08:00-04:00,SNY,negative
1163598.0,Write A Prescription For Health Care ETFs,2013-09-19 08:06:00-04:00,SNY,positive
1163599.0,Analysts Getting More Bullish On ViroPharma Following Friday's 28+% Surge On Takeover Chatter,2013-09-16 11:00:00-04:00,SNY,neutral
1163600.0,Benzinga's Top Upgrades,2013-09-16 08:02:00-04:00,SNY,positive
1163601.0,Barclays Upgrades Sanofi to Overweight,2013-09-16 07:42:00-04:00,SNY,negative
1163602.0,Viropharma Rises 25% on Reports of Goldman Hiring to Explore Sale,2013-09-13 13:10:00-04:00,SNY,neutral
1163603.0,ViroPharma Incorporated Halted on Circuit Breaker,2013-09-13 13:02:00-04:00,SNY,neutral
1163604.0,Viropharma Said to hire Goldman Sachs to Explore Possible Sale -Bloomberg,2013-09-13 13:01:00-04:00,SNY,neutral
1163605.0,Benzinga's Top Pre-Market Gainers,2013-09-05 08:10:00-04:00,SNY,positive
1163606.0,"Stocks To Watch For September 5, 2013",2013-09-05 04:20:00-04:00,SNY,neutral
1163607.0,"Sanofi, Pozen Announce Exclusive License Deal for Commercialization of PA8140/PA32540 Tablets in US",2013-09-04 16:05:00-04:00,SNY,positive
1163608.0,Cowen & Company Downgrades Sanofi to Market Perform,2013-08-21 09:23:00-04:00,SNY,neutral
1163609.0,How Much Does It Cost To Develop A New Drug?,2013-08-14 09:32:00-04:00,SNY,neutral
1163610.0,Anonymous Europe ETFs You Need To Know Now,2013-08-09 15:20:00-04:00,SNY,neutral
1163611.0,Sanofi Announces FDA Panel Recommends Approval of Nasacort Spray,2013-07-31 17:47:00-04:00,SNY,positive
1163612.0,FDA Issues Review of Proposed OTC USage of Sanofi's Nasacort Spray,2013-07-29 08:06:00-04:00,SNY,neutral
1163613.0,Sanofi Pasteur Announces Shipment of First Lots of 2013-2014 Seasonal Influenza Vaccine in U.S. ,2013-07-25 08:08:00-04:00,SNY,neutral
1163614.0,Sanofi Pasteur Vaccine Suspended as Precautionionary Measury - WHO Citing Quality Problem,2013-07-12 09:59:00-04:00,SNY,negative
1163615.0,ETFs For a European Recovery,2013-06-25 14:37:00-04:00,SNY,neutral
1163616.0,ViroPharma and Other Biotech Stocks Recommended by Oppenheimer (VPHM),2013-06-24 15:16:00-04:00,SNY,positive
1163617.0,"Stocks To Watch For June 24, 2013",2013-06-24 04:07:00-04:00,SNY,neutral
1163618.0,Sanofi Reports Positive Phase 3 Results for Insulin U300 ,2013-06-22 12:20:00-04:00,SNY,positive
1163619.0,Sanofi Announces Positive Phase 3 Data for Lixisenatide for Type 2 Diabetes ,2013-06-22 11:08:00-04:00,SNY,positive
1163620.0,"Top-Performing Dividend Payers in Health Care with the Most Upside Potential (AET, ENSG, QCOR)",2013-06-08 12:47:00-04:00,SNY,positive
1163621.0,"Sanofi, Regeneron Says Phase 2a Trial of Dupilumab Demonstrated 87% Cut i Asthma Risk",2013-05-21 08:16:00-04:00,SNY,negative
1163622.0,Sanofi Wins Appeal to Revive Infringement Claim related to Allegra,2013-05-20 11:17:00-04:00,SNY,positive
1163623.0,Sanofi Wins FDA Orphan Status for Systemic Sclerosis Treatment,2013-05-15 13:05:00-04:00,SNY,positive
1163624.0,"Sanofi, Regeneron Announce Patient Enrollment in Two Phase 3 Sarilumab Trials for Rheumatoid Arthritis",2013-05-15 05:55:00-04:00,SNY,neutral
1163625.0,Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With The Lowest PEG Ratio,2013-05-08 04:51:00-04:00,SNY,negative
1163626.0,Banco Sabadell Downgraded Sanofi to Sell,2013-05-03 10:29:00-04:00,SNY,neutral
1163627.0,S&P Upgrades Sanofi to AA; Outlook Stable,2013-05-03 08:45:00-04:00,SNY,positive
1163628.0,Regeneron Pharmaceuticals: The Stock That Only Goes Up?,2013-05-01 16:42:00-04:00,SNY,neutral
1163629.0,"FDA Issues Review of Amgen, Sanofi Drugs for Radiation Treatment for May 3rd Panel Meeting",2013-05-01 07:55:00-04:00,SNY,neutral
1163630.0,A Peek Into The Market Before The Trading Starts,2013-04-25 07:57:00-04:00,SNY,neutral
1163631.0,Genzyme Announces Positive Top-Line Results from TOPIC Trial for AUBAGIO,2013-04-25 05:57:00-04:00,SNY,positive
1163632.0,"Eli Lilly Earnings Preview: EPS, Sales Growth Expected",2013-04-23 12:43:00-04:00,SNY,positive
1163633.0,ETF Showdown: A Pharma Fight,2013-04-11 16:21:00-04:00,SNY,negative
1163634.0,Pieris and Sanofi Expand Collaboration ,2013-04-10 05:53:00-04:00,SNY,positive
1163635.0,Moody's Upgrades Sanofi to A1; Outlook Stable,2013-03-28 07:36:00-04:00,SNY,positive
1163636.0,Sanofi and Transgene Announce Long-Term Collaboration,2013-03-25 06:00:00-04:00,SNY,neutral
1163637.0,"Moves in Smaller Health Care Stocks (ANAC, HALO, PBYI, QCOR)",2013-03-23 11:33:00-04:00,SNY,positive
1163638.0,"Sanofi Commenting on DoJ Investigation in June Related to Disclosures on Response to Plavix, Says Cooperating, Became Aware of Probe in June",2013-03-08 12:56:00-05:00,SNY,neutral
1163639.0,3 International Dividend ETFs Your Broker Forgot to Mention,2013-03-06 12:45:00-05:00,SNY,neutral
1163640.0,3 ADR ETFs Your Broker Forgot to Mention,2013-03-05 14:42:00-05:00,SNY,neutral
1163641.0,Hedged ETFs Working Well in 2013,2013-03-04 14:09:00-05:00,SNY,positive
1163642.0,"Sanofi, Regeneron Report Positive Phase 1b Data for Dupilumab in Atopic Dermatitis ",2013-03-02 10:47:00-05:00,SNY,positive
1163643.0,These ETFs Have Moving Average Problems,2013-02-27 15:23:00-05:00,SNY,negative
1163644.0,Are Global Health Care ETFs Worth Prescribing?,2013-02-22 11:24:00-05:00,SNY,positive
1163645.0,JP Morgan Cautious on Sanofi Buying Regeneron,2013-02-11 10:54:00-05:00,SNY,positive
1163646.0,"Sanofi Says No Plan to Take Controlling Stake in Regeneron, Says Could Increase Stake Over Time - Bloomberg",2013-02-11 09:53:00-05:00,SNY,neutral
1163647.0,UPDATE: Regeneron Pharm Announces Receipt of HSR Notice Sanofi to Buy Stock in Open Market,2013-02-11 09:38:00-05:00,SNY,neutral
1163648.0,Regeneron Announces Receipt of HSR Notice Sanofi Intends to buy Stock in Open Market,2013-02-11 09:37:00-05:00,SNY,neutral
1163649.0,Sanofi Q4 Profit Down 72%,2013-02-07 03:39:00-05:00,SNY,positive
1163650.0,Three ETFs That Could Suffer from a Weaker Yen,2013-02-05 14:21:00-05:00,SNY,negative
1163651.0,Time to Hedge Euro Risk?,2013-01-30 14:57:00-05:00,SNY,negative
1163652.0,Isis and Sanofi's Drug OK'd to Treat Inherited Cholesterol Disease,2013-01-30 12:52:00-05:00,SNY,positive
1163653.0,Isis Surges on FDA Approval of KYNAMRO,2013-01-30 11:18:00-05:00,SNY,positive
1163654.0,Barclays Downgrades Sanofi to Equalweight,2013-01-29 08:26:00-05:00,SNY,neutral
1163655.0,Goldman Sachs Upgrades Sanofi to Neutral,2013-01-28 09:45:00-05:00,SNY,neutral
1163656.0,Sanofi Launches AUVI-Q in US - Bloomberg,2013-01-28 08:03:00-05:00,SNY,neutral
1163657.0,A Peek Into The Market Before The Trading Starts,2013-01-28 07:19:00-05:00,SNY,neutral
1163658.0,Genzyme's LEMTRADA Application for MS Accepted for Review by FDA ,2013-01-28 05:59:00-05:00,SNY,positive
1163659.0,Genzyme's LEMTRADA Application for MS Accepted for Review by FDA ,2013-01-28 05:59:00-05:00,SNY,positive
1163660.0,2 Attractively Valued Blue Chips,2013-01-27 19:19:00-05:00,SNY,positive
1163661.0,Sanofi Won't Comment on Specific Bausch & Lomb Interest,2013-01-25 09:34:00-05:00,SNY,positive
1163662.0,Sanofi Won't Comment on Specific Bausch & Lomb Interest,2013-01-25 09:34:00-05:00,SNY,positive
1163663.0,S&P Likes 2 ETFs For Europe's Rebound ,2013-01-24 13:38:00-05:00,SNY,positive
1163664.0,New York Governor Cuomo Declares Public Health Emergency Due to Severe Flu Outbreak,2013-01-12 12:00:00-05:00,SNY,negative
1163665.0,Three Stocks to Buy for Flu Season,2013-01-11 13:57:00-05:00,SNY,negative
1163666.0,Washington Post Reporting the FDA to Require Lower Recommended Dosages for Sleep Drugs,2013-01-10 11:53:00-05:00,SNY,negative
1163667.0,"Sanofi CEO Viehbacher Says Co. to Stick to Bolt-On Purchases in 2013, Looking for Deals in Emerging Markets, Prefers Dividends to Return Cash to Holders",2013-01-08 12:24:00-05:00,SNY,neutral
1163668.0,Sanofi CEO Viehbacher: 'We Have a Strong Hub in China and Europe',2013-01-07 16:47:00-05:00,SNY,positive
1163669.0,Sanofi CEO Viehbacher: 'Sanofi is an Exciting R&D Story Now',2013-01-07 16:46:00-05:00,SNY,positive
1163670.0,Sanofi CEO Christopher A. Viehbacher: 'Sold About 60M Doses of Flu Vaccine This Season; We are Still Able to Supply the Market',2013-01-07 16:45:00-05:00,SNY,negative
1163671.0,4 Health Care ETFs Your Broker Forgot to Mention,2013-01-07 15:52:00-05:00,SNY,positive
1163672.0,Sanofi Buys OTC Antacid Rolaids from J&J's McNeil-PPC,2013-01-07 08:08:00-05:00,SNY,neutral
1163673.0,"Merck, Pfizer, Abbott, J&J, Sanofi Said to Show Interest in Bausch & Lomb Bid - Bloomberg",2013-01-03 16:00:00-05:00,SNY,positive
1163674.0,Aegerion Pharmaceuticals Wins Approval for Cholesterol Drug,2012-12-24 13:01:00-05:00,SNY,positive
1163675.0,Sanofi-Aventis US Agrees to Pay $109M to Resolve False Claims,2012-12-19 15:38:00-05:00,SNY,positive
1163676.0,Benzinga's Top Upgrades,2012-12-14 07:14:00-05:00,SNY,positive
1163677.0,"Benzinga's M&A Chatter for Wednesday December 12, 2012",2012-12-12 17:59:00-05:00,SNY,neutral
1163678.0,Hearing Unconfirmed Chat Room Chatter in Dendreon Regarding Possible Sanofi Bid,2012-12-12 11:19:00-05:00,SNY,negative
1163679.0,"Benzinga's M&A Chatter for Tuesday December 11, 2012",2012-12-11 17:23:00-05:00,SNY,neutral
1163680.0,"Warburg Pincus Said to Hire Goldman Sachs to Sell Bausch & Lomb, Seeking At Least $10B; Abbott, Glaxo, Merck, Sanofi Said to Be Contacted - Bloomberg",2012-12-11 16:56:00-05:00,SNY,neutral
1163681.0,Sanofi Phase II Trial of JAK2 Inhibitor in Myelofibrosis Met Primary Endpoint ,2012-12-09 19:32:00-05:00,SNY,negative
1163682.0,"Genzyme's Once-Daily, Oral AUBAGIO Approved in Australia",2012-11-21 16:00:00-05:00,SNY,positive
1163683.0,"Post Downgrade, Say Oui to France?",2012-11-20 13:49:00-05:00,SNY,neutral
1163684.0,iShares Strategist Upgrades France,2012-11-20 07:06:00-05:00,SNY,neutral
1163685.0,"SEC Charges Celgene, Sanofi, Stryker Employees with Insider Trading",2012-11-19 13:31:00-05:00,SNY,negative
1163686.0,From Earlier:  CHMP Recommends Granting of Marketing Authorization for ZALTRAP,2012-11-16 10:11:00-05:00,SNY,positive
1163687.0,"Sanofi, Regeneron Begin Enrollment in CV Outcomes Trial with PCSK9 Antibody for Hypercholesterolemia",2012-11-05 08:15:00-05:00,SNY,neutral
1163688.0,Beating Buffett With ETFs,2012-10-26 14:02:00-04:00,SNY,negative
1163689.0,Zalicus  Prednisporin Licensee Sanofi Provides Update on Development Status,2012-10-25 07:10:00-04:00,SNY,neutral
1163690.0,Sanofi Request for IPOL BLA Approved by FDA,2012-10-23 10:03:00-04:00,SNY,positive
1163691.0,FDA Advisory Committee Votes to Recommend Isis' KYNAMRO ,2012-10-18 17:30:00-04:00,SNY,positive
1163692.0,Sanofi's Genzyme to Present New Data from AUBAGIO and LEMTRADATM,2012-10-09 06:00:00-04:00,SNY,neutral
1163693.0,"Benzinga's M&A Chatter for Thursday October 4, 2012",2012-10-04 18:13:00-04:00,SNY,neutral
1163694.0,Rosetta Genomics Spokesperson Had No Knowledge of Sanofi Bid; Responding to Earlier Chatter,2012-10-04 10:36:00-04:00,SNY,negative
1163695.0,Sanofi To Buy Genfar,2012-10-03 04:08:00-04:00,SNY,neutral
1163696.0,Sanofi Recalls Some Lots of Typhim VI Vaccine,2012-09-28 14:16:00-04:00,SNY,neutral
1163697.0,Not So Bad After All For Europe ETFs,2012-09-25 11:42:00-04:00,SNY,positive
1163698.0,"Sanofi to Cut 1,500 to 2,000 Jobs in France -Le Figaro",2012-09-15 09:30:00-04:00,SNY,negative
1163699.0,FDA Approves Genzyme's AUBAGIO Oral Treatment for Relapsing Multiple Sclerosis ,2012-09-12 23:13:00-04:00,SNY,positive
1163700.0,Seven Cheap Large-Caps Yielding Over 4% ,2012-09-06 14:07:00-04:00,SNY,neutral
1163701.0,"Three Biotech Stocks Analysts Are Keen On (MDVN, GEVA, OPTR)",2012-09-05 15:34:00-04:00,SNY,positive
1163702.0,Pharma Companies Switch Drugs to OTC Market,2012-08-30 16:15:00-04:00,SNY,neutral
1163703.0,A New Twist on an Old ETF,2012-08-30 08:32:00-04:00,SNY,neutral
1163704.0,Veracyte Receives New York State License for Afirma Gene Expression Classifier,2012-08-29 08:17:00-04:00,SNY,neutral
1163705.0,Genzyme Provides Update on U.S. LEMTRADA™ Filing ,2012-08-27 05:59:00-04:00,SNY,neutral
1163706.0,"Benzinga's M&A Chatter for Thursday August 23, 2012",2012-08-23 17:01:00-04:00,SNY,neutral
1163707.0,Regeneron Pharmaceuticals Spokesperson Declines Comment on Earlier Takeover Chatter,2012-08-23 14:21:00-04:00,SNY,neutral
1163708.0,Regeneron Pharmaceuticals Hits 52-Week High on Takeover Rumors,2012-08-23 11:15:00-04:00,SNY,neutral
1163709.0,Hearing Unconfirmed Takeover Chatter in Regeneron,2012-08-23 10:52:00-04:00,SNY,negative
1163710.0,"Sklice Lotion, 0.5% Now Available in the US for Topical Treatment of Head Lice ",2012-08-20 14:47:00-04:00,SNY,neutral
1163711.0,Sanofi Announces FDA Approval for Auvi-Q,2012-08-13 08:19:00-04:00,SNY,positive
1163712.0,Standpoint Research Downgrades Sanofi-Aventis from Buy to Hold,2012-08-03 14:14:00-04:00,SNY,neutral
1163713.0," Regeneron, Sanofi Win FDA Approval for Colon Cancer Drug Zaltrap",2012-08-03 11:49:00-04:00,SNY,positive
1163715.0,Sanofi Q2 Net Profit Surges 16%,2012-07-26 04:47:00-04:00,SNY,positive
1163716.0,Put Seller in Alpha Natural Resources,2012-07-24 11:32:00-04:00,SNY,positive
1163717.0,"Sanofi Says It Has Full Confidence in Products from Its Facilities, Has Taken Actions to Address FDA Findings -Bloomberg",2012-07-24 11:11:00-04:00,SNY,positive
1163718.0,"Financial Breakfast: Morning News Summary for July 20, 2012",2012-07-20 07:17:00-04:00,SNY,neutral
1163719.0,Sanofi and Regeneron Launch Comprehensive Phase 3 Clinical Program With LDL Cholesterol-Lowering PCSK9 Antibody ,2012-07-20 06:34:00-04:00,SNY,positive
1163721.0,New Study Suggests That Use of Veracyte's Afirma® Gene Expression Classifier Helps to Significantly Reduce Surgeries in Patients with Ambiguous Thyroid Nodule Cytology Results ,2012-07-17 10:28:00-04:00,SNY,positive
1163722.0,Popular Drug Manufacturing Stocks Among Hedge Funds,2012-07-17 07:47:00-04:00,SNY,positive
1163723.0,Sanofi Biosurgery Product MACI® Demonstrates Statistically Significant Clinical Outcomes Compared to Microfracture ,2012-07-12 07:47:00-04:00,SNY,positive
1163724.0,BioMarin Pharmaceutical Hits New 52-Week High on Continued Takeover Chatter,2012-06-29 12:03:00-04:00,SNY,neutral
1163725.0,"Benzinga's M&A Chatter for Thursday June 28, 2012",2012-06-28 18:20:00-04:00,SNY,neutral
1163726.0,Spokesperson for BioMarin Pharmaceutical Won't Comment on Guardian Report on Takeover Bids,2012-06-28 13:45:00-04:00,SNY,neutral
1163727.0,Editor of Little Bear Blog is Long BioMarin Pharmaceutical on Takeover Chatter,2012-06-28 12:26:00-04:00,SNY,neutral
1163728.0,"UPDATE: BioMarin Spikes Higher on Report GlaxoSmithKline, Sanofi, Biogen Could Bid $60/Share -Guardian",2012-06-28 12:10:00-04:00,SNY,neutral
1163729.0,"Benzinga's M&A Chatter for Tuesday June 26, 2012",2012-06-26 18:04:00-04:00,SNY,neutral
1163730.0,Spokesperson for Amylin Pharmaceuticals Won't Comment on Rumor of Bids from Pharma Companies,2012-06-26 13:17:00-04:00,SNY,neutral
1163731.0,Amylin Pharmaceuticals Spiking to Highs on Earlier Bid Reports,2012-06-26 11:57:00-04:00,SNY,neutral
1163732.0,FDA Panel Rejects Proposed Sanofi Drug Semuloparin,2012-06-20 12:00:00-04:00,SNY,negative
1163733.0,"Benzinga's M&A Chatter for Wednesday June 13, 2012",2012-06-13 17:48:00-04:00,SNY,neutral
1163734.0,Dendreon Spokesperson Declined Comment on Earlier Chatter of Sanofi Bid,2012-06-13 14:06:00-04:00,SNY,neutral
1163735.0,Dendreon Surges 10% on Takeover Chatter,2012-06-13 10:55:00-04:00,SNY,neutral
1163736.0,Genzyme Submits Applications to FDA and EMA for Approval of LEMTRADA for Multiple Sclerosis  ,2012-06-12 07:54:00-04:00,SNY,positive
1163737.0,From Earlier: Zealand Pharma Announces That Its Partner Sanofi Has Applied for Regulatory Approval of Lixisenatide 1 for the Treatment of Type 2 Diabetes in Japan  ,2012-06-11 07:57:00-04:00,SNY,positive
1163738.0,"Sanofi, Zealand Pharma Announces GetGoal Duo 1 and GetGoal-L Phase III Data on Lixisenatide to be Presented at ADA",2012-06-09 11:29:00-04:00,SNY,neutral
1163739.0,"Benzinga's M&A Chatter for  Friday June 1, 2012",2012-06-03 10:47:00-04:00,SNY,neutral
1163740.0,Amylin Pharmaceuticals Spokesperson Declines Comment on Renewed Takeover Chatter,2012-06-01 15:14:00-04:00,SNY,neutral
1163741.0,Hearing Renewed Takeover Chatter in Amylin Pharmaceuticals,2012-06-01 13:50:00-04:00,SNY,neutral
1163742.0,"Benzinga's M&A Chatter for Wednesday May 30, 2012",2012-05-30 17:08:00-04:00,SNY,neutral
1163743.0,Genzyme and Isis Announce Filing of U.S. NDA for KYNAMRO in Homozygous Familial Hypercholesterolemia   ,2012-05-29 08:02:00-04:00,SNY,neutral
1163744.0,"Benzinga's M&A Chatter for Friday May 25, 2012",2012-05-28 01:21:00-04:00,SNY,neutral
1163745.0,"Amylin Shares Jump as Sanofi, Merck Sumbit Bids",2012-05-25 15:15:00-04:00,SNY,positive
1163746.0,Merck Spokesperson Would Not Comment on Reports of Bid for Amylin,2012-05-25 14:24:00-04:00,SNY,neutral
1163747.0,Amylin Spokesperson Would Not Comment on Bloomberg Report of Bids from Merck and Sanofi,2012-05-25 14:18:00-04:00,SNY,neutral
1163748.0,Option Alert: Heavy Volume in Sanofi June 33 to 37 Calls; Currently $37.99,2012-05-04 15:00:00-04:00,SNY,positive
1163749.0,FDA Considering Letting Patients Purchase Drugs Without Prescriptions,2012-04-30 12:09:00-04:00,SNY,neutral
1163750.0,Sanofi Q1 EPS EU 1.85; Sales EU 8.51B ,2012-04-27 08:17:00-04:00,SNY,neutral
1163751.0,Sanofi Q1 Net Profit Jumps 50%,2012-04-27 05:18:00-04:00,SNY,positive
1163752.0,Sanofi and Michael J. Fox Foundation Collaborate on Potential New Treatment for Parkinson's Disease  ,2012-04-19 08:09:00-04:00,SNY,neutral
1163753.0,From Earlier: Sanofi and Regeneron Announce Regulatory and Clinical Update for ZALTRAP ,2012-04-05 07:37:00-04:00,SNY,neutral
1163754.0,Genzyme and Isis Announce Submission of U.S. NDA for KYNAMRO in Homozygous Familial Hypercholesterolemia  ,2012-03-29 11:01:00-04:00,SNY,neutral
1163755.0,ImmunoCellular's Intellectual Property Steadily Increases,2012-03-28 22:43:00-04:00,SNY,positive
1163756.0,UPDATE: Sanofi and Regeneron Report Phase 2 Data for Potential First-in-Class Lipid-Lowering PCSK9 Antibody ,2012-03-26 11:32:00-04:00,SNY,neutral
1163757.0,"Sanofi Loses Appeal in Roche Suit Over Rituxan, Avastin",2012-03-22 13:08:00-04:00,SNY,negative
1163758.0,"Benzinga's M&A Chatter for Wednesday March 21, 2012",2012-03-21 19:21:00-04:00,SNY,neutral
1163759.0,Positive Rumors Circulate About Dendreon,2012-03-21 10:09:00-04:00,SNY,positive
1163760.0,"St. Jude, Novo Nordisk and Other Health Care Stocks Worth a Look Now",2012-03-21 07:20:00-04:00,SNY,positive
1163761.0,UPDATE: Bird Flu Found in the Netherlands,2012-03-19 13:56:00-04:00,SNY,negative
1163762.0,"Benzinga's M&A Chatter for Friday March 16, 2012",2012-03-17 18:43:00-04:00,SNY,neutral
1163763.0,"Sanofi to Acquire Pluromed, Inc., Expanding Its Presence in Biosurgery ",2012-03-16 08:02:00-04:00,SNY,neutral
1163764.0,Sanofi To Buy Pluromed,2012-03-16 05:08:00-04:00,SNY,neutral
1163765.0,Shire Analyst: Replagal Application Withdrawal Could Allow Sanofi's Fabrazyme Competing Drug to Capture Market Share,2012-03-15 15:54:00-04:00,SNY,positive
1163766.0,"The Peyton Manning ETF Portfolio (XLP, XLY, IYG)",2012-03-07 12:52:00-05:00,SNY,neutral
1163767.0,Genzyme Announces EMA Accepts Oral Teriflunomide Marketing Application for Treatment of Multiple Sclerosis,2012-02-23 09:01:00-05:00,SNY,positive
1163768.0,From Earlier: Sanofi and Bristol-Myers Squibb Collect Damages in Plavix Patent Litigation with Apotex  ,2012-02-08 08:20:00-05:00,SNY,negative
1163769.0,Sanofi Announces FDA Approval of Sklice® Lotion for the Treatment of Head Lice  ,2012-02-07 14:05:00-05:00,SNY,positive
1163770.0,Sanofi Receives Positive Mad Money/Jim Cramer Mention -CNBC,2012-01-27 18:33:00-05:00,SNY,positive
1163771.0,Genzyme Announces FDA Approval of Framingham Manufacturing Plant  ,2012-01-24 06:55:00-05:00,SNY,positive
1163772.0,Genzyme and Veracyte Announce Global Co-Promotion Agreement to Deliver Personalized Solution for Thyroid Patients,2012-01-20 08:15:00-05:00,SNY,positive
1163773.0,Sanofi's Genzyme Announces European Approval of Framingham Manufacturing Plant  ,2012-01-18 07:04:00-05:00,SNY,positive
1163774.0,"Benzinga's M&A Chatter for Tuesday January 10, 2012",2012-01-10 18:43:00-05:00,SNY,neutral
1163775.0,Regeneron CEO Schleifer: 'We're Excited About the Prospects We've been Working on with Sanofi',2012-01-10 18:25:00-05:00,SNY,positive
1163776.0,Sanofi Announces Court Ruling Granting Preliminary Injunction Against Synvisc-One Competitor Product ,2012-01-05 08:47:00-05:00,SNY,positive
1163777.0,"Regeneron Informed by Sanofi that on December 19, 2011, Sanofi Voluntarily Withdrew Biologics License Application Submitted to the US FDA for Marketing Approval of ZALTRAP",2011-12-21 16:33:00-05:00,SNY,positive
1163778.0,Merck Hands Exelixis $12 Million Up Front For a Preclinical Compound Program,2011-12-21 11:28:00-05:00,SNY,neutral
1163779.0,Genzyme Reports Top-line Results for TENERE Study of Oral Teriflunomide in Relapsing Multiple Sclerosis  ,2011-12-20 07:34:00-05:00,SNY,neutral
1163780.0,Valeant Pharmaceuticals Receives Approval From FTC in Connection With Acquisition of Ortho Dermatologics and Dermik ,2011-12-12 13:15:00-05:00,SNY,positive
1163781.0,VIX: Volatility and the Viability of Investing in Stocks,2011-12-09 14:13:00-05:00,SNY,neutral
1163782.0,Sanofi-Aventis Hits 52-Week High of $34.96,2011-12-06 13:57:00-05:00,SNY,neutral
1163783.0,"Financial Breakfast: Morning News Summary for December 6, 2011",2011-12-06 07:36:00-05:00,SNY,neutral
1163784.0,A Peek Into The Market Before The Trading Starts,2011-12-06 07:33:00-05:00,SNY,neutral
1163785.0,Positive Results Reported by Sanofi for Once-Daily Lixisenatide in Combination With Lantus in Type 2 Diabetes  ,2011-12-06 06:47:00-05:00,SNY,positive
1163786.0,"Mad Money Lightning Round: Cramer Dislikes Microsoft, Radioshack",2011-12-01 05:52:00-05:00,SNY,negative
1163787.0,Notable Call Options Activity in Sanofi,2011-11-30 11:14:00-05:00,SNY,neutral
1163788.0,Mad Money Lightning Round: Cramer Likes Waste Management,2011-11-22 04:33:00-05:00,SNY,negative
1163789.0,Mad Money Lightning Round: Cramer Likes Sanofi-Aventis,2011-11-21 03:59:00-05:00,SNY,negative
1163790.0,Genzyme and Cystic Fibrosis Foundation Therapeutics Announce Collaboration to Discover New CF Drugs   ,2011-11-16 08:33:00-05:00,SNY,neutral
1163791.0,Sanofi's Multaq Death Toll Doubled from Heart Disease in Study,2011-11-14 12:31:00-05:00,SNY,negative
1163792.0,From Earlier: Genzyme Announces Successful Phase III Results for Alemtuzumab in Multiple Sclerosis  ,2011-11-14 09:24:00-05:00,SNY,positive
1163793.0,Notable Put Options Activity in Sanofi,2011-11-10 12:02:00-05:00,SNY,neutral
1163794.0,"Market Madness, Rampant Irrationality, & Animal Spirits: What Are Investors To Do?",2011-11-09 23:41:00-05:00,SNY,negative
1163795.0,"Windstream, Solar Capital, Energy Transfer Partners, American Electric Power, Sanofi Receive Positive Mad Money/Jim Cramer Mention -CNBC",2011-11-09 18:19:00-05:00,SNY,positive
1163796.0,Watch for YM BioSciences' Upcoming Clinical Data Catalyst,2011-10-31 23:15:00-04:00,SNY,neutral
1163797.0,Sanofi Pasteur Presents Additional Data on Investigational Quadrivalent Influenza Vaccine ,2011-10-21 12:30:00-04:00,SNY,neutral
1163798.0,Sanofi Pasteur Presents New Data Confirming Fluzone® High-Dose (Influenza Virus Vaccine) Produces Higher Antibody Response in the Age 65+ Population ,2011-10-21 12:30:00-04:00,SNY,neutral
1163799.0,Mad Money Lightning Round: Cramer Likes Coca-Cola,2011-10-17 05:06:00-04:00,SNY,negative
1163800.0,Sanofi Prices $1B Bond Issue   ,2011-09-29 09:45:00-04:00,SNY,neutral
1163801.0,China Hit with Polio Outbreak ,2011-09-21 07:10:00-04:00,SNY,neutral
1163802.0,Jim Cramer Interviews CEO Christopher A. Viehbacher of Sanofi on Mad Money,2011-09-19 18:47:00-04:00,SNY,negative
1163803.0,Notable Put Options Activity in Sanofi,2011-09-14 12:26:00-04:00,SNY,neutral
1163804.0,Notable Call Options Activity in Synovus Financial,2011-08-26 12:54:00-04:00,SNY,neutral
1163805.0,12 Most Popular Healthcare Stocks Among Hedge Funds,2011-08-25 17:10:00-04:00,SNY,positive
1163806.0,12 Most Popular Healthcare Stocks Among Hedge Funds,2011-08-25 11:36:00-04:00,SNY,positive
1163807.0,Sanofi Aventis in Talks to Buy Universal Medicare - Economic Times,2011-08-22 15:58:00-04:00,SNY,neutral
1163808.0,Top Yielding French Stocks,2011-08-21 18:47:00-04:00,SNY,positive
1163809.0,Mad Money Lightning Round: Cramer Likes Sanofi-Aventis,2011-08-19 03:48:00-04:00,SNY,negative
1163810.0,Profiting from the Zero Growth French Economy,2011-08-12 06:57:00-04:00,SNY,positive
1163811.0,Puts Purchased on Sanofi,2011-08-10 11:05:00-04:00,SNY,neutral
1163812.0,Options Brief: Sanofi,2011-08-09 11:43:00-04:00,SNY,neutral
1163813.0,Top Yield Stocks of Warren Buffett,2011-07-28 01:19:00-04:00,SNY,positive
1163814.0,FDA Issues Draft Guidance On Device Changes That Warrant New Premarket Review,2011-07-26 13:10:00-04:00,SNY,neutral
1163815.0,Valeant Pharmaceuticals Announces Distribution Agreement with sanofi-aventis  for Zuacta in Canada  ,2011-07-19 17:04:00-04:00,SNY,positive
1163816.0,Sanofi-Aventis (SNY): Low-risk potential,2011-07-18 20:00:00-04:00,SNY,neutral
1163817.0,Sanofi and Regeneron Report Positive Phase 2b Trial Results with Sarilumab in Rheumatoid Arthritis,2011-07-12 16:07:00-04:00,SNY,positive
1163818.0,Sanofi Divests Dermik Dermatology Unit to Valeant Pharmaceuticals International for $425M ,2011-07-11 08:01:00-04:00,SNY,neutral
1163819.0,Deutsche Bank Comments On Valeant's Acquisition Of Dermik,2011-07-11 06:14:00-04:00,SNY,neutral
1163820.0,Earnings Ahead  07-08-2011,2011-07-08 17:26:00-04:00,SNY,neutral
1163821.0,Market Reacts to Unemployment  07-08-2011,2011-07-08 13:27:00-04:00,SNY,negative
1163822.0,Catalysts Abound For Regeneron Pharmaceuticals ,2011-07-07 14:57:00-04:00,SNY,neutral
1163823.0,Sanofi Enters Into Research Collaboration With Audion Therapeutics to Develop Potential Treatments for Hearing Loss ,2011-06-16 08:08:00-04:00,SNY,negative
1163824.0,Calls Purchased on Sanofi-Aventis,2011-06-15 10:23:00-04:00,SNY,neutral
1163825.0,Options Brief: Sanofi-Aventis,2011-06-10 10:53:00-04:00,SNY,neutral
1163826.0,New pipeline boosts Sanofi-Aventis (SNY),2011-05-26 20:00:00-04:00,SNY,positive
1163827.0,New pipeline boosts Sanofi-Aventis (SNY),2011-05-26 20:00:00-04:00,SNY,positive
1163828.0,Top Healthcare and Major Drugs stocks to watch- Sector Performance,2011-05-22 14:55:00-04:00,SNY,positive
1163829.0,10 Stocks Billionaire Steven Cohen Is Buying,2011-05-17 14:00:00-04:00,SNY,neutral
1163830.0,"FTC Staff Finds Sanofi, Watson Failed To Report Patent Pacts -Bloomberg (SNY, WPI) ",2011-05-10 09:10:00-04:00,SNY,negative
1163831.0,FDA Licenses Sanofi Pasteur's New Influenza Vaccine Delivered by Intradermal Microinjection (SNY),2011-05-10 08:09:00-04:00,SNY,neutral
1163832.0,"Benzinga's Top Upgrades (SNY, FSLR, VCLK, BLK)",2011-05-04 08:08:00-04:00,SNY,positive
1163833.0,"CEOWORLD Top 5 Analyst Calls of the Week- DNDN, INSP, MCP, SIRI, VICL",2011-05-02 03:32:00-04:00,SNY,positive
1163834.0,Sanofi-aventis and Regeneron Report Positive Phase III Results With ZALTRAP in Second-line Metastatic Colorectal Cancer  ,2011-04-26 16:14:00-04:00,SNY,negative
1163835.0,"Sanofi-aventis and Regeneron Report Positive Phase III Results With ZALTRAP™ (SNY, REGN)",2011-04-26 16:09:00-04:00,SNY,positive
1163836.0,Sanofi Pasteur Announces FDA Approval of Menactra Meningococcal Conjugate Vaccine Indication for Infants (SNY),2011-04-25 08:03:00-04:00,SNY,positive
1163837.0,Merck and Sanofi Pasteur Initiate Phase III Study in the United States of Pediatric Combination Vaccine to Help Prevent Six Infectious Diseases   ,2011-04-21 08:05:00-04:00,SNY,positive
1163838.0,  Five-year Alemtuzumab Phase 2 Data Shows Large Percentage of MS Patients Remain Free of Clinically-Active Disease (SNY),2011-04-14 12:03:00-04:00,SNY,positive
1163839.0,Sanofi-Aventis Seeks Buyer For Its U.S. Dermatology Business - Bloomberg (SNY),2011-04-13 16:08:00-04:00,SNY,neutral
1163840.0,U.S. Says Stolen Drugs Were Manufactured By Sanofi-aventis (SNY),2011-04-07 16:40:00-04:00,SNY,negative
1163841.0,Sanofi-aventis Subsidiary Genzyme Presents New Data from Alemtuzumab Phase 2 MS Trial at 63rd Annual Meeting of the American Academy Of Neurology   ,2011-04-07 09:07:00-04:00,SNY,neutral
1163842.0,"FDA Warns Doctors Of Deadly Side Effects With Benzocaine Sprays (PBH, CMN, SNY, ULU)",2011-04-07 09:06:00-04:00,SNY,negative
1163843.0,"Sanofi Gets Control On Genzyme, CVR's Starting To Trade (SNY, GENZ)",2011-04-04 08:16:00-04:00,SNY,neutral
1163844.0,Crude on the Move,2011-03-31 16:21:00-04:00,SNY,negative
1163845.0,"BlackRock To Replace Genzyme In The S&P 500 Index (BLK, GENZ)",2011-03-30 07:29:00-04:00,SNY,neutral
1163846.0,Sanofi-aventis Announces Statement Related to Genzyme Acquisition: Effective for $74.00 per Share,2011-03-29 11:00:00-04:00,SNY,positive
1163847.0,Sanofi-aventis Announces  Research Collaboration With Columbia University,2011-03-24 08:06:00-04:00,SNY,neutral
1163848.0,"Zings Of The Day (SNY, MRK, AAPL, AMZN)",2011-03-22 15:57:00-04:00,SNY,neutral
1163849.0,ETF Showdown: A Biotech Battle,2011-02-18 16:05:00-05:00,SNY,negative
1163850.0,"US Stock Market Daily Report (February 17, 2011, Thursday)  ",2011-02-17 15:42:00-05:00,SNY,neutral
1163851.0,FOMC Minutes Optimistic  02-16-2011,2011-02-16 18:43:00-05:00,SNY,positive
1163852.0,Data Points to Inflation  02-16-2011,2011-02-16 18:42:00-05:00,SNY,neutral
1163853.0,"Benzinga's Volume Movers (GENZ, ELOS, KNXA, DELL)",2011-02-16 10:32:00-05:00,SNY,neutral
1163854.0,"NASDAQ Stocks Hitting 52-Week Highs (LINTA, GENZ, CMCSA, ASMI)",2011-02-16 10:22:00-05:00,SNY,neutral
1163855.0,"Citi Discusses Sanofi, Genzyme Deal (SNY, GENZ)",2011-02-16 08:47:00-05:00,SNY,neutral
1163856.0,A Peek Into The Market Before The Trading Starts,2011-02-16 07:55:00-05:00,SNY,neutral
1163857.0,Sanofi-aventis to Acquire Genzyme for $74 per Share Totaling $20.1B,2011-02-16 07:25:00-05:00,SNY,positive
1163858.0,"US Stock Futures Up Ahead Of Producer Price Data, FOMC Minutes; Dell Reports Upbeat Earnings",2011-02-16 06:30:00-05:00,SNY,neutral
1163859.0,"Stocks To Watch For February 16 (GENZ, SNY, ADI, NVDA, DELL, FDO)",2011-02-16 02:54:00-05:00,SNY,neutral
1163860.0,"Sanofi, Genzyme Deal As Soon As Tomorrow (SNY, GENZ)",2011-02-15 13:20:00-05:00,SNY,neutral
1163861.0,Sanofi-aventis and Sunnybrook Health Sciences Centre to Develop Treatment for Diabetic Foot Ulcers,2011-02-15 08:09:00-05:00,SNY,neutral
1163862.0,Sanofi-Aventis Reports Q4 EPS of 1.41 EUR,2011-02-09 07:36:00-05:00,SNY,neutral
1163863.0,"US Stock Futures Signal Lower Start On Wall Street, Earnings In Focus",2011-02-09 06:34:00-05:00,SNY,negative
1163864.0,"Benzinga's Top Pre-Market NASDAQ Gainers (OREX, PGNX, GOLD, GENZ)",2011-02-07 08:18:00-05:00,SNY,positive
1163865.0,"Sanofi, Genzyme Closer To $74-A-Share Deal",2011-02-05 22:03:00-05:00,SNY,neutral
1163866.0,Hospira Misses; 2011 View Weak - Analyst Blog,2011-02-02 13:31:00-05:00,SNY,negative
1163867.0,Hospira Misses; 2011 View Weak - Analyst Blog,2011-02-02 13:15:00-05:00,SNY,negative
1163868.0,Biogen Beats by a Wide Margin - Analyst Blog,2011-02-01 14:24:00-05:00,SNY,neutral
1163869.0,Biogen Beats by a Wide Margin - Analyst Blog,2011-02-01 14:00:00-05:00,SNY,neutral
1163870.0,"Sanofi, Genzyme May Reach Deal in One Week (SNY, GENZ)",2011-02-01 08:54:00-05:00,SNY,neutral
1163871.0,"Company News for January 31, 2011 - Corporate Summary",2011-01-31 09:13:00-05:00,SNY,neutral
1163872.0,"Company News for January 31, 2011 - Corporate Summary",2011-01-31 09:09:00-05:00,SNY,neutral
1163873.0,Genzyme to Allow Sanofi-Aventis to Conduct Due Diligence   ,2011-01-31 08:37:00-05:00,SNY,positive
1163874.0,Sanofi-aventis Reports Top-line Results from Phase III Study with Iniparib,2011-01-27 16:41:00-05:00,SNY,neutral
1163875.0,BMY Misses by a Penny in Q4 - Analyst Blog,2011-01-27 13:31:00-05:00,SNY,negative
1163876.0,BMY Misses by a Penny in Q4 - Analyst Blog,2011-01-27 13:00:00-05:00,SNY,negative
1163877.0,Covance in Tune with Zacks Est. - Analyst Blog,2011-01-27 10:01:00-05:00,SNY,neutral
1163878.0,Covance in Tune with Zacks Est. - Analyst Blog,2011-01-27 09:30:00-05:00,SNY,neutral
1163879.0,China's Ministry of Commerce Grants Clearance for BMP Sunstone and Sanofi-aventis Subsidiary Merger,2011-01-27 09:03:00-05:00,SNY,positive
1163880.0,FDA Approves Sanofi-aventis Allegra for Over-The-Counter Use,2011-01-25 13:25:00-05:00,SNY,positive
1163881.0,Bristol-Myers Squibb and sanofi-aventis Announce FDA Decision to Grant Pediatric Exclusivity For PLAVIX,2011-01-25 12:00:00-05:00,SNY,positive
1163882.0,AstraZeneca Responds to FDA Letter - Analyst Blog,2011-01-24 16:01:00-05:00,SNY,neutral
1163883.0,AstraZeneca Responds to FDA Letter - Analyst Blog,2011-01-24 15:40:00-05:00,SNY,neutral
1163884.0,Sanofi Extends Genzyme Bid Again as Talks Continue ,2011-01-24 15:11:00-05:00,SNY,positive
1163885.0,GENZ to Expand Production Capacity - Analyst Blog,2011-01-21 18:31:00-05:00,SNY,positive
1163886.0,GENZ to Expand Production Capacity - Analyst Blog,2011-01-21 18:00:00-05:00,SNY,positive
1163887.0,Genzyme Cuts 2011 Outlook - Analyst Blog,2011-01-14 11:01:00-05:00,SNY,negative
1163888.0,Genzyme Cuts 2011 Outlook - Analyst Blog,2011-01-14 10:30:00-05:00,SNY,negative
1163889.0,Top 10 Warren Buffett Dividend Stocks,2011-01-14 07:30:00-05:00,SNY,positive
1163890.0,"Isis CEO Expects Sanofi To Buy Genzyme (SNY, GENZ)",2011-01-12 09:33:00-05:00,SNY,neutral
1163891.0,Sanofi-aventis Enters Into Two Research & Development Collaborations,2011-01-12 09:02:00-05:00,SNY,neutral
1163892.0,Jefferies Downgrades Sanofi-Aventis to Hold (SNY),2011-01-11 08:57:00-05:00,SNY,neutral
1163893.0,Jefferies Downgrades SNY To Hold,2011-01-11 06:01:00-05:00,SNY,neutral
1163894.0,'Fast Money' Recap: Merger Buzz,2011-01-10 20:15:00-05:00,SNY,neutral
1163895.0,"Genzyme Rises On Deal Talk (GENZ, SNY)",2011-01-10 13:27:00-05:00,SNY,neutral
1163896.0,"Benzinga's Top Pre-Market NASDAQ Gainers (CNXT, GENZ, XING, LXRX)",2011-01-10 08:21:00-05:00,SNY,positive
1163897.0,"Genzyme, Verizon: After-Hours Trading",2011-01-07 18:57:00-05:00,SNY,neutral
1163898.0,High Yield French Stocks,2011-01-07 14:09:00-05:00,SNY,neutral
1163899.0,Data on Sanofi Cancer Candidate - Analyst Blog,2011-01-07 11:33:00-05:00,SNY,negative
1163900.0,Data on Sanofi Cancer Candidate - Analyst Blog,2011-01-07 11:00:00-05:00,SNY,negative
1163901.0,"How Close Is A Sanofi, Genzyme Deal? (GENZ, SNY)",2011-01-07 10:20:00-05:00,SNY,neutral
1163902.0,Positive Phase II Results with Iniparib (BSI-201),2011-01-05 17:01:00-05:00,SNY,positive
1163903.0,"Stock Market News for Dec 30, 2010 - Market News",2010-12-30 09:36:00-05:00,SNY,neutral
1163904.0,"Stock Market News for Dec 30, 2010 - Market News",2010-12-30 09:07:00-05:00,SNY,neutral
1163905.0,Novo Presents Positive Insulin Data - Analyst Blog,2010-12-29 14:33:00-05:00,SNY,positive
1163906.0,Novo Presents Positive Insulin Data - Analyst Blog,2010-12-29 14:00:00-05:00,SNY,positive
1163907.0,Jolt for Regeneron's Pipeline - Analyst Blog,2010-12-28 09:03:00-05:00,SNY,neutral
1163908.0,Jolt for Regeneron's Pipeline - Analyst Blog,2010-12-28 08:45:00-05:00,SNY,neutral
1163909.0,What's Hot on TheStreet,2010-12-22 11:44:00-05:00,SNY,neutral
1163910.0,Another Setback for AstraZeneca  - Analyst Blog,2010-12-22 09:03:00-05:00,SNY,neutral
1163911.0,Another Setback for AstraZeneca  - Analyst Blog,2010-12-22 08:15:00-05:00,SNY,neutral
1163912.0,2011 Big-Cap Biotech Preview,2010-12-22 07:00:00-05:00,SNY,neutral
1163913.0,"Genzyme Climbs On Deal Talk (GENZ, SNY)",2010-12-21 13:46:00-05:00,SNY,neutral
1163914.0,Big Pharma in Frenzy of Drug Deals,2010-12-21 11:34:00-05:00,SNY,negative
1163915.0,Sanofi Expands Oncology Pipeline - Analyst Blog,2010-12-20 14:00:00-05:00,SNY,positive
1163916.0,Sanofi Expands Oncology Pipeline - Analyst Blog,2010-12-20 13:36:00-05:00,SNY,positive
1163917.0,Regulatory Setback for AstraZeneca - Analyst Blog,2010-12-17 19:03:00-05:00,SNY,neutral
1163918.0,Regulatory Setback for AstraZeneca - Analyst Blog,2010-12-17 18:21:00-05:00,SNY,neutral
1163919.0,Sanofi-aventis and Oxford University Collaborate to Conduct Oncology Research,2010-12-17 10:03:00-05:00,SNY,neutral
1163920.0,INTELligent Investing.... in INTC,2010-12-15 19:17:00-05:00,SNY,positive
1163921.0,Neutral on Optimer Pharma - Analyst Blog,2010-12-15 18:33:00-05:00,SNY,neutral
1163922.0,Neutral on Optimer Pharma - Analyst Blog,2010-12-15 17:49:00-05:00,SNY,neutral
1163923.0,Loss at BIOD Narrower than Expected - Analyst Blog,2010-12-13 13:33:00-05:00,SNY,negative
1163924.0,Loss at BIOD Narrower than Expected - Analyst Blog,2010-12-13 12:58:00-05:00,SNY,negative
1163925.0,"Genzyme Board: ""Sanofi Offer Substantially Undervalues Genzyme""",2010-12-13 10:16:00-05:00,SNY,neutral
1163926.0,Sanofi-Aventis Extends Offer For Genzyme,2010-12-13 09:36:00-05:00,SNY,positive
1163927.0,"US Stock Futures Up On Gain In Overseas Markets, GE In Focus",2010-12-13 06:57:00-05:00,SNY,positive
1163928.0,Sanofi Extends Offer for Genzyme,2010-12-13 04:03:00-05:00,SNY,positive
1163929.0,Sanofi-Aventis S.A. - ADR (SNY) - Bull of the Day,2010-12-13 02:03:00-05:00,SNY,neutral
1163930.0,Sanofi-Aventis S.A. - ADR (SNY) - Bull of the Day,2010-12-13 00:00:00-05:00,SNY,neutral
1163931.0,Stocks Both Cheap and Improving - Analyst Blog,2010-12-06 15:36:00-05:00,SNY,positive
1163932.0,Stocks Both Cheap and Improving - Analyst Blog,2010-12-06 15:22:00-05:00,SNY,positive
1163933.0,Merck Strikes Deal with SmartCells  - Analyst Blog,2010-12-03 11:16:00-05:00,SNY,negative
1163934.0,Merck Strikes Deal with SmartCells  - Analyst Blog,2010-12-03 10:11:00-05:00,SNY,negative
1163935.0,Enrollment for Medivation Study - Analyst Blog,2010-12-03 03:06:00-05:00,SNY,neutral
1163936.0,Enrollment for Medivation Study - Analyst Blog,2010-12-02 12:52:00-05:00,SNY,neutral
1163937.0,Good News for Spectrum Pharma - Analyst Blog,2010-11-30 18:30:00-05:00,SNY,positive
1163938.0,AMAG Avoids Black Box Warning - Analyst Blog,2010-11-30 13:30:00-05:00,SNY,negative
1163939.0,Good News for Spectrum Pharma - Analyst Blog,2010-11-30 12:41:00-05:00,SNY,positive
1163940.0,AMAG Avoids Black Box Warning - Analyst Blog,2010-11-30 08:14:00-05:00,SNY,negative
1163941.0,Neutral on Regeneron - Analyst Blog,2010-11-29 15:00:00-05:00,SNY,neutral
1163942.0,Perrigo and Synthon Announce FDA Final Approval of Generic Xyzal,2010-11-29 09:43:00-05:00,SNY,positive
1163943.0,Neutral on Regeneron - Analyst Blog,2010-11-29 09:37:00-05:00,SNY,neutral
1163944.0,GENZ Meets Consent Decree Deadline - Analyst Blog,2010-11-26 14:00:00-05:00,SNY,positive
1163945.0,GENZ Meets Consent Decree Deadline - Analyst Blog,2010-11-26 08:27:00-05:00,SNY,positive
1163946.0,Genzyme Mulls New Sanofi Deal Structure,2010-11-22 03:36:00-05:00,SNY,neutral
1163947.0,GENZ in Deal for Sale of Diag Biz  - Analyst Blog,2010-11-19 13:00:00-05:00,SNY,neutral
1163948.0,"Unconfirmed Rumors continue to swirl that Questcor Pharmaceuticals, Inc. (QCOR) will be acquired by a Major Pharma at $24.00 a share ",2010-11-19 10:01:00-05:00,SNY,positive
1163949.0,GENZ in Deal for Sale of Diag Biz  - Analyst Blog,2010-11-19 07:30:00-05:00,SNY,neutral
1163950.0,Exclusive Interview with Ken Fisher Part 5 - Where the Market is Going after the Election,2010-11-13 14:28:00-05:00,SNY,positive
1163951.0,Exclusive Interview with Ken Fisher Part 4 - Behavior Finance,2010-11-11 20:35:00-05:00,SNY,positive
1163952.0,"Zacks Industry Outlook Highlights: Bayer, Sanofi-Aventis, Alcon, Gilead Sciences and Biogen Idec   - Press Releases",2010-11-10 10:33:00-05:00,SNY,neutral
1163953.0,Pharma & Biotech Industry Outlook - Nov. 2010 - Zacks Analyst Interviews,2010-11-09 17:03:00-05:00,SNY,neutral
1163954.0,Pharma & Biotech Industry Outlook - Nov. 2010 - Industry Outlook,2010-11-09 17:03:00-05:00,SNY,neutral
1163955.0,Pharma and Biotech Industry Outlook - Nov. 2010 - Industry Outlook,2010-11-09 17:03:00-05:00,SNY,neutral
1163956.0,Sanofi-aventis Seeks Clarification on Genzyme's Potential Board Actions,2010-11-08 10:44:00-05:00,SNY,neutral
1163957.0,"Exclusive Interview with Ken Fisher Part 3 - Con Artists, Madoff, Rats",2010-11-06 15:36:00-04:00,SNY,positive
1163958.0,Formula for a Bull Market  11-05-2010,2010-11-05 18:41:00-04:00,SNY,neutral
1163959.0,Genzyme Higher On Deal Rumors (GENZ),2010-11-05 13:55:00-04:00,SNY,neutral
1163960.0,Puts Purchased on Sanofi-Aventis (SNY),2010-11-05 13:28:00-04:00,SNY,neutral
1163961.0,SNY Announces Acquisition Of BJGP,2010-10-29 09:19:00-04:00,SNY,neutral
1163962.0,BMP Set To Resume Up Significantly (BJGP),2010-10-28 12:15:00-04:00,SNY,neutral
1163963.0,Sanofi-aventis to Acquire BMP Sunstone for $10 per Share,2010-10-28 11:46:00-04:00,SNY,positive
1163964.0,Sanofi-Aventis Nine Month EPS 3.85 EUR,2010-10-28 08:21:00-04:00,SNY,neutral
1163965.0,"US Stock Futures Point Higher Start On Wall Street, Earnings In Focus",2010-10-28 07:00:00-04:00,SNY,neutral
1163966.0,Buffett's Underperformers: A Good Bet On A Blue-Chip Rebound?,2010-10-25 13:39:00-04:00,SNY,positive
1163967.0,Buffett's Blue-Chip Bargains,2010-10-25 11:07:00-04:00,SNY,neutral
1163968.0,Sanofi Pasteur to Conduct Phase III Trials of Quadrivalent Influenza Virus Vaccine,2010-10-25 08:46:00-04:00,SNY,neutral
1163969.0,Genzyme CEO Says Company Worth $89 (GENZY),2010-10-22 11:50:00-04:00,SNY,positive
1163970.0,Genzyme Provides Details on Financial Recovery and Other Factors Driving Company's Value ,2010-10-22 11:47:00-04:00,SNY,positive
1163971.0,Encouraging Data on Sanofi MS Drug  - Analyst Blog,2010-10-18 15:00:00-04:00,SNY,positive
1163972.0,Sanofi Pasteur Wins Workplace Health Award,2010-10-18 08:08:00-04:00,SNY,positive
1163973.0,Sanofi Pasteur Awarded a $56.94M Contract,2010-10-08 15:02:00-04:00,SNY,positive
1163974.0,Another Job Cut Announced ,2010-10-08 11:32:00-04:00,SNY,negative
1163975.0,"Stocks To Watch For October 8 (MU, GENZ, AA)",2010-10-08 05:15:00-04:00,SNY,neutral
1163976.0,Brian Stutland's Sanofi-Aventis SA (SNY) Trade,2010-10-07 19:54:00-04:00,SNY,neutral
1163977.0,Genzyme Board Rejects Sanofi Bid (GENZ),2010-10-07 16:51:00-04:00,SNY,negative
1163978.0,Sanofi Aventis Makes Hostile Offer But Willing To Negotiate,2010-10-05 07:27:00-04:00,SNY,negative
1163979.0,Genzyme Board Urges Shareholders to Take No Action On Sanofi-Aventis' Proposal,2010-10-04 10:56:00-04:00,SNY,negative
1163980.0,"News Summary (MIM, AER, SNY, GENZ)",2010-10-04 09:57:00-04:00,SNY,neutral
1163981.0,"SNY Goes Hostile, Launches $18.5 Billion GENZ Bid",2010-10-04 09:40:00-04:00,SNY,negative
1163982.0,US Stock Futures Signal Low Start To Week,2010-10-04 07:10:00-04:00,SNY,negative
1163983.0,Sanofi-Aventis Takes Genzyme Bid Hostile ,2010-10-04 03:04:00-04:00,SNY,negative
1163984.0,Citi Reiterates Buy On  Sanofi-Aventis (SNY),2010-10-01 08:22:00-04:00,SNY,neutral
1163985.0,Sanofi-Aventis Mulling Higher Genzyme Offer,2010-09-29 05:40:00-04:00,SNY,neutral
1163986.0,Pieris Signs Broad Collaboration With Sanofi-Aventis ,2010-09-28 07:41:00-04:00,SNY,neutral
1163987.0,Positive EU Opinion for AZN Drug - Analyst Blog,2010-09-28 00:03:00-04:00,SNY,positive
1163988.0,Sanofi Pasteur to Acquire VaxDesign for $60M,2010-09-27 12:14:00-04:00,SNY,neutral
1163989.0,Sanofi-Aventis Keeps Genzyme Offer At $69 Per Share,2010-09-27 05:13:00-04:00,SNY,positive
1163990.0,BMY's Diabetes Candidate Encourages - Analyst Blog,2010-09-21 14:33:00-04:00,SNY,positive
1163991.0,Genzyme Rejects Sanofi's Offer Twice,2010-09-21 09:55:00-04:00,SNY,negative
1163992.0,"Zacks Analyst Blog Highlights: Johnson & Johnson, Crucell NV, GlaxoSmithKline, Merck and Sanofi-Aventis    - Press Releases",2010-09-21 07:34:00-04:00,SNY,neutral
1163993.0,J&J Makes a Pitch for Crucell - Analyst Blog,2010-09-18 11:06:00-04:00,SNY,neutral
1163994.0,How to Profit off the Yen,2010-09-15 14:03:00-04:00,SNY,positive
1163995.0,How to Profit off the Yen,2010-09-15 14:03:00-04:00,SNY,positive
1163996.0,FDA Accepts Sanofi Pasteur File Submission for Novel Influenza Vaccine,2010-09-13 13:35:00-04:00,SNY,positive
1163997.0,BMY to Acquire ZymoGenetics - Analyst Blog,2010-09-09 07:21:00-04:00,SNY,neutral
1163998.0,"MKM Partners Expects More On The M&A Front (HTZ, CAR, DTG, ARG, APD",2010-09-07 10:58:00-04:00,SNY,neutral
1163999.0,The Essential Biotech Sector Fall Preview,2010-09-07 08:02:00-04:00,SNY,neutral
1164000.0,"GLOBAL MARKET BRIEF SEPT 7th Mid-Day GMT: Stocks, Commodities, Forex -EU Crisis Back Again",2010-09-07 06:07:00-04:00,SNY,negative
1164001.0,"GLOBAL MARKET BRIEF SEPT 6th Mid-Day GMT: Stocks, Commodities, Forex -Rally Continues",2010-09-06 04:58:00-04:00,SNY,neutral
1164002.0,"Could Pfizer Be Interested In Genzyme? (PFE, GENZ, BMRN, SNY)",2010-09-03 12:52:00-04:00,SNY,positive
1164003.0,Genzyme Options Pricing In More Upside (GENZ),2010-09-01 16:44:00-04:00,SNY,neutral
1164004.0,Merger Twist - S&P Upgrades  Sanofi Aventis (SNY) to Buy,2010-09-01 13:25:00-04:00,SNY,neutral
1164005.0,Genzyme Rejects Sanofi Offer - Analyst Blog,2010-08-31 06:21:00-04:00,SNY,negative
1164006.0,"Genzyme Rejects $18.5 Billion Offer, Shares Gain (GENZ, SNY)",2010-08-30 14:33:00-04:00,SNY,positive
1164007.0,"Benzinga’s Volume Movers (COGT, GENZ, FOSL, LOGM)",2010-08-30 13:23:00-04:00,SNY,neutral
1164008.0,"News Summary (HPQ, PAR, ORCL, AAPL, IBM, INTC, IFNNY, GENZ, SNY, BAC, C)",2010-08-30 10:50:00-04:00,SNY,neutral
1164009.0,Genzyme Rejects Sanofi Bid; Shares Rise,2010-08-30 09:23:00-04:00,SNY,negative
1164010.0,US Stock Futures Down On Uncertainty Surrounding Economy,2010-08-30 09:21:00-04:00,SNY,negative
1164011.0,Oppenheimer Reiterates Perform Rating on Genzyme (GENZ),2010-08-30 09:19:00-04:00,SNY,neutral
1164012.0,SNY Seeks to Expand Vaccine Label - Analyst Blog,2010-08-30 08:34:00-04:00,SNY,positive
1164013.0,"Benzinga’s Top Pre-Market NASDAQ Gainers (COGT, GENZ, IMGN, COCO)",2010-08-30 08:22:00-04:00,SNY,positive
1164014.0,"Stocks To Watch For August 30 (DCI, SNY, GENZ, WINN, PAR, HPQ, DELL)",2010-08-30 06:19:00-04:00,SNY,neutral
1164015.0,Sanofi Takes Bid For Genzyme Public,2010-08-30 01:46:00-04:00,SNY,neutral
1164016.0,Somaxon Strikes Deal with P&G - Analyst Blog,2010-08-26 15:09:00-04:00,SNY,negative
1164017.0,"Benzinga’s Volume Movers (OSIS, GENZ, VECO, ISRG)",2010-08-25 13:50:00-04:00,SNY,neutral
1164018.0,"Value Stocks! (VOD, ESV, SNY, SVU)",2010-08-23 13:48:00-04:00,SNY,positive
1164019.0,Biogen Strikes Licensing Deal  - Analyst Blog,2010-08-19 14:34:00-04:00,SNY,negative
1164020.0,Rodman & Renshaw Could Benefit From Increased M&A (RODM),2010-08-18 13:54:00-04:00,SNY,positive
1164021.0,"Berkshire Hathaway & Buffett’s Latest Stock Holdings ‘S to Z’ (BRK-B, BRK-A, SNY, TIF, TMK, USB, USG, UPS, WMT, WPO, WFC, WSC)  ",2010-08-17 07:40:00-04:00,SNY,neutral
1164022.0,Isis Loss Widens  - Analyst Blog,2010-08-16 15:46:00-04:00,SNY,negative
1164023.0,How to Get a Dividend from Warren Buffett's Berkshire Hathaway,2010-08-11 01:34:00-04:00,SNY,neutral
1164024.0,Market Pulls Back on China News  08-10-2010,2010-08-10 14:40:00-04:00,SNY,neutral
1164025.0,ALNY's 2Q Loss Down on Lower Costs - Analyst Blog,2010-08-05 14:44:00-04:00,SNY,negative
1164026.0,"Stock Market News for August 4, 2010 - Market News",2010-08-04 10:01:00-04:00,SNY,neutral
1164027.0,Sanofi-Aventis May Need To Up Bid For Genzyme,2010-07-31 19:46:00-04:00,SNY,neutral
1164028.0,Sanofi-Aventis May Need To Up Bid For Genzyme,2010-07-31 19:46:00-04:00,SNY,neutral
1164029.0,REGN's Loss Narrower than Expected - Analyst Blog,2010-07-30 17:10:00-04:00,SNY,negative
1164030.0,Options Bet Genzyme Doesn’t See a Higher Bid (GENZ),2010-07-29 15:29:00-04:00,SNY,neutral
1164031.0,"Stock Market News for July 29, 2010 - Market News",2010-07-29 10:12:00-04:00,SNY,neutral
1164032.0,Genzyme Pops In Late Trading After Wall Street Journal Report (GENZ) ,2010-07-28 17:06:00-04:00,SNY,neutral
1164033.0,Genzyme Continues To Head Higher (GENZ),2010-07-28 15:40:00-04:00,SNY,neutral
1164034.0,Market Waffling  07-27-2010,2010-07-27 20:24:00-04:00,SNY,neutral
1164035.0,ISI Group Believes That Genzyme Corporation  (GENZ) Could Jump to $80 ,2010-07-27 19:43:00-04:00,SNY,neutral
1164036.0,A Peek Into The Market At The Start Of The Trading Day,2010-07-27 09:49:00-04:00,SNY,neutral
1164037.0,Sanofi-aventis and Merck Appoint CEO for Joint Venture,2010-07-27 09:15:00-04:00,SNY,neutral
1164038.0,"Market Roundup (GENZ, SNY, BP, C, BAC, MOT, AAPL, KO)",2010-07-26 15:27:00-04:00,SNY,neutral
1164039.0,"Benzinga’s Volume Movers (MNTA, ONXX, IDSA, GENZ)",2010-07-26 13:27:00-04:00,SNY,neutral
1164040.0,"Stock Market News for July 26, 2010 - Market News",2010-07-26 10:21:00-04:00,SNY,neutral
1164041.0,"Benzinga’s Top Pre-Market NASDAQ Gainers (ONXX, AONE, GENZ, MLNX)",2010-07-26 08:39:00-04:00,SNY,positive
1164042.0,"Benzinga’s Top Upgrades (RNST, SNY, WFR, T)",2010-07-26 06:52:00-04:00,SNY,positive
1164043.0,Sanofi-Aventis Warns On 2010 Profits,2010-07-26 03:56:00-04:00,SNY,positive
1164044.0,"Stock To Keep An Eye On For Monday (LO, CALM, BP, FLR, GENZ, SNY)",2010-07-25 19:13:00-04:00,SNY,positive
1164045.0,"Biotech Love Quarrel On Takeover Reports (BIIB, AGN)",2010-07-23 14:02:00-04:00,SNY,positive
1164046.0,"Genzyme Corp. Soars on Takeover Rumors (GENZ, SNY)",2010-07-23 13:58:00-04:00,SNY,neutral
1164047.0,Genzyme Shares Exploding After Takeover Reports  (GENZ),2010-07-23 13:55:00-04:00,SNY,positive
1164048.0,Options Activity Picking Up In Biogen Idec (BIIB),2010-07-21 12:48:00-04:00,SNY,neutral
1164049.0,"Stocks To Watch For July 6 (AGN, BIIB, GENZ, SNY, AAPL, PCS, MDR)",2010-07-06 07:24:00-04:00,SNY,neutral
1164050.0,"Market Closes Lower Ahead of July 4th Holiday (SPY, AA, VIX, BIIB, SNY, GENZ) ",2010-07-02 16:21:00-04:00,SNY,positive
1164051.0,"Benzinga’s Volume Movers (MEND, BIIB, GENZ, MIDD)",2010-07-02 14:22:00-04:00,SNY,neutral
1164052.0,"AGN, BIIB And GENZ Advance On Takeover Speculation",2010-07-02 12:50:00-04:00,SNY,neutral
1164053.0,"Calls Purchased on Biogen Idec (BIIB, SNY)",2010-07-02 12:35:00-04:00,SNY,neutral
1164054.0,Motorola (MOT) Sees Put Buying; Biotechs Active on Takeover Rumors,2010-07-02 11:50:00-04:00,SNY,positive
1164055.0,Biogen Idec And Genzyme Rising On Unusual Volume (BIIB) ,2010-07-02 11:16:00-04:00,SNY,neutral
1164056.0,"Calls Spread Purchased on Genzyme (GENZ, SNY)",2010-07-02 10:40:00-04:00,SNY,neutral
1164057.0,"Calls Sold on Allergan (AGN, SNY)",2010-07-02 10:35:00-04:00,SNY,neutral
1164058.0,"Company News for July 2, 2010 - Corporate Summary",2010-07-02 10:10:00-04:00,SNY,neutral
1164059.0,SNY Falls As It Seeks US Acquisition,2010-07-02 09:50:00-04:00,SNY,neutral
1164060.0,Pharmaceutical ETFs on the Rise ,2010-06-30 14:49:00-04:00,SNY,neutral
1164061.0,US Stock Futures Point To Higher Opening Today,2010-06-30 09:47:00-04:00,SNY,neutral
1164062.0,"Company News for June 28, 2010 - Corporate Summary",2010-06-28 10:20:00-04:00,SNY,neutral
1164063.0,Vive La France Stocks,2010-06-27 18:00:00-04:00,SNY,neutral
1164064.0,"US Stock Futures Down, Focus on G-20 meeting and Quadruple Witching",2010-06-18 09:22:00-04:00,SNY,neutral
1164065.0,"Late Market Roundup (SNY, FIATY.PK, T)",2010-06-07 14:14:00-04:00,SNY,neutral
1164066.0,"Afternoon Market Update (SNY, DRG, BTK, NTAP, TIF)",2010-05-27 11:49:00-04:00,SNY,neutral
1164067.0,"Buffett’s Biggest Upside Stocks, Summer 2010 (BRK-A, AXP, BAC, CMCSA, XOM, GCI, GE, IRM, MCO, SNY, WFC, WLP)",2010-05-26 07:36:00-04:00,SNY,neutral
1164068.0,"Abbott Laboratories To Buy Piramal (ABT, SNY, PFE, GSK)   ",2010-05-21 10:36:00-04:00,SNY,neutral
1164069.0,"France Telecom Falls Short Of Expectations, Banco Santander Excels In Net Interest Income And Sanofi-Aventis Net Income Jumps 10%",2010-04-29 07:05:00-04:00,SNY,positive
1164070.0,"France Telecom Falls Short Of Expectations, Banco Santander Excels In Net Interest Income And Sanofi-Aventis Net Income Jumps 10%",2010-04-29 07:05:00-04:00,SNY,positive
1164071.0,"Sanofi-Aventis Settles Law Suit (SNY, TEVA, NVS)",2010-04-07 14:39:00-04:00,SNY,neutral
1164072.0,"Benzinga’s News Roundup (BLK, NGA, FIG, SNY)",2010-04-01 07:53:00-04:00,SNY,neutral
1164073.0,Gary Motyl of Templeton is Bullish – Likes BP (BP) & Sanofi  (SNY)  ,2010-03-23 19:35:00-04:00,SNY,positive
1164074.0,William Blair Reiterates Outperform Rating Of PetMed Express (PETS),2010-03-15 09:06:00-04:00,SNY,neutral
1164075.0,"COO Andreotti Is New Bristol-Myers CEO (BMY, SNY)",2010-03-02 18:47:00-05:00,SNY,neutral
1164076.0,Warren Buffett's Top Yielding Stocks,2010-03-02 01:53:00-05:00,SNY,positive
1164077.0,Sanofi Sales Rise Due To Flu Sales: Profits Above Estimates (SNY),2010-02-10 08:37:00-05:00,SNY,positive
1164078.0,"AstraZeneca Upgraded, Sanofi-Aventis Downgraded",2010-01-21 06:52:00-05:00,SNY,neutral
1164079.0,"U.S Futures Slip Despite Optimism in the Economy (BAC, MS, WFC)",2010-01-20 09:28:00-05:00,SNY,negative
1164080.0,No Sunshine In The US Stock Markets,2010-01-20 08:48:00-05:00,SNY,positive
1164081.0,"Company News for December 24, 2009 - Corporate Summary",2009-12-24 08:44:00-05:00,SNY,neutral
1164082.0,"Stock Market News for December 22, 2009 - Market News",2009-12-22 09:18:00-05:00,SNY,neutral
1164083.0,Chattem Inc (CHTT) Downgraded To Neutral After Acquisition,2009-12-22 08:38:00-05:00,SNY,neutral
1164084.0,"Health Brings Wealth To The Street (PFE, MRK, AET, UNH, SNY, CHTT)",2009-12-21 14:23:00-05:00,SNY,positive
1164085.0,Holiday Gift To Chattem (CHTT) Holders From Sanofi (SNY),2009-12-21 13:44:00-05:00,SNY,positive
1164086.0,"Company News for December 21, 2009 - Corporate Summary",2009-12-21 09:17:00-05:00,SNY,neutral
1164087.0,"Benzinga’s Top Pre- Market Gainers (CHTT, BUCY, SGEN, INCY, MAIL, ATHX)",2009-12-21 08:25:00-05:00,SNY,positive
1164088.0,"Benzinga’s News Roundup (AIG, ATHX, NOK, INTC, SNY, WAG, CAG)",2009-12-21 08:06:00-05:00,SNY,negative
1164089.0,Sanofi-Aventis Buying Chattem For $93.50 A Share,2009-12-21 07:23:00-05:00,SNY,positive
1164090.0,"Cramer Talks About VIP, T, VZ, NVS, SNY, CIEN",2009-11-24 06:56:00-05:00,SNY,positive
1164091.0,"Jim Cramer Names His Best Picks for Cancer Cures (BMY, IMGN, PFE, DNDN, EXEL)",2009-11-09 17:47:00-05:00,SNY,negative
1164092.0,Sanofi-aventis (SNY) Completes Acquisition of Merial ,2009-09-18 03:38:00-04:00,SNY,neutral
1164093.0,"RothmanResearch.com Stock Review for AHR, DTV, RL, GVA, SNY and ATI",2009-08-18 06:46:00-04:00,SNY,neutral
